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The  emergence  of antibiotic-resistant bacteria has become a major threat to public 
health.  The  increased  use  of  antibiotics  has  selected  for  the  dissemination  of 
antibiotic  resistance  genes  between  organisms  from  different  species  and  different 
genera. There is a large body of evidence that the indigenous microbiota can act as a 
reservoir of antibiotic-resistant bacteria. However little is known about the molecular 
basis for this in bacteria from the oral cavity. Therefore the aim of this work was to 
determine  the  prevalence  of  antibiotic-resistant  bacteria  and  antibiotic  resistance 
genes in the cultivable oral microbiota.  Saliva and plaque samples were taken from 
each of 60 healthy adults who had not taken any antibiotics during the previous three 
months. Each sample was plated onto antibiotic-containing media to quantitate and 
identify antibiotic-resistant strains. All of the individuals harboured bacteria resistant 
to erythromycin, gentamicin, vancomycin and tetracycline.  Only 4 individuals (7%) 
did not have any cultivable bacteria resistant to amoxycillin. Oral bacteria resistant to 
gentamicin were the most commonly  isolated  (constituting  23%  of total  cultivable 
oral bacteria) followed by erythromycin (18% of the total viable count), vancomycin 
(16%  of the  total  viable  count),  tetracycline  (10%  of the  total  viable  count)  and 
amoxycillin  (4%  of the  total  viable  count).  Multiply-resistant  bacteria were  found 
with 55% of tetracycline-resistant isolates being resistant also to erythromycin and 
6% resistant also to both amoxycillin and erythromycin.  The most prevalent genes 
encoding tetracycline  and erythromycin resistance were  tet(M),  tet(W),  tet(O),  and 
mef and erm(B) respectively. In some cases, tet(M) and ermB were contained within 
a  Tn/545-like  conjugative  transposon  and  could  be  co-tranferred  to  Enterococcus 
faecalis.  Finally the nature of the genetic support for one of the tet(W) genes,  was 
determined and found to be flanked by two transposases belonging to two different 
families of insertion sequences (IS30 and IS256). This element was highly unstable 
in  E.  coli.  This  study  showed  that  antibiotic-resistant  bacteria  and  antibiotic 
resistance genes are present in the oral microbiota and that oral bacteria are likely to 
play  an  important  role  in  the  evolution  and  dissemination  of antibiotic  resistance 
genes.
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Introduction
1.1 The evolution of bacteria and infectious diseases
Bacteria existed long before the evolution of humans (208); they were, and still are, 
responsible  for  various  infectious  diseases  such  as  tuberculosis,  plague,  cholera; 
some of which were shown to be common in prehistoric humans (316). However the 
mechanism of pathogenicity of bacteria became apparent only with the discovery of 
this microworld,  and  it led to the  discovery  of antibiotics to treat these  infections. 
From then on a new fascinating world was revealed; bacteria were shown to inhabit 
different environments and be able to transfer information between one another so as 
to facilitate their adaptation and survival (240). However one of the consequences of 
this adaptation was the  emergence  of antibiotic-resistant bacteria,  which have now 
become a major threat to public health (122).
1.1.1 The relationship between humans and bacteria
1.1.1.1 History
The History of antimicrobial chemotherapy
•  2000  B.C. -  Here,  eat this root
•  1000 A.D. -  That root is heathen. Here, say this prayer.
•  1850 A.D. -  That prayer is superstition. Here, drink this potion.
•  1920 A.D. -  That potion is snake oil. Here, swallow this pill.
•  1945 A.D. -  That pill is ineffective. Here, take this penicillin.
•  1955 A.D. -  Oops....bugs mutated. Here,  take this tetracycline.
•  1960-1999 -  39 more "oops"...Here, take this more powerful antibiotic.
•  2000 A.D. -  The bugs have won! Here, eat this root.
—  Anonymous from the WHO report.
14Over time a pattern emerged between the evolution of bacteria and the evolution of 
civilisation.  In  the  early  days  humans  were  living  as  nomads  rather than  in  large 
groups,  which  limited  the  spread  of  disease.  No  domestic  animals  were  kept, 
curtailing  any  spread  of  diseases  by  reducing  the  contact  between  humans  and 
animals. But then humans started living in societies, in villages raising animals and 
crops for food. People and animals often shared the same dwelling, and as a result of 
this close proximity infectious diseases emerged (137). The appearance of epidemics 
is  a  good  indicator  of  the  ready  adaptation  of  bacteria  to  new  environments. 
Movement  of people  into  larger  settlements  or military  invasion  encouraged these 
epidemics,  affecting  only  local  people,  to  spread,  sometimes  into  pandemics 
affecting the whole population or a number of countries (Table 1.1).
15Table 1-1: Bacterial infections and humans
Period Infection Infectious
agent
History
430 BC- 
1542
The plague Yersinia pestis Spread across Egypt, Rome, Syria, 
China and Europe killing millions of 
people and sometimes marked a 
turning point in the history of a 
population.
1492 Tuberculosis and 
gonorrhoea
Mycobacterium 
tuberculosis 
and Neisseria 
gonorrhoeae
These already endemic european 
diseases spread to the Caribbean with 
Columbus leading to the infection of 
millions of local people who had no 
immunity to them.
Early 
trading 
period 
and the 16th 
century
Dysentery Enteric
pathogens
Caused devastating epidemics with 
African and European infections. It 
was then introduced by the Spanish 
into Central and South America.
As trade 
journeys 
lengthened
Chronic 
infections such 
as tuberculosis
Mycobacterium
tuberculosis
Introduced by European sailors to the 
Pacific Islands.
Present time Lyme disease,
chlamydia,
gonorrhoea,
tuberculosis,
food-borne
diseases
Borrelia
burgdorfer,
Chlamydia
trachomatis,
Even during the past few decades, 
there has been a resurgence of 
epidemics (38, 107, 227).
Adapted from Kiple KF (137).
161.1.1.2 Discovery of the microworld 
«
The first description of bacteria was made by van Leeuwenhoek who observed them 
through  a  microscope  at  the  end  of the  17th  century  (290).  Then  in  1857  Louis 
Pasteur noted that some microorganisms (defined as organisms that are so small that 
they  are  invisible  to  the  naked  eye)  could  be  responsible  for  fermentation  and 
putrefaction  leading  him  to  invent  pasteurization  in  1863,  a  process  by  which 
fermentation  and  thus  contamination  is  prevented  by  sterilising  a  medium 
(http://www.pasteur.fr/exteme.html).  Ten  years  later  Robert  Koch  discovered  the 
cause  of anthrax  in horses  by  isolating  anthrax  bacilli  and  showing their abiliy to 
cause  diseases  and  their  capacity  to  form  spores  (186).  He  deduced  that  specific 
organisms  could  produce  specific  diseases;  he  went  on  to  develop  techniques  to 
culture bacteria in the laboratory that resulted in a Nobel Prize in 1905 (186). At the 
end of the  19  century, Vuillemin noticed that fungi could destroy bacteria; this was 
further  investigated  by Alexander  Fleming,  who  reported  in  1929  the  antibacterial 
action of a fungus, Penicillium notatum (89).  However it was only in  1940 that the 
role of penicillin G was recognised and used to treat various bacterial infections (41). 
The  age  of  antibiotics  had  begun;  some  bacteria  were  found  to  be  resistant  to 
penicillin (1) and so the search for new antibiotics started and it continues to this day.
1.1.1.3 Increase in antibiotics and antibiotic-resistant bacteria
Anti-infective  agents  have  been  used  for  thousands  of  years  to  treat  infectious 
diseases;  sulfur  and  mercury  were  used  to  treat  scabies  and  syphilis  respectively 
(286).  However  the  search  for  satisfactory  antibacterial  therapy  was  unsuccessful
tVi
until  the  early  20  century  when  sulphonamides  were  discovered.  In  1927,  the 
German  scientist  Gerhard  Domagk  discovered  sulphonamides  (Table  1.2)  and 
received the Nobel  Prize  for his work  in  1939  (286).  He  used  sulphonamide,  then 
known as protonsil red, to relieve his daughter of a persistent streptococcal infection 
(75).  Further  studies  identified  the  sulphonamide  group  as  the  active  ingredient; 
sulfanilamide  derivatives  proved  effective  against  pneumonia,  meningitis,  blood 
poisoning and gonorrhoea (286). This was followed by the discovery of penicillin in
•  th the mid 20  century (1). This discovery triggered a health care revolution, and from
17this flowered an entire family of penicillin-based antibiotics (178). Selman Waksman 
isolated  the  first  aminoglycoside  antibiotic  in  1944  from  an  Actinomyces, 
Streptomyces  griseus  (63),  and  Benjamin  Duggar  discovered  the  first  tetracycline 
class of antibiotics  in  1949  by isolating chlortetracycline  and oxytetracycline  from 
Streptomyces  aureofaciens  and  Streptomyces  rimosus  respectively  (45).  Macrolide 
antibiotics  were  discovered  by  McGuire  and  colleagues  in  1952  in  Streptomyces 
erythreus (247). Among other important antibiotics discovered was the glycopeptide 
vancomycin in  1956, the product of Streptomyces orientalis (149). After a flurry of 
discoveries  between  1930  and  1970,  the  past  40  years  have  witnessed  fewer 
discoveries (325). Although antibiotic resistance has been a problem since the 1940s, 
new antibiotics have allowed physicians to keep ahead of resistant strains. However 
we  are  now  experiencing  a  reduced  availability  of  new  antibiotics  to  curtail 
infections caused by resistant organisms.
The  introduction  of a  new  antibiotic  was  often  followed  by  the  development  of 
resistance  in  bacteria  (Table  1.2).  The  first  penicillin-resistant  Escherichia  coli 
appeared  in  the  1940s  (1)  and  were  soon  followed  by  penicillin-resistant 
Staphylococcus  aureus,  and  in  1967  penicillin-resistant Streptococcus pneumoniae 
and Neisseria gonorrhoeae (Table  1.2). Streptomycin-resistant enterococci appeared 
in  1967  in  Japan  (63).  Erythromycin  was  used  in  1952  as  the  first  macrolide 
antibiotic and within a year erythromycin-resistance appeared in Staphylococcus spp. 
in the US, Europe and Japan (247). Prior to the mid-1950s, the majority of bacteria 
were  susceptible  to  tetracycline  (123),  the  first  tetracycline-resistant  bacterium, 
Shigella  dysenteriae,  was  isolated  in  1953,  followed  by  a  dramatic  increase  in 
tetracycline-resistance in pathogenic as well as commensal bacteria (45). This direct 
correlation  over  time  between  use  of antibiotics  and  the  increased  proportion  of 
resistant to non-resistant strains indicated that bacteria were evolving in response to 
the selective pressure due to increased use of antibiotics.
18Table 1.2: Emergence of resistance to newly-discovered antibiotics
Antibiotic Year
discovered
First resistant strain Reference
Sulphonamide 1927 1946, 
Streptococcus spp.
62
Penicillin 1929 
(but used 
commercially 
in 1940)
early 1940s,
E. coli, S. aureus, 
1967,
S. pneumoniae, N. 
gonorrhoeae
1
106
Aminoglycoside 1944 1967, 
Enterococcus spp.
63
Chloramphenicol 1947 1950, 
Salmonella typhi
55
Tetracycline 1949 1953, 
Shigella sp.
45
Macrolide 1952 1952-53, 
Staphylococcus spp.
247
Vancomycin 1956 1987,
Enterococcus spp.
...
149
191.1.2  Antibiotic-resistant bacteria: they are everywhere!
The wide use of antimicrobial agents in human medicine and agriculture (Table 1.3), 
has led to the emergence of infections caused by bacteria that have become resistant 
to  most  available  drugs  so  that  antibiotic-resistant  bacteria  have  become  a  major 
threat to public health (122).
Table 1.3: Use of antibiotics 
Where antibiotics are
used  Types of use  Questionable use
Human use (50%)a  20% Hospital  20-50% Unnecessaryb
80% Community
Agricultural use (50%)a  20% Therapeutic  40-80% Highly
80% Prophylactic/growth  questionable
promotion
Table taken from Wise et al. (328).
a 18 million kilograms of antibiotics are used in the US each year (309). 
b Prophylactic  use  of antibiotics before  surgery,  empiric  use  (without knowing the 
aetiological  agent),  paediatric  use  for  viral  infections  are  some  of the  factors  that 
have led to an overuse and misuse of antimicrobial agents in humans (121).
1.1.2.1  In the hospitals
Hospitals  offer a prime  opportunity  for the  development and transfer  of antibiotic 
resistance,  because  of heavy  exposure  to  antimicrobial  agents,  patients  prone  to 
infections and a high population density (296). Consequently they now have to face 
the emergence of nosocomial infections caused by multidrug-resistant Gram-positive 
and Gram-negative bacteria.
201.1.2.1.1  MRSA (methicillin-resistant Staphylococcus aureus)
MRS  A  is  a  major  cause  of hospital-acquired  infections  worldwide  (161).  These 
resistant  organisms  cause  bacteraemia,  pneumonia  and  surgical  wound  infections; 
they can develop resistance very readily both by mutation and by DNA transfer. The 
problem  started  with  the  appearance  of penicillin-resistant  Staphylococcus  aureus 
soon after the introduction of the antibiotics in the  1940s (Table  1.2); by the  1950s, 
half of the  strains were penicillin-resistant worldwide through the production of P- 
lactamases, and by the  1980s the figure went up to 90% (161). One response to this 
has been the development of new p-lactamase-resistant penicillins, such as oxacillin 
and methicillin.  Unfortunately methicillin-resistant Staphylococcus aureus emerged 
in the  1970s and increased in frequency as hospital pathogens during the  1980s and 
1990s in many countries (229). Resistance to methicillin is due to the production of 
altered  penicillin  binding  proteins  (PBPs)  with  low  affinity  for  all  p-lactam 
antibiotics (161). These altered PBPs are encoded by the mec gene, carried by large 
mobile  genetic  elements  inserted  into  the  host  DNA  and  termed  staphylococcal 
cassettes  chromosome  mec  (SCCmec),  these  cassettes  consist  of  the  mec  gene 
complex (the mec  A gene and its regulators) and the ccr gene complex which encodes 
site  specific  recombinases  responsible  for  the  mobility  of  SCC mec  (135).  Most 
MRSA  strains  are  resistant  to  most  other  antibiotics  leaving  the  glycopeptide 
antibiotics  as  the  last  choice  to  treat  such  infections  (295).  Recently,  treatment 
failures  caused  by  some  strains  with  decreased  susceptibility  to  vancomycin  were 
reported in Japan (117), USA (118) and UK (331). The mechanisms of resistance are 
thought to  be  due  to  elevated mutation  frequencies  allowing  the  strain to  develop 
resistance  by  stepwise  selection  in  the  presence  of  increasing  concentrations  of 
vancomycin (261). However, recently one vanA gene was identified in a strain from 
the US. This gene is plasmid-mediated and is thought to have been transferred from 
another nosocomial pathogen, a vancomycin- resistant enterococcus VRE (295).
1.1.2.1.2 VRE (vancomycin-resistant enterococci)
A similar problem with nosocomial infections has been the emergence of VRE (26). 
Enterococci are normal inhabitants of the gastrointestinal tract.  However they have
21become  a  major  nosocomial  pathogen  in  the  last  decade  (26).  Enterococci  are 
intrinsically  resistant  to  several  commonly  used  antibiotics  and  they  are  able  to 
acquire  resistance  to  all  currently  available  antibiotics  either  by  mutation  or  by 
transfer of mobile genetic elements (26, 239). The first VRE was reported in the UK 
and France in  1987 (149) and by  1993  14% of patients with enterococcus infections 
in intensive  care  units  had vancomycin-resistant  strains,  the prevalence  of VRE  in 
Europe has been increasing ever since (40, 332). The spread has been even greater in 
the  last  decade  in  US  hospitals  where the  figures  reached  25%  in  2000  (26).  The 
emergence of VRE is thought to have been caused by excessive antibiotic usage and 
also by cross-contamination in hospitals (27). VanA is the most common mediator of 
resistance to  vancomycin  in enterococci  in Europe  and America (26).  The  gene  is 
located  on  a transposon,  Tnl546,  in  a  cluster  of 4  other  van  genes  (vanR,  vanS, 
vanH,  vanX)  necessary  for  glycopeptide  resistance  (332).  This  cluster  of genes  is 
induced by the presence of the antimicrobial agent which leads to the production of 
modified target  sites  with  low affinity  for glycopeptide  antibiotics  (332).  Recently 
there  has  been  some  controversy  about  the  transmission  of VRE  from  animals  to 
humans (129, 306, 318) as will be discussed later (see chapter 1.1.2.3.1).
1.1.2.1.3  Nosocomial infections due to Gram-negative bacteria
The distribution of antimicrobial resistant pathogens causing nosocomial  infections 
varies with time and among hospitals. However, a common fact observed worldwide 
is  the  continuing  increase  in  the  prevalence  of  resistance  (Fig  1.1).  Multiple 
antibiotic resistance to useful classes of antibiotics has gradually increased among a 
number of Gram-negative hospital  pathogens  creating a wide  range  of nosocomial 
infections  including  bacteraemia,  pneumonia,  urinary  tract  and  surgical  wound 
infections  (109,  229).  The  increase  is  particularly  marked  for  third  generation 
cephalosporin-resistant  Enterobacteriacae,  imipenem-  and  ciprofloxacin-resistant 
Pseudomonas aeruginosa and Acinetobacter baumanii because it is worldwide and 
can compromise the treatment of infections caused by any of these organisms (Fig 
1.1).
22Figure 1.1: Increase in selected antimicrobial resistant pathogens associated with 
nosocomial infections in ICU patients in the US from 1995 to 2002
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These data were adapted from the results obtained in different studies in the US from 
1995 to 2002 (94, 95, 200, 201, 202).
ICU  =  Intensive  care  unit,  VRE  =  vancomycin  resistant  enterococci,  CNS  = 
coagulase  negative  staphylococci,  3rd  ceph  =  resistance  to  third  generation  of 
cephalosporins (cefriataxone, cefotaxime or ceftazidime),  quinolone = resistance to 
either ciprofloxacin  or ofloxacin.  Resistant rates  (%)  for each organism  from  ICU 
patients from 1995-2002.
23In  the  industrialised  world,  as  many  as  60%  of hospital-acquired  infections  are 
caused  by  VRE  and  MRSA.  These  organisms  have  now  started  spreading  to  the 
community  (325).  We  are  heading  towards  a  situation  in  which  infections  might 
become virtually untreatable.
1.1.2.2  In the community
As  in the  hospital,  community-acquired  infections  are becoming  a threat to public 
health because of an increase in multidrug-resistance (106). Although the community 
is  not  bombarded  with  high  levels  of  antibiotics  to  select  for  resistant  strains, 
community-acquired  infections  by  resistant  organisms  have  increased  in  recent 
decades  because  organisms  can  be  spread  from  hospitals,  or  farms,  and  also  can 
emerge within the community in response to the selective pressure of antimicrobial 
use or can be transmitted between communities (106).
1.1.2.2.1  Community acquired respiratory pathogens
One  of the  pathogens  that  has  a  large  impact  on  morbidity  and  mortality  in  the 
community  is  Streptococcus pneumoniae  (106).  This  organism  is  acquired  by  the 
respiratory route causing diseases such as pneumonia and meningitis. Penicillin is the 
antibiotic  of choice  for treatment;  however it  is  substituted  by erythromycin when 
patients  are  allergic  to  penicillin.  There  have  been  concerns  about  the  increased 
prevalence  of  penicillin-  and  erythromycin-resistant  S.  pneumoniae  as  well  as 
multidrug  resistant  strains.  The  prevalence  of  penicillin-resistant  S.  pneumoniae 
(PRP) is variable in different countries but high prevalence rates have been reported 
in Spain (84, 224), France (224) and United States, 33.5% (297). Many of these PRP 
are  also  resistant  to  other  antimicrobial  agents,  including  tetracycline, 
chloramphenicol  and  trimethoprim-sulfamethoxazole  (73,  297).  S.  pneumoniae 
became  resistant  to  penicillin  due  to  the  acquisition  of  mosaic  genes  (by 
transformation) that encode for altered PBPs (64, 232). An increased consumption of 
macrolides was paralleled by an increase in resistance to  erythromycin through the 
acquisition of methylase (erm(B)) or efflux (mej) genes (83, 98, 234). The prevalence
24and the mechanism of resistance to macrolides vary geographically and are likely to 
be due to differential antibiotic consumption (218).
The emergence of resistance in two other important respiratory pathogens, Group A 
streptococci  (S. pyogenes)  and Neisseria meningitidis has  also  been observed.  The 
drug  of choice  for both pathogens  is penicillin (106).  Whereas S. pyogenes is  still 
susceptible to this drug, high rate resistance to erythromycin has been reported; it is 
due to the acquisition of a methylase or efflux genes as in S. pneumoniae (83, 317). 
Strains  of N.  meningitidis  with  decreased  susceptibility  to  penicillin  have  been 
described worldwide. In Canada, the incidence reached  18% in  1995  (24), 43.6% in 
Spain (90); however in some other countries it is still very low with a prevalence of 
4.3% in the Netherlands (303). Both P-lactamases and modified PBPs were identified 
in  this  species  (219).  These  facts  underline  the  importance  of  monitoring  the 
susceptibility  of these  pathogens  to  different  antimicrobials  before  they  become 
resistant to most of the antibiotics available.
1.1.2.2.2  Bacterial gastroenteritis
As  for VRE,  resistance  mechanisms in Salmonella  spp.  and  Campylobacter jejuni, 
the most frequent cause of bacterial gastroenteritis, are thought to have been acquired 
in animals and then transmitted into humans  (305).  Fluoroquinolone  is used as the 
drug of choice in empirical treatment, and the use of this drug in the farming industry 
has contributed to the selection of resistant Campylobacter and salmonella (80, 299). 
Resistance  to  this  antibiotic  has  been  rising  since  the  late  1990s  due  to  a  point 
mutation which alters the binding site of the antimicrobial agent (166), the incidence 
has  now  reached  50%  for  Campylobacter  spp.  in  UK  (221).  Fluoroquinolone 
resistance  in  Salmonella  spp.  has  increased  only  in  the  recent  years  (170 
).  However the  situation is worrying  in salmonella with the  increase worldwide of 
strains resistant to  different classes of antibiotics  (104,  298,  335).  Erythromycin is 
the  first  line  antibiotic  used  to  treat  infections  caused  by  Campylobacter,  and 
resistance to  this  antibiotic  has been  observed  (47);  although the  incidence  is  still 
low, the increase in resistance narrows the choice of antibiotics for treatment.
25The extensive use of antimicrobial agents both in the hospital environment and in the 
community  has  led  to  the  emergence  of  antibiotic-resistant  bacterial  infections. 
Emergence of resistance limits the therapeutic options available to physicians in the 
treatment of infections caused by such pathogens.  Therefore,  careful monitoring of 
these pathogens and their susceptibilities as well as appropriate and prudent use of 
antibiotics is required to constrain and prevent the emergence of resistance.
1.1.2.3  In the agricultural environment
Antimicrobials are also used in food animals to treat or prevent diseases and also to 
promote  growth  (132).  The  most  commonly  used  antimicrobial  drugs  in  animals 
reared for food are from six major classes: aminoglycosides, p-lactams, tetracyclines, 
macrolides, sulphonamides and quinolones (132). In  1969, the Swann Committee of 
the United Kingdom gave a warning about the cross-resistance exerted by the same 
antibiotics used in animals and humans (287). Although it is difficult to establish a 
direct link between antibiotic resistance in humans and in animals, as noted above, 
some studies have shown that antibiotic use in agriculture can act as a driving force 
for the  development of antibiotic resistance  in certain pathogenic  bacterial  species 
(129, 130, 288, 305,318).
1.1.2.3.1  In animals
The acquisition of the same mechanism of resistance in animal and human bacteria is 
evidence  of  genetic  exchange  between  organisms  from  these  two  different 
environments although exchange via an intermediate organism can also take place. 
Enterococci  are  a dominant bacterial  group  in the  intestinal  microbiota of humans 
and  animals  and  VRE  have  emerged  as  an  important  human  pathogen  due  to 
selection pressure exerted by the use of vancomycin in hospitals (27).  However in 
Europe  a glycopeptide,  avoparcin,  has  been  used  as  a  growth promoter  in  animal 
feed, and its use was shown to create a reservoir of VRE in animals (13). Avoparcin 
resistance  is  mediated  by  the  vanA  gene  located  on  a  transposon,  Tnl546  (332). 
These genetic elements are indistinguishable from the ones found in human isolates
26(130). vanA was also isolated from sewage (320), meat products (316, 320), and from 
turkeys and farmers on farms where avoparcin was used as an antimicrobial growth 
promoter (281).
The fact that pulse-field gel electrophoresis (PFGE) of ciprofloxacin-resistant E.  coli 
from  poultry  and  poultry  farmers  and  broiler  and  broiler  farmers  had  identical 
patterns  is  evidence  that  identical  clones  were  present  in  humans  and  in  poultry 
(304).
Recently the  genomes  of MRSA  isolates  from  food  animals  compared  by random 
amplified polymorphic  DNA (RAPD) were  found to  be  closely related to those  of 
human MRSA in Korea (124) and thus might be  a possible  source of infections to 
humans via contaminated food products.
The observation of the  same clones of Salmonella newport  serotype MDR-AmpC, 
which  is  multidrug  resistant,  in  dairy  cattle,  in  animals  and  humans  (336)  further 
demonstrates that animal pathogens could be a source of infections in humans.
There  is  good  evidence  that  the  use  of  antimicrobial  agents  in  animals  for  the 
treatment  or prevention  of infections  or for  growth promotion has  encouraged the 
establishment of a reservoir of antibiotic-resistant bacteria and antibiotic resistance 
genes in animals that can be transferred to humans directly or indirectly as described 
in Figure 1.2.
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As discussed in chapter 1.1.2, the use of antibiotics has created reservoirs of 
antibiotic-resistant bacteria and antibiotic resistance genes in each environment 
where antimicrobials are used; this figure underlines the transfer of antibiotic- 
resistant organisms between these different environments.
1.1.2.3.2  In plants
An estimated 0.1% of the total  antimicrobials used in the United States are used in 
plant  agriculture  (309).  Streptomycin,  an  aminoglycoside  antibiotic,  and 
oxytetracycline,  a  tetracycline  antibiotic,  are  the  main  antibiotics  used  to  prevent 
bacteria-induced rotting of commercially valuable  fruits  (263).  Because  of its high 
efficacy and low toxicity, streptomycin has been the antibiotic of choice; however its 
repeated use for fire blight control in pears and apples has led to the establishment of 
streptomycin-resistant Erwinia amylovora populations, the causative agent of the fire 
blight disease.  The resistance  also  spread to  other phytopathogenic  bacteria and  is 
due to either a mutation in the ribosomal binding site or due the presence of a Tni- 
type  transposon,  Tn5393,  containing  linked  strA-strB  genes  that  encode 
streptomycin-inactivating  phosphotransferases  (176).  Tn5393  is  located  on  a 
plasmid, pEa8.7 that is  closely related or identical to the broad-host range plasmid
28RFS1010, which is commonly found in a variety of clinically important bacteria of 
hupian and animal origin (44, 213). The concerns are that even though streptomycin 
has  stopped being used  for some decades,  the prevalence  of streptomycin-resistant 
Erwinia amylovora is still very high (176, 213, 263).
Oxytetracycline  is  used  as  the  second  antibiotic  of  choice  when  resistance  to 
streptomycin  has  emerged;  resistance  to  this  antibiotic  has  not  been  reported  in 
phytopathogenic  bacteria,  although  it  has  been  found  in  plant  surface-associated 
bacteria (263). Resistance has emerged through the acquisition of genes encoding an 
efflux mechanism such as tet(A), tet(B), tet(C), tet(G); most of them were located on 
transposons  identical,  or  similar,  to  transposons  already  described  in  tetracycline- 
resistant  bacteria  of  environmental,  animal  or  human  origin.  For  instance  Tn 10 
containing tet(B)  was  also  found  in Shigella dysenteriae  (263),  causative  agent of 
gastroenteritis  in humans  and Tn/ 720,  a variant of Tn 1721,  containing  tet(A)  was 
also found in Salmonella enterica,  also causative agent of gastroenteritis in humans 
(220).  In  some  cases,  tetracycline resistance was  linked to  streptomycin  resistance 
determinants and so the use of oxytetracycline in plant agriculture would select for 
tetracycline and streptomycin resistance (263).
Many  different  factors  have  contributed  to  the  emergence  of  antibiotic-resistant 
bacteria  as  seen  above.  The  presence  of homologous  resistance  determinants  in 
bacteria associated with plants, soil, animals and humans is likely to be due to gene 
exchange between organisms from these different environments, therefore different 
habitats can  serve  as  a reservoir for antibiotic resistance  genes,  which can then be 
transmitted to other environments (Fig.  1.2).
1.2  Origins of the rise of antibiotic-resistant bacteria
1.2.1  Point of view of the bacterium
Bacteria are part of us; human beings are made up of 1014 cells, only  10% of these 
are mammalian cells, the remainder are the microbes which constitute the indigenous
29microbiota  (155).  Bacteria  have  a  short  generation  time  and  so  are  able  to  adapt 
efficiently to a change in the environment, which means they can become more or 
less resistant in response to selection pressures exerted by the presence or absence of 
an antibiotic in their environment.
1.2.1.1 Bacteria challenged by antimicrobial agents
1.2.1.1.1  Increase in the proportion of antibiotic-resistant bacteria
When  an  antibiotic  is  administered,  the  entire  microbiota  is  exposed  to  the 
compound;  it first affects the  susceptible bacteria,  by  either preventing them  from 
growing any further or by killing them, thus  giving additional  resources and more 
opportunity  for the  resistant bacteria to  proliferate  in  this  new environment  (155). 
The administration of tetracycline to an oral biofilm in vitro was shown to increase 
the overall resistant population and decrease the susceptible one  (230).  The second 
effect  caused  by  the  consumption  of  an  antibiotic  is  an  increase  in  antibiotic 
resistance gene exchange between bacteria. One study on the effect of tetracycline on 
Bacteroides  spp.  showed  that  exposure  of  the  bacteria  to  a  low,  subinhibitory 
concentration of the drug upregulates the expression of the gene transfer apparatus of 
the  conjugative  transposon  CTnDOT  (280,  323);  also  tetracycline  was  shown  to 
increase the transfer frequency of Tn916 in a culture of Bacillus subtilis (39). Thus 
antimicrobial agents create a selective pressure on the bacterial population favouring 
the  growth  of  resistant  bacteria  and  encouraging  the  bacteria  to  acquire  new 
mechanisms of resistance.
1.2.1.1.2  Origin of the antibiotic resistance genes
Plasmids  isolated  during the pre-antibiotic  era were  common but carried very  few 
antibiotic resistance genes; out of 433 enterobacterial strains studied, including those 
belonging  to  the  genera  Proteus,  Salmonella,  Escherichia,  Klebsiella,  from  the 
period  of  1917-1952,  only  one  Proteus  strain  was  shown  to  be  resistant  to 
tetracycline, one Klebsiella strain was resistant to ampicillin and no other antibiotic
30resistance  was  found  (123).  Recently  the  urinary  pathogens  Escherichia  coli, 
Klebsiella pneumoniae and Proteus mirabilis were studied (864,  71  and 62 isolates 
respectively)  in  the  UK  for their  resistance  to  different  antimicrobials  and  it  was 
found that 25.6% of E.  coli,  18.3% of K. pneumoniae and 100% of P. mirabilis were 
resistant to tetracycline  and resistance to  amoxycillin,  ampicillin and trimethoprim 
were found in all  species (82),  suggesting that they have acquired resistance genes 
following the increased use of antibiotics. The origin of these resistance genes is not 
well  understood.  There  is  some  evidence  that  most  of them  originated  from  the 
antibiotic-producing organisms as a way to protect themselves against the activity of 
the antibiotics they produce (64).  The best example is the  striking  similarity of the 
genes  conferring  vancomycin  resistance  (vanA,  vanB,  vanH,  vanX)  in  enterococci 
and  the  related  clusters  in  glycopeptide  antibiotic  producers  (171,  172).  In  some 
cases  it  has  been  shown  that  antibiotic  resistance  genes  might  have  evolved  from 
housekeeping genes (64).  The aminoglycoside modifying enzymes, aminoglycoside 
acetyltransferases and aminoglycoside phosphotransferases, have significant primary 
sequence  similarities  to  the  housekeeping  genes  acetyltransferases  and  kinases 
respectively found in streptomycetes (63), now these two antibiotic resistance genes 
can be found in a wide variety of species (248).
1.2.1.1.3  Cross-resistance
One  major problem  is  the  co-selection  for multiply-resistant  organisms  (25,  248). 
The antimicrobial  agents have selected for the assembly and evolution of complex 
genetic  vectors  encoding,  expressing,  linking  and  spreading  different  resistance 
genes.  It  is  not  uncommon  to  isolate  one  bacterium  resistant  to  more  than  one 
antibiotic  eg  MRSA,  VRE,  multidrug-resistant  Salmonella,  penicillin-resistant 
Streptococcus pneumoniae (325) and it is easy to  understand how,  considering the 
array of genetic elements able to carry and transfer antibiotic resistance genes and the 
presence  of  gene  cassettes  able  to  accumulate  different  resistance  genes  and  to 
subsequently transfer them to  transposons  and plasmids  (see  chapter  1.2.2.2).  The 
linkage of antibiotic resistance genes on the same element is of concern; the use of 
any of the antibiotics can select for multidrug-resistant isolates and aid the survival 
of resistance genes even in the absence of the drug to which they encode resistance.
31Moreover, biocides and antibiotics use some common mechanisms of resistance such 
as the QAC (quaternary ammonium compounds) efflux pumps (Table  1.4) and some 
genes coding for resistance to biocides or disinfectants have also been linked with 
antibiotic  resistance  genes;  the  quaternary  ammonium  compounds  resistance  gene 
(iqacA/B)  was  linked  to  (3-lactam  resistance  genes  on  the  same  plasmid  in  food- 
related  Staphylococcus  spp.  (270)  therefore  co-selection  for  multidrug-resistant 
strains is also likely to take place in any environment where biocides are used (153, 
177,  222).  The  use  of  mercury  in  dental  amalgams  is  likely  to  promote  the 
development  and  maintenance  of mercury-  and  antibiotic-resistant  bacteria  in  the 
oral cavity; there are some reports of antibiotic-resistant bacteria also being resistant 
to  mercury  (283)  and  mercury  resistance  has  been  associated  with  conjugative 
plasmids or/and transposons in the environment (212).
1.2.1.2  Mechanisms of resistance
There  are  various  ways  for  bacteria  to  protect  themselves  from  the  effect  of an 
antibiotic: the production of enzymes that inhibit the activity of the agent, the active 
efflux of the drug from the cell,  a decreased uptake of the drug, the creation of an 
alternative metabolic pathway that bypasses the target action or the modification of 
the target site preventing the antibiotic from binding to it.
1.2.1.2.1  Intrinsic and acquired resistance
Acquired resistance is present only in certain isolates of a species or genus.
A  bacterium  can  be  resistant  to  an  antibiotic  through  an  intrinsic  or  acquired 
mechanism.  Intrinsic resistance is present in all the members of a given  species or 
genus. For example enterococci are intrinsically resistant to different antibiotics such 
as  penicillin  because  the  (3-lactam  antibiotics  bind  very  weakly  to  enterococcal 
penicillin-binding  proteins  involved  in  bacterial  cell  wall  synthesis,  to  macrolides 
because of a modified ribosomal target and finally to aminoglycosides which cannot 
efficiently cross the cell wall (69).  Intrinsic resistance differs in Gram-negative and
32Gram-positive bacteria because of their differing cell wall composition (225). In both 
Gram-positive  and  Gram-negative  organisms,  the  envelope  consists  of  a 
peptidoglycan layer,  a periplasmic  space  followed by the  inner plasma membrane, 
however in Gram-negative bacteria the peptidoglycan layer is surrounded by an extra 
outer membrane that consists of lipids,  lipoproteins,  lipopolysaccharides  and porin 
proteins.  One  important function of the  outer membrane  is to  prevent  or  slow the 
entry  of bile  salts,  antibiotics  and  other  toxic  substances.  Aminoglycosides  and 
glycopeptides are high hydrophilic  compounds which prevents them  from crossing 
the  highly  lipophilicity  of the  outer  membrane  of most  Gram-negative  organisms 
therefore they are inactive against most of these organisms (63, 83).
1.2.1.2.2  Active efflux of the drug
Efflux pumps, or energy-dependent export, evolved to protect bacteria from the toxic 
substances  resulting  from  their  own  metabolism  (156).  However,  some  of these 
pumps excrete antimicrobial agents out of the cells fortuitously, thus preventing the 
intracellular accumulation necessary for antibiotics to exert their lethal activity and 
conferring diminished susceptibility to these different compounds.
The efflux pumps  can be  divided  into  four superfamilies  according to  their amino 
acid  sequence  morphologies  (Table  1.4).  Most of these  efflux  pumps  (MFS  major 
facilitator  superfamily,  SMR  small  multidrug  resistance  protein  family  and  RND 
resistance,  nodulation,  division)  are proton motive  force-dependent efflux  systems; 
that is, systems that use the chemical gradient of hydrogen ions and/or the electrical 
charge gradient across the membrane to drive drug efflux (150, 229). Whereas, ABC 
transporters  (ATP-binding  cassette),  which  contain  two  ATP  binding  cassettes, 
derive their energy from the hydrolysis of ATP (Fig  1.3). Although the mechanisms 
of  antibiotic  substrate  specificity  are  difficult  to  establish,  it  is  thought  that 
transporters recognise molecules with a polar, often slightly charged head, associated 
with a hydrophobic domain (156, 217).
Efflux  pumps  can have  an  important  role  in  intrinsic  resistance  of Gram-negative 
bacteria  to  different  antibiotics.  Among  Gram-negative  bacteria,  three  types  of
33multidrug efflux pumps have been reported (Table 1.4): MFS, SMR and RND, which 
work in synergy with the membrane barrier, giving rise to increased resistance to a 
wide range of antibiotics. Efflux systems of Gram-positive organisms belong either 
to the MFS, SMR or ABC families (Table 1.4); they usually exhibit narrow substrate 
specificities  and  confer  resistance  to  weakly  lipophilic  agents  or  organic  cations. 
Elevated expression of some of these efflux proteins can be caused by a mutation in 
the promoter region as is the case of the NorA protein (133) or by a mutation in the 
regulator of the  genes encoding the efflux pump,  as is the case for the  Mex pump 
(338).  The  broad-substrate  range  of  efflux  systems  is  of  concern,  since 
overexpression of a pump  will  result in  resistance  to  antibiotics  of more than one 
class as well as to some dyes, detergents and disinfectants (Table  1.4). Moreover, it 
underlines  the  risk  of commonly  used  biocides  that  could  also  select  for  cross- 
resistant bacteria (92, 153).
34Table 1.4: Multi-drug resistance families and members
MDR
fami­
lies
Proper­
ties
Membrane
topology
Distribu­
tion
Determinant Resistance
Phenotype
Microorganims
MFS •PMF 
• And 
specific 
translo- 
cases
12-14 trans­
membrane 
helices
prokaryotes
and
eukaryotes
qac(A)/qac(B) 
nor(  A) 
pmr(A) 
bmr, bit 
mef 
mdr(  1) 
tet(K)/tet(L) 
tet(A)-tet(E)
QAC
Quinolone
Quinolone
Quinolone
Macrolide
MDR
Tet
Tet
Staph, aureus 
Staph, aureus 
Strep pneumoniae 
B. subtilis 
Strep, Neisseriae 
L. monocytogenes 
Gram-positive 
Gram-negative
SMR PMF 4 trans­
membrane 
helices 
(most likely 
organized in 
trimers)
Gram- 
positive and 
Gram- 
negative 
species
smr 
qac(E) 
emr(  E)
MDR
QAC
MDR
Staph, aureus 
Broad host range 
E. coli
RND PMF 12 trans­
membrane 
helices
Gram-
negative
species
acr
mex
mtr
MDR
MDR
MDR
E. coli
P. aeruginosa 
N. gonorrhoeae
ABC Specific
translo-
cases
12 trans­
membrane 
helices
prokaryotes
and
eukaryotes
msr(  A) 
vg(A)/vg(B)
Macrolide 
Strepto- 
gramin A
Staph, aureus 
Staph spp.
Adapted  from  Kohler  et  al.  (141),  Lewis  et  al.  (157),  Paulsen  et  al.  (217)  and 
VanBambeke et al. (302).
MFS  =  major  facilitator  superfamily,  SMR  =  small  multidrug  resistance  protein 
family, RND = resistance, nodulation, division, ABC = ATP-binding cassette, MDR 
= multidrug resistance, PMF = proton motive force, QAC = quaternary ammonium 
compounds used as antiseptics, Tet = tetracycline, Strep = Streptococcus spp., Staph 
= Staphylococcus.
35Figure 1.3: Structure of bacterial efflux systems
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From Kohler et al. (141).
The bacterial efflux systems are composed of a cytoplasmic pump protein that allows 
the export of substrates from within the cell  into the external medium.  MFS,  SMR 
and RND derive their energy from the proton gradient force whereas ABC uses the 
hydrolysis of ATP.  RND is composed of two additional proteins believed to form a 
channel as represented in this figure.
Drug efflux appears to  be a widespread mechanism  of resistance  in Gram-positive 
and  Gram-negative  bacteria  including  medically-important  species  such  as 
staphylococci,  streptococci,  enterobacteria  and  opportunistic  pathogens  like 
Pseudomonas aeruginosa (Table  1.4). Its ability to export unrelated compounds, and 
to increase bacterial resistance by overexpression of the efflux systems, makes it an 
important mechanism of resistance to antimicrobial agents and biocides.
361.2.1.2.3  Resistance to classes of antibiotics
1.2.1.2.3.1  P-lactam antibiotics
Some bacteria can become resistant to antimicrobial agents through the production of 
enzymes that inactivate the drug. The best examples known are the P-lactamases. P- 
lactam  antibiotics  act  by  binding  to  penicillin  binding  proteins  (PBPs),  which  are 
enzymes involved in the terminal  stages of assembling the cell wall during growth 
and division (178); they are bactericidal antibiotics and usually used against Gram- 
negative  bacilli  and  Gram-positive  cocci.  P-lactamases  act  by  hydrolysing  the  p- 
lactam ring  in  p-lactam molecules with the resulting  loss of antimicrobial  activity. 
They are produced by both Gram-positive and Gram-negative organisms and are the 
products  of genes  that  can  be  found  on  plasmids,  transposons,  integrons  or  the 
chromosomes (28).
The second most common mechanism of resistance against P-lactam antibiotics after 
the production of inactivating enzymes is the change by mutations, or replacements 
by transformation, of parts of the various PBP genes leading to a decreased affinity 
for the antibiotic (28).
1.2.1.2.3.2 Aminoglycosides
This  class  of  antibiotics  inhibits  protein  synthesis  in  Gram-positive  and  Gram- 
negative organisms. The mechanism of resistance to aminoglycosides is through the 
production  of enzymes  which modify the  antibiotic  and  usually  lead to  high-level 
resistance. These enzymes are classified as adenyltransferases, acetyltransferases and 
phosphotransferases;  they  add  an  adenine,  acetyl  or phosphate  group  respectively, 
onto  the  aminoglycoside  molecule,  preventing them  from  binding  to  the  ribosome 
target  site  (63).  Within  each  group  there  are  increasing  numbers  of  different 
enzymes, which differ in the aminoglycosides that they can use as substrate and the 
position on the aminoglycoside where the modifying molecule is added.  The genes 
for  the  enzymes  may  be  located  in  the  chromosome,  plasmids,  transposons  or 
integrons (63).
37Aminoglycoside  resistance  can  also  occur  by  base  modification  in  the  ribosomal 
RN4  (rRNA),  the binding  site of the antibiotic,  by an RNA methylase  and confer 
high level of resistance. However, this has not yet been identified in clinical isolates 
(63).
1.2.1.2.3.3  Macrolides
The  macrolides  are  bacteriostatic;  they  bind  to  the  bacterial  ribosome  and 
consequently  inhibit  protein  synthesis.  Erythromycin,  one  of  the  macrolides,  is 
effective against Gram-positive cocci and is often used as a substitute for penicillin 
against streptococcal and pneumococcal infections (138).
The most common mechanism of resistance to macrolides (M) is target modification 
that  leads  to  the  alteration  of  a  site  in  23 S  rRNA  common  to  the  binding  of 
macrolides  as  well  as  the  unrelated  lincosamide  (L)  and  streptogramin  B  (S) 
antibiotics and thus conferring cross-resistance to  MLS  antibiotics (247). This type 
of resistance  is  conferred  by  the  presence  of rRNA  methylases  (encoded  by  erm 
genes) that modify a single adenine residue at position 2058  in the 23 S rRNA and 
prevent  MLS  antibiotics  from  binding  to  the  50S  ribosomal  subunit.  There  are 
around 20 different erm genes coding for rRNA methylases; they have been isolated 
from  a  variety  of bacteria  and  are  associated  with  conjugative  or  nonconjugative 
transposons (Table  1.5) that tend to reside on the chromosome although some have 
been found on plasmids (247).
Inactivating enzymes produced against macrolides are very rare although some have 
been  found  in  lactobacilli,  staphylococci  and  E.  coli  (11,  247,  330).  They  are 
plasmid-mediated  erythromycin  esterases  typel  and  typell  (ereA  and  ereB 
respectively)  (11)  or transposon-mediated macrolides  2’-phosphotransferase  (mphA 
and  mphB)  (204,  205)  and  they  confer  high  levels  of resistance  to  14-membered 
macrolides  which  are  erythromycin  and  clarithromycin  (ereA,  ereB,  mphA,  mphB) 
and to 16-membered macrolides which are spiramycin, josamycin and tylosin (mphA, 
mphB) (Table 1.5).
38A third mechanism of resistance to macrolides  is through the production of efflux 
proteins that pump the antibiotics out of the cell of which there are two types. One 
set  of proteins,  coded  by  the  mef gene,  has  homology  with  the  major  facilitator 
superfamily;  they  are  found  in Streptococcus  spp.  and  oral  Neisseria  spp.  and are 
associated with conjugative elements found in the chromosome (247). The second set 
of proteins, coded by the msr gene, belongs to the ABC transporter family, but has 
been isolated so far only from Staphylococcus spp. (Table 1.4).
A  fourth  mechanism  of resistance,  a  base  substitution  in  the  23 S  rRNA  where 
macrolides make several contacts with the ribosome, has emerged in clinical isolates 
since the 1990s (247). The most common mutation is at position A2058; methylation 
of the rRNA at A2058 by erm methyltransferases is thought to confer resistance by a 
similar mechanism. Mutation conferring resistance to macrolides can also appear in 
the  ribosomal  proteins  (L4,  L22)  (308,  319).  These  mutations  lead  to  different 
phenotypes (36, 308).
Intrinsic  resistance  to  MLS  antibiotics  in  Gram-negative  bacilli  is  due  to  low 
permeability of the outer membrane to these hydrophobic compounds (148).
39Table 1.5: Distribution of erythromycin resistance genes
Clasfc of 
macrolide 
resistance 
genea
Protein Gene
name
Localisation Species where the gene 
resides
Reference
Methylases ErmA
ErmB
ErmC
ErmF
ErmQ
ErmT
erm(  A)
erm(  B) 
erm(  C) 
erm(  F)
erm(Q) 
erm(  T)
Tn  554
Tn1545, plasmid 
Plasmid 
Tn4551, 
plasmid, chr, Tn 
chr
Plasmid
Actinobacter, Staph, 
Strep, Peptostrep 
Broad host-range 
Broad host-range 
Broad host-range
Actinomyces, Strep 
Lactobacillus
247, 233
247 
247 
48, 324
247
247
Inactivating
Enzymes
EreA
EreB
ere(  A) 
ere(  B)
pIPllOO
pIP1527
Enterobacteriacae
Enterobacteriacae
247
247
MphA
MphB
MphC
mph(A) 
mph(B) 
mph(  C)
Tn
Plamid, Tn 
ND
E. coli 
E. coli 
Staph
205 
203, 204 
247
Efflux
pumps
Mefc mefi  A) Tn1207.3 
Tn2009
Enterococcus, Strep, 
Staph, Neiss, Acineto
251
68
MsrA msr{  A) pSRl, pEP2104 Staph 247
a The distinction of the erm methylases is based on their amino acid sequence 
variability (247)
•  two genes with <80% amino acid sequence identity provide enough 
variability to permit distinct probes to be designed
•  if two genes have an amino acid sequence identity >=80%,  they are assigned
to the same class and same letter designation
•  if two genes have an amino acid sequence identity <=79%,  they are given a
different letter designation.
b erm(TR) is also designated erm(A) according to current nomenclature (247). 
c mef{A) originally described in S. pyogenes (49) and mefiE), originally described in 
S. pneumoniae (247), are 90% identical and were assigned the same mef{A) class of 
macrolides resistance determinants (247).
Chr = chromosome, Tn = Transposons, Staph = Staphylococcus, Strep = 
Streptococcus, Neiss = Neisseria, Acineto = Acinetohacter,  Peptostrep = 
Peptostreptococcus, ND = not determined.
401.2.1.2.3.4  Tetracyclines 
«
Tetracyclines  are  bacteriostatic,  inhibiting  bacterial  protein  synthesis.  They  are 
broad-spectrum  antibiotics  effective  against  a  wide  range  of  Gram-positive  and 
Gram-negative  bacteria  (45).  The  production  of ribosomal  proteins  that  bind  and 
protect the ribosomes from the action of tetracycline is very common as a mechanism 
of resistance  to  this  antibiotic  in  both  Gram-positive  and  Gram-negative  bacteria 
(274). These ribosomal proteins have extensive homology to the elongation factor G- 
like  proteins  that  are  required  for  the  correct  binding  of aminoacyl-tRNA  to  the 
ribosomal acceptor site in the presence of guanosine triphosphate  (GTP) (45,  139). 
So far, nine classes of genes encoding ribosome protection proteins (RPP) have been 
described: tet(M), tet(O), /e/B(P),  tet(Q),  tet(S),  tet{W), tet(T), tet(32) and tet(36) 
(Table  1.6). The most common of which is tet(M) (45, 249). One of the reasons for 
the  success  of these  genes  is  the  fact  that  they  are  commonly  contained  within 
conjugative  transposons,  which have  an extraordinarily  broad host range  (45,  236, 
274).
Enzymatic  inactivation  of tetracycline  is  encoded  by  two  determinants  similar  in 
their functions:  Tet X and Tet 37. The tet(X) gene was isolated from the anaerobic 
intestinal  bacteroides  transposons  (275)  whereas  tet(31)  was  cloned  from  the  oral 
metagenome (72). Both gene products chemically modify tetracycline in the presence 
of  both  oxygen  and  nicotinamide  adenine  dinucleotide  phosphate  (NADPH). 
However, to date no surveys have been conducted to assess the distribution of these 
two genes.
A third mechanism of resistance to tetracycline is through the production of efflux 
proteins  (Table  1.6).  They  are  encoded  by  different  tetracycline  resistance  genes, 
tet(A) to tet(I),  including tet(39) found mostly in Gram-negative species and tet(K) 
and tet(L) widely distributed among Gram-positive organisms. They all belong to the 
same family of the MFS  (Table  1.4).  The Gram-negative efflux genes are normally 
associated  with  large  plasmids,  most  of which  are  conjugative,  while  the  Gram- 
positive efflux genes are generally found on smaller transmissible plasmids (45).
41A  novel  tet gene  tet(34)  has  recently  been  described  from  a  Vibrio  sp.  (206);  the
•  •  •  94-  •
possible  function  of  this  determinant  is  activation  of  Mg  -dependent  purine 
nucleotide synthesis, thus providing an excess of guanosine triphosphate stimulating 
the  elongation  factor proteins  required  for  the  binding  of aminoacyl-tRNA  to  the 
ribosomal acceptor site. Consequently, an excess supply of GTP might accelerate the 
binding  of  aminoacyl-tRNA  and  elongation  factor,  which  would  attenuate  the 
inhibition by tetracycline antibiotics (206).
Finally,  tetracycline  resistance  can  also  arise  through  mutation  at  the  ribosomal 
binding  site  of the  antibiotic.  These  mutations  have  been  found  in  two  different 
clinical  species, Propionobacterium  acnes  (252)  and Helicobacter pylori  (99),  and 
were shown to have a different effect on bacterial fitness, depending on the type of 
mutation carried (99).
42Table 1.6: Distribution of tetracycline resistance genes
Class p f tet
resistance
gene
Protein Gene Localisation Species where the gene 
resides
Ref
Ribosomal Tet M tet(  M) Plasmid, CTn Broad host-range 45
protective TetO tet(  0) Plasmid, CTn Broad host-range 249
proteinsa Tet P tetB(  P) Plasmid Clostridium 154
Tet Q tet(Q) CTn Broad host-range 151
TetS tet( S) Plasmid, CTn, chr Listeria, Enterococcus, 
Streptococcus
43
144
TetT tet(  T) ND Streptococcus 45
Tet W tet(  W) CTn, associated 
with mob proteins
Rumen bacteria, human 
faeces bacteria, animal 
pathogen
17,21,
264
Tet 32 tet(  32) ND Clostridium 180
Tet 36 tet(  36) ND Cytophaga- Flavobacter-
Bacteroides,
Proteobacteria
322
Inactivating Tet X tet(X) Tn Bacteroides 275
enzymes Tet 37 tet(31) ND ND 72
Efflux Tet A tet(  A) Plasmid Gram-negative 45
pumpsa Tet B tet(  B) Plasmid, Tn, chr Gram-negative 45
TetC tet(C) Plasmid Gram-negative 45
TetD tet(  D) Plasmid Gram-negative 45
TetE tet(E) Plasmid, chr Gram-negative 45
Tet F tet(F) Plasmid Bacteroides 45
Tet G tet(G) Plasmid Vibrio, Pasteurella 45,  136
TetH tet(  H) Plasmid, Tn Pasteurella 136
Tet I tet(  I) Plasmid Providencia 249
Tet J tet(  J) Unsequenced Proteus 45
Tet K tet(  K) ND Gram-positive 45
TetL tet(  L) Plasmid Gram-positive 45
Tet P tetA(  P) Plasmid, chr Clostridium 154
Tet V tet(V) Plasmid Mycobacterium 154
Tet Y tet(  Y) ND E. coli 154
TetZ tet(Z) Plasmid Coryne bacterium 154
Tet 30 tet(  30) Plasmid Agrobacterium 154
Tet 33 tet(33) Tn Corynebacterium 291
Tet 39 tet(  39) Plasmid Acinetobacter 4
Mg2+
dependent
resistance
Tet 34 ^/(34) ND Vibrio 206
Unknown
mechanism
TetU” /g^(U) Plasmid Enterococcus 238
a The distinction of the tet genes is based on their amino acid identity and <= 80% is
chosen as the dividing line (154).
43b The resistance mechanism of this gene appears to be ribosomal protection however 
the sequence of the gene shows no homology to the elongation factor G-like proteins 
(238).
tet = tetracycline, Ref = References, Chr = chromosome, Tn = Transposons, CTn = 
Conjugative Transposons, ND = not determined.
1.2.1.2.3.5  Glycopeptides
Glycopeptides interfere with the synthesis of the bacterial cell wall by binding to the 
D-alanines  on  the  precursors  of the  peptidoglycan  cross  bridges  preventing  their 
cross-linking and leading to cell lysis (235). Vancomycin was introduced clinically 
in  1958  for the treatment of infections due to Gram-positive bacteria (277).  Use of 
this agent has increased dramatically in the last 20 years, in large part because it has 
become  the  antibiotic  of  last  resort  for  infections  due  to  some  organisms  (e.g. 
MRSA)  as resistance to the other antibiotics has become more common.  The  only 
known  acquired  mechanism  of  resistance  to  glycopeptides  in  Gram-positive 
organisms  is  through  the  modification  of  the  drug  target  (91).  Resistance  has 
developed through the acquisition of genes (vanA, vanB, vanD, vanE) that produce a 
ligase resulting in the modification of the peptidoglycan side chain with less affinity 
to  glycopeptides  (91).  These  genes  confer  different  levels  of resistance  and  were 
described in different microorganisms (100, 223, 295). The most common of those is 
vanA  which  is  encoded  by  Tnl546,  resulting  in  high  level  of  resistance  in 
Enterococcus spp. (69).
Gram-negative  organisms  are  intrinsically  resistant  to  vancomycin  since  the 
peptidoglgycan  inside  the  outer  cell  membrane  cannot  be  reached  by  the 
glycopeptide  molecule  (91).  Natural  resistance  exists  in  Gram-positive  organisms 
such as Lactobacillus spp. due to a lower affinity to glycopeptide antibiotics (22).
441.2.2 Mechanisms of disseminating antibiotic resistance genes
1.2.2.1 Discovery of bacterial gene exchange
Until the discovery of transformation in the early 1940's, it was assumed that bacteria 
lacked any means of exchanging genetic material. Within a few years, two additional 
means  of  genetic  exchange  by  bacteria,  conjugation  and  transduction,  were 
discovered. All three of these mechanisms result in the transfer of DNA from a donor 
to  a recipient  bacterium  (240).  The  extent  of horizontal  gene  transfer  (HGT)  was 
further demonstrated  by the  characterisation  of nucleic  acids  in bacterial  genomes 
(146).  Sequencing  and  comparisons  of  genomes  from  different  species  revealed 
regions with atypical  base compositions or codon usage patterns, which have been 
described  as  ‘alien  genes’  and  is  evidence  of  a  HGT  between  bacteria  (146). 
Bacterial  genomes  are  extremely  dynamic  and  mosaic  in  nature,  HGT  are  often 
involved in the rapid adaptation of bacteria to novel environments and thus are likely 
to play a major role in the acquisition of antibiotic resistance.
1.2.2.2 Mechanisms of HGT
1.2.2.2.1  Transformation
Transformation  is  a process  by  which  bacteria  can  take  up  naked  DNA  from  the 
environment.  Many  bacteria  are  naturally  transformable;  they  can  take  up  DNA 
during  a  specialised  physiological  state  termed  competence,  the  development  of 
competence depends on different factors according to the  species (272).  More than 
40 naturally transformable species have been identified (163).
Different steps are involved for successful transformation to take place.  First of all, 
free bacterial DNA in the environment is required and it is usually provided by the 
lysis of bacterial cells.  The DNA must persist in the environment and be protected 
from  the  action  of free  nucleases.  Some  studies  showed  that  adsorbed  DNA  on 
surfaces such as minerals, sand and clay particles is less susceptible to the action of 
DNAse, however the mechanisms of protection are unknown (251).
45Extracellular DNA can be taken up efficiently only by competent bacteria; in most 
bactefia competence is inducible, but in N. gonorrhoeae, and probably Acinetobacter 
spp., it is constitutive (272). In transiently competent bacteria, competence develops 
when the cell is in the correct physiological condition (76), but it also depends on the 
expression  of  genes  whose  proteins  provide  the  necessary  functions  to  induce 
competence (50, 272). These proteins are produced from the com genes in B. subtilis, 
and they also have analogues in other species (77, 78).
In B.  subtilis and S. pneumoniae, the binding of DNA onto the cell  surface is non 
covalent, it takes place through the presence of binding proteins encoded by the com 
genes  (226)  whereas  the  interaction  between  DNA  and  a  competent  cell  in  N. 
gonorrhoeae and H.  influenzae occurs through the presence of short specific DNA- 
uptake  sequences  (DUS)  in the  donor DNA which  is why N.  gonorrhoeae  and H. 
influenzae preferentially take up double-stranded DNA only from the same or closely 
related species (20, 272).
In  most  species,  after  binding  to  the  cell  surface  of competent  cells,  the  DNA 
undergoes double-strand cleavage. While one strand of the bound DNA is degraded 
to  acid  soluble  products,  the  other  strand  becomes  resistant  to  DNAse  and  is 
transported  across  the  cytoplasmic  membrane  (163).  The  uptake  is  dependent  on 
monovalent and divalent cations in most species and is similar in Gram-positive and 
Gram-negative  organisms.  One  marked  difference  in  the  uptake  system  of  H. 
influenzae and N. gonorrhoeae is that the donor DNA is taken up as a double strand 
into vesicles called transformasomes  which are  located onto the cell  surface.  Thus 
the DNA contained  in the transformasome  is protected against exogenous DNAse. 
However, once in the cytoplasm the DNA becomes single stranded (163).
Integration of the donor DNA into the  recipient chromosome  is via a homologous 
recombination that is dependent on the activity of the RecA protein:  single stranded 
molecules  interact with  complementary  sequences  in the  recipient  chromosome to 
yield heteroduplex DNA, while the old strand with the  same  sequence is displaced 
and  subsequently  degraded.  This  recombination  appears  to  be  identical  in  Gram- 
positive  and  Gram-negative  bacteria  (163).  Also  bacteria  can  be  transformed  by
46plasmids,  which  then  replicate  and  do  not  need  homologous  recombination  to 
becoijie established (163).
HGT by transformation has been demonstrated in different bacteria in a variety of 
natural  ecosystems  (Table  1.7)  and also  in the  laboratory among  different bacteria 
(163), showing that it is an important factor in the evolution of bacteria, including the 
acquisition of antibiotic resistance.
47Table 1.7: Transformation in natural environments
Bacterial host Environmental
Situation
Genetic marker Reference
P. stutzeri Marine water 
microcosm
Chromosomal RifR 65
Pseudomonas sp. Marine  Water  and
sediment
microcosm
Plasmid multimers 65
A. calcoaceticus Ground  water  and 
soil extract
Chromosomal trp 65
A. calcoaceticus Ground and aquifer 
water
Plasmid 65
A. calcoaceticus River epilithon Chromosomal his 65
A. calcoaceticus Soil microcosm Chromosomal DNA + 
KmR, GmR cassette
65
E. coli River and spring 
water
Plasmid 65
P. stutzeri Soil microcosm Chromosmal his and 
plasmid
65
A. tumefaciens 
P. fluorescens
Soil microcosm Plasmid 70
Acinetobacter sp. Soil microcosm Chromosomal  +  KmR 
cassette
198
S. gordonii Human saliva Plasmid 181
Acinetobacter sp. Soil and 
rhizospheres
Plasmid KmR 71
Table adapted from Davison et al. (65).
RifR = rifampicin resistance,  trp = tryptophan,  his  = histidine,  KmR = kanamycin 
resistance, GmR = gentamicin resistance.
481.2.2.2.2  Transduction
Transduction involves the transfer of DNA from one bacterium by a bacteriophage (a 
virus that  infects  bacteria).  There  is  a wide  variety  of bacteriophages  (250),  some 
contain  single-  or  double-stranded  RNA  or  DNA,  but  only  double-stranded  DNA 
(dsDNA) containing phages can mediate transduction and thus will be the focus of 
this  section.  Tailed phages  are  the  most  efficient transducing  vectors  (115).  Their 
structure reveals a densely compacted phage DNA,  encased in a protective protein 
shell protecting the DNA from degrading enzymes. The phage tail and its associated 
fibres (Fig  1.4) assure both the specific recognition of the appropriate host cell and 
the guided injection of the phage DNA into the bacterial cell (152).
Phages can be divided into two general classes, the lytic (or virulent) and temperate 
(or lysogenic)  (34).  In both cases there must be interaction between specific phage 
proteins and receptors on the host cell. This interaction triggers a process that allows 
infection of the viral DNA or dsDNA into the cytoplasm of the host bacterium. The 
dsDNA  enters  the  target  cell  as  a linear  form,  however the  ends  of the  DNA  are 
single stranded and cohesive (they are complementary to one another) therefore the 
phage DNA is able to circularise by means of the cohesive ends (258). In the case of 
a lytic phage, the phage DNA directs the biosynthesis of viral parts using the host 
cell’s  machinery  (protein  coat,  chromosome);  the  phages  mature  as  the  parts  are 
assembled causing the cell to lyse and release approximately 102 to 103 progeny (Fig 
1.5).  In lysogeny, the phage DNA remains latent in the host until it breaks out in a 
lytic  cycle;  the  lysogenic  phages  possess  the  same  ability  as  the  lytic  phages, 
however they have the  ability to  integrate  into the  host chromosome,  usually by a 
site-specific  recombination  event  which  results  in  an  integrated  phage  termed  the 
prophage.  When the  prophage  becomes  activated  it  excises  from  the  chromosome 
and  enters  the  lytic  cycle  (Fig  1.5).  Some  prophages  are  maintained  as  plasmids 
within the host cell (103).
49Figure  1.4: Electron micrographs showing the structure of dsDNA phages (T4 phage 
at the% top and X phage at the bottom)
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From http://www.asm.org/division/rn/foto/UrLamMic.html
50Figure 1.5: The life cycle of dsDNA phages
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This diagram represents the two different life cycles of phage X
How could transduction  be  involved  in the  evolution of bacteria?  During the  lytic 
process  the  phage  DNA  encodes  a  nuclease,  which  causes  fragmentation  of the 
bacterial DNA, therefore the host’s DNA may be packaged in place of the phage’s. If 
this transducing phage attaches to a susceptible bacterial cell, the exogenous bacterial 
DNA  may  be  inserted  into  the  susceptible  bacterium  and  be  integrated  into  its 
chromosome. This process is called generalised transduction and because the phage 
does not contain a complete phage genome, the transducing particles are defective, 
no progeny phages are produced and no cell lysis takes place, therefore a horizontal 
gene transfer event has occurred (240).
51In  the  second  type  of transduction,  specialised  transduction,  a  lysogenic  phage  is 
integrated into the bacterial  genome  so that when the prophage  excises  it can take 
some  adjacent  bacterial  DNA  with  it,  which  is  packaged  into  a  new phage  head. 
When this transducing phage infects another cell, phage and bacterial DNA integrate 
into  the  new  recipient  chromosome  forming  a  recombinant  cell.  The  transducing 
particles  may  be  effective  or  defective  in  producing  new  transducing  particles 
following  infection,  depending  on  which  viral  genes  are  replaced  with  bacterial 
DNA.  As  seen  previously,  both  temperate  and  virulent  phages  can  perform 
generalised  transduction;  however  specialised  transducing  phages  are  solely 
temperate  bacteriophages  which  integrate  within  the  host  chromosome  and  are 
capable of transferring only specific chromosomal genes located close to the phage 
integration site (240).
The global phage population is estimated to be in the order of 1031 individuals (115). 
Using a mathematical  model the rate of transduction in a marine environment was 
estimated  at  about  1.3  x  1014  events  per year (131).  The  recent  study  of bacterial 
genomes reveals that they contain a large number of intact or defective prophages; 
phages  can  constitute  up  to  16%  of the  bacterial  genome  (35).  Therefore  it  is 
tempting  to  say  that  prophages  must  have  played  and  must  play  a  major  role  in 
bacterial evolution (35,  37)  including the acquisition of antibiotic resistance genes, 
although examples are scarce (see chapter 1.3.2.1.3).
1.2.2.2.3  Conjugation
Bacterial conjugation is defined as the direct transfer of DNA from the cytoplasm of 
a  donor  bacterium  to  the  cytoplasm  of  a  recipient  cell  and  it  is  mediated  by 
specialised genetic elements; it is thought to be the primary route of broad host range 
DNA  transfer  between  different  genera  of bacteria  (65).  This  process  is  normally 
specified by plasmids and conjugative transposons.
521.2.2.2.3.1 Plasmids
Plasmids  are  circular  dsDNAs  that  replicate  independently  from  the  host 
chromosome and carry genes that sometimes benefit the host.  They have their own 
origin of replication (oriV) and can range in number from one to many per cell (108). 
Some  plasmids  have  the  ability to  move  from  one  cell  to  another by  conjugation. 
Conjugation involves the transfer of the plasmid as  single-stranded DNA.  A well- 
studied conjugative plasmid is F from E. coli; as well as or/T, it also contains a series 
of tra genes, which are essential for plasmid transfer (183), some of which encode a 
sex pilus that makes contact with a potential recipient cell that does not have an F 
plasmid.  The pilus then contracts and pulls the cells together so that DNA transfer 
can take place (Fig 1.6). The particularity of the pilus system is its close resemblance 
to  the  type  IV  secretion  system  (108);  this  type  of  secretion  family  includes 
conjugation machines and ancestrally related systems that deliver effector molecules 
to eukaryotic cells (46).
The transfer of plasmid DNA starts at the oriT. The tra genes do not only encode the 
proteins necessary for the  synthesis and assembly of the  sex pili, but they are  also 
involved in the relaxosome formation and, subsequently, DNA replication (87). The 
relaxosome is the pre-transfer complex at the oriT; there is cleavage at the oriT by a 
‘nicking’ enzyme, accessory proteins bind to the oriT region allowing DNA transfer 
to  start,  a  DNA  helicase  unwinds  the  dsDNA  and  liberates  the  ssDNA  that  is 
subsequently  transfered  to  the  recipient  cell  (87).  Both  strands  are  replicated, 
resulting in a copy of the plasmid in both the donor and the recipient cell (Fig  1.6). 
Conjugative transfer between Gram-positive cells is not as well understood, although 
functional  oriT  sequences  have  been  identified  within  the  streptococcal  and 
staphylococcal  conjugative  plasmids  pIP501  and  pGOl  respectively  (52,  313), 
suggesting  that  conjugative  systems  in  both  Gram-positive  and  Gram-negative 
bacteria share a common transfer mechanism (108).
Non-self  conjugative  plasmids  can  be  mobilised  in  trans  by  both  conjugative 
plasmids and conjugative transposons. The basic requirement for mobilisation is the 
presence  of an  oriT and  frequently  a  mob  gene,  which  encodes  a  protein  which 
specifically nicks the oriT site and is required to help form the relaxosome prior to
53transfer (58). Other transfer functions are provided by the mobilising element. Non­
self conjugative  plasmids  can  also  be  mobilised  in  cis  via the  formation  of a  co- 
integrate with a conjugative element (255).
Fig 1.6: Plasmid conjugation from F+ cell to F- cell
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From Firth et al. (87).
a) Cell-to-cell contact mediated by F-pili.
b) Mobilisation and transfer of a single stranded DNA to the recipient cell.
c) The double stranded DNA is nicked and one strand is transferred into the recipient 
cell.
54d) The cells separate and both donor and recipient have  a complete F plasmid and 
can conjugate with other F- recipient cells.
1.2.2.2.3.2  Transposons
Transposons  are  pieces  of DNA  which  can  copy  and  insert  themselves  at  non- 
homologous regions  of the genome.  Unlike plasmids,  transposons  do  not have the 
necessary machinery for autonomous replication and  so  depend on the replication- 
proficient vector molecule in which they integrate (plasmid or chromosomal DNA) 
for  their  replication.  There  are  two  types  of transposition:  replicative  and  non- 
replicative. The non-replicative transposition is a ‘cut-and-paste’ mechanism with the 
help of a transposase. First the transposase makes a double-stranded cut in the donor 
DNA at the ends of the transposon and makes a staggered cut in the recipient DNA. 
Each end of the donor DNA is then joined to the overhanging end of the recipient 
DNA.  DNA  polymerase  fills  in  the  short  overhanging  sequences.  Replicative 
transposition  occurs  via a  strand transfer reaction  involving the  nicked  transposon 
and  a  target  to  generate  a  strand  transfer  intermediate.  Replication  of  this 
intermediate  resuts  in  duplication  of the  transposon  and  a  co-integrate  structure 
resolved  by the  resolvase  enzyme.  Non-conjugative transposition  always  creates  a 
short direct repeat of the target sequence that flanks the transposon (53).
1.2.2.2.3.2.1  Insertion sequences (IS)
Insertion sequences are the simplest of the transposable elements; they are small and 
genetically compact (Fig 1.10). IS elements generally encode no functions other than 
those  involved  in  their  mobility,  they  consist  of a  recombinationally  active  DNA 
sequence which defines the ends of the element together with a transposase, which 
recognises and processes the ends  (169).  Any region of chromosomal  DNA which 
becomes  flanked  by  copies  of the  same  IS  can  potentially  become  a  compound 
transposon (Table  1.8) (236).  These transposons consist of IS  sequences and genes 
that  encode  antibiotic  resistance  or  catabolic  activities.  Most  of  these  mobile 
elements carry only one or two resistance loci (169).
55Figure 1.7: Insertion sequence
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a-  The  central  region  of an  IS  element  encodes  a  transposase  and  is  flanked  by 
inverted repeats (IR) elements that can vary in size between IS elements, 
b- When a gene is flanked by two IS it is called a composite transposon.
1.2.2.2.3.2.2  Conjugative transposons
Some transposons are able to transfer only intracellularly, these are known as non- 
conjugative transposons whereas others are capable of transferring intracellularly and 
intercellularly, they are known as conjugative transposons.  Conjugative transposons 
are  common  in  Gram-positive  and  Gram-negative  bacteria;  some  of them  have  a 
broad host-range (255).
These  elements  are  plasmid-like  in  that  they  have  a  covalently  closed  circular 
transfer intermediate and are transferred by conjugation (Fig 1.7) but unlike plasmids 
the circular intermediate of a conjugative transposon does not replicate. Site specific 
recombinases  encoded  by  these  elements  promote  their  excision  and  integration
(183).
56Fig 1.8: Example of conjugative transposon and the mechanism of transfer
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From Salyers et al. (255).
This is an example of intercellular transposition of a conjugative transposon.
a) The conjugative transposon excises from the donor chromosome to form a circular 
intermediate.
b) A cleavage takes place at the oriT and a single strand DNA is transferred to the 
recipient cell by a mechanism similar to plasmid transfer (see chapter 1.2.2.2.3.1).
c) Replication from ssDNA to dsDNA in both the donor and recipient cells.
d) Integration of the dsDNA into the host chromosome.
57The closely related conjugative transposons TnP/d and Tnl545 have been found in a 
wid$ host range (51) including oral bacteria (143, 249). Tn1545 is larger than Tn916 
and  carries  kanamycin  and  erythromycin  resistance  genes  in  addition  to  the 
tetracycline resistance gene tet{M), but its ends and most of its interior are virtually 
identical to the corresponding regions of Tn916 (Fig 1.8). The excision-integration of 
Tn916 is shown in Figure  1.9. Excision and integration require the integrase protein 
Int (a tyrosine recombinase) and the excisionase Xis (188). To excise the transposon, 
staggered nicks are generated by Int on each strand at 5 or 6 bp from the end of the 
element, these stretches of DNA are called coupling sequences (253). These coupling 
sequences  often  contain  a  heteroduplex  however  they  are  joined  covalently  to 
produce a circular intermediate (Fig  1.9). Prior to transfer to the new recipient cell, 
the  double  stranded  circular  form  is  nicked  (at  the  oriT)  and  a  single  strand  is 
transferred  (255).  Second  strand  synthesis  occurs  in  the  donor  and  recipient,  the 
resulting  double  stranded  molecule  then  integrates  into  the  recipient  and  donor 
genomes.  Other  conjugative  transposons  were  found  to  have  different  integration 
and/or  excision  systems;  the  bacteroides  conjugative  transposons  CTnDOT 
containing tet(Q) use an integrase and a topoisomerase Exc instead of an excisionase 
Xis,  Tn53P7,  closely  related  to  TnP7d,  uses  a  serine  recombinase  TndX  for  its 
integration and excision (188).
Excision and transfer of TnP7d, Tn53P7 and CTnDOT are regulated by tetracycline 
that  leads  to  an  increased  expression  of the  transfer  genes  and  thus  an  increased 
excision  of the  CTn  (188,  323).  Therefore  antibiotics  not  only  select  for resistant 
strains but can also stimulate transfer of resistance genes.
Unlike  plasmids  that  are  grouped  into  incompatibility  groups  according  to  their 
inability to stably coexist in a single host cell, conjugative transposons are sociable 
elements;  they  can  coexist  with  each  other  in  the  same  genome  and  they  can 
physically  associate  with  each  other  and  with  other  genetic  elements  (Table  1.8) 
(300).
58Figure 1.9: Comparison of Tn916 and Tnl545 family of conjugative transposons 
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a)  Diagram of Tn916 (18 kb)
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b) Diagram of Tn1545 (25.3 kb) 
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a) The top diagram represents Tn9/d. The open reading frames of Tn97d are 
represented by red and blue arrows showing the probable direction of transcription 
and are named as described in the work of Flannagan et al. (88). The bottom line is 
the scale in kilobases.
b) The green arrows represent the two extra antibiotic resistance genes (aphA3  and 
erm(B)) present  in  Tn1545  according  to  Caillaud  et al.  (33)  and  the  red  and  blue 
arrows represent the identical ends common in both Tn9/d and Tn1545,  the arrows 
show the  probable  direction  of transcription.  The  dashed  black  line  represents  the 
unknown sequence of Tnl545.
59Figure 1.10: Excision and integration of Tn916
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From Salyers e/ al. (255).
The  transposon  is  represented  by  the  thick  line.  The  coupling  sequences  are 
represented  by  XXX/YYY  or  QQQ/RRR  to  indicate  that  initially  they  are 
complementary but QQQ does not pair with YYY. Staggered cuts, represented by the 
black arrows, occur 5  to  6 nucleotides from the  ends of the element leading to the 
formation  of  single-standed  overhangs  (coupling  sequences),  which  are  joined 
covalently to produce the circular transposition intermediate. Staggered cuts open up 
the circular intermediate and its target site. Ligation produces a heteroduplex.
60Table 1.8: Examples of transposons containing one or more functional module
Transposon a Size (Kb) Functional modules Antibiotic resistance 
genes present
Ref
Tnl545 25.3 TnP7 6 tet(  M)
erm(B), aphA-3
51
Tn3872 21.6 Tn916
Tn917
tet(  M) 
erm( B)
174
Tn3701 >50 Tn  916 
Tn3703
tet(  M) 
erm(  B)
147
Tn5253 65.5 Tn5251 
Tn5252
tet( M) 
caf
12
Tnl207.3 52 Tnl207.1 meJ{A) 259
Tn200? 23.5 Tn916 tet(  M) 
mefiE)
68
TnJ38J 65 2 x lS1216b 
Tn5381 + 2 x IS7276b 
Tn5384 + 2 x IS256b
tet( M)
Aac-6’-aph2,  erm(B), 
mer
236
a Most of the transposons listed are also conjugative except Tn2009 that was shown
to be transferred only by transformation (68).
b The transposon is flanked by two copies of an insertion element.
cat = chloramphenicol resistance gene, aphA-3 = kanamycin resistance gene, Aac-6
aph2 = aminoglycoside resistance gene, mer =  mercuric chloride resistance gene.
611.2.2.2.3.2.3 Mobilisable transposons
Like  the  conjugative  plasmids,  conjugative  transposons  can  mobilise  a  coresident 
plasmid by providing the mating bridge through which the plasmid DNA transfers. 
Moreover,  conjugative  plasmids  and  conjugative  transposons  can  also  trigger  the 
excision  and  circulation  of  unlinked  integrated  elements  called  mobilisable 
transposons  (159,  255).  So  far,  mobilisable  transposons  have  been  found  only  in 
Bacteroides (NBU, non-replicating Bacteroides units and Tm/555) and Clostridium 
species  (Tn4451,  Tn4453)  (2).  Mobilisable  transposons  are  much  smaller  than 
conjugative  transposons  and  contain  genes  required  for  excision,  mobilisation  and 
integration;  however,  they  rely  on  transfer  proteins  supplied  by  coresident 
conjugative  elements  in order to  transfer  intercellulary,  and  on regulatory proteins 
that  stimulate  excision.  Mobilisable  transposons  can  become  part  of other  mobile 
elements (324); they can also carry anbtibiotic resistance genes (2, 159).
1.2.2.2.3.3 Integrons
Integrons  are  composed  of three  key  elements  necessary  for  the  procurement  of 
exogenous genes: a gene coding an integrase (inti), a recombination site (attl) and a 
strong promoter (Fig 1.11). Integrons are able to capture genes from the environment 
and  incorporate  them  by  using  site-specific  recombination.  The  structural  genes 
inside the integrons are assembled as cassettes, these gene cassettes are the smallest 
mobile  elements  known  and  include  only  one  open  reading  frame  (ORF)  and  a 
recombination site or attC  site that is recognised by the integron-encoded integrase 
(inti) (54, 215).  These gene cassettes can exist as free circular molecules, unable to 
replicate, or as part of an integron (231). Most of these gene cassettes do not contain 
a  promoter,  therefore  their  expression  is  dependent  on  integration  in  the  correct 
orientation into an integron that supplies an upstream promoter adjacent to the attl 
site (54).  The arrangement of the cassettes can be altered by excision of individual 
cassettes in the integrons or reassortment or new cassettes can be inserted (54). Over 
60  cassettes  have  been  identified  (197),  and  most  of them  contain  an  antibiotic 
resistance gene, making these mobile elements a very efficient way of capturing and
62disseminating antibiotic resistance genes  and a very efficient mechanism by which 
plasmids and transposons acquire multiple antibiotic resistance determinants (231).
Figure 1.11: Structure of an integron
gene cassette 
P  aMC
r   /— — '  rs
— C   Mtf  o«fl  X >— I  o»Q  X >
a ttl
Two cassette array
Adapted from Nield et al. (197).
Structure  of  an  integron  showing  the  positions  of  the  integrase  (inti),  the 
recombination site (attl), the promoter (P) with the black arrow showing the direction 
of the promoter.  This integron possesses two cassettes open reading frame  1   and 2 
(orfl and orfl) with their own recombination site (attC).
Multidrug resistance  in bacteria has  been  spreading  alarmingly  in the  last decades 
(see chapter  1.2.1.1.3) and it is easy to understand why, considering the ways these 
genetic elements (IS, integron, CTn and plasmids) can acquire antibiotic resistance 
genes  and  spread  them  to  a  variety  of  different  bacteria  (254).  Because  these 
elements  can  also  recombine  with  each  other  to  generate  mosaic  mobile  genetic 
elements  (Table  1.8),  their  classification  and  nomenclature  is  becoming  blurred, 
therefore they are often described as functional modules (32, 212, 300).
631.3  Antibiotic resistance in the oral cavity 
«
The  oral  microbiota  consists  of  over  700  species  (326),  although  this  figure  is 
continually being revised upwards as molecular methods are being used to explore 
the diversity of the microbial communities inhabiting the complex ecosystem (216, 
310).  The  majority  are  commensal  bacteria  while  a  minority  are  opportunistic 
pathogens  that  can  cause  systemic  diseases  when  they  are  outside  their  normal 
environments (66,  162, 268, 292, 326).  There is considerable evidence that the oral 
microbiota acts as a reservoir for antibiotic resistance genes and can pass these on to 
pathogenic bacteria (see chapter 1.3.2.2.2).
1.3.1 The oral microbiota
1.3.1.1  Oral bacteria organised in biofilms
The  presence  of  nutrients,  epithelial  debris  and  secretions  make  the  mouth  a 
favourable habitat for a great variety of bacteria. Bacteria have colonised not only the 
teeth but the whole oral cavity including the tongue, the gingivae and between the 
gingivae and the teeth (321). Although the oral cavity provides some unique habitats 
for bacterial colonisation (teeth, mucosal surfaces, gingival crevices), the mouth has 
a resident microbiota which consists of many different species and genera. The oral 
streptococci comprise a large proportion of the resident microbiota and are isolated 
from  all  sites;  they  are  classified  in  four  groups  (mutans,  salivarius,  oralis  and 
milleri) and are commonly known as viridans streptococci. The oral microbiota also 
consists of Staphylococcus  spp.  that may be present transciently; Actinomyces  spp. 
that are  commonly found in dental plaques; Neisseria  spp.,  low number are  found 
from most oral  sites;  Veillonella  spp., mostly located on the tongue  surface and in 
dental plaque; Haemophilus spp., commonly found in saliva, dental plaque, and on 
epithelial  surfaces,  while Eikenella,  Porphyromona,  Prevotella  and Fusobacterium 
spp. are commonly found in subgingival plaques (14).
Most of the bacteria in the oral cavity live in biofilms; they form complex dynamic 
communities on the surface of the teeth called dental plaque and are responsible for
64inducing  caries  and  periodontal  diseases  (3).  Bacteria  organised  in  biofilms  have 
been shown to be 10-1000 times less susceptible to the effect of antimicrobial agents 
than their planktonic counterparts (312, 337). Multiple mechanisms are thought to be 
involved in this reduced susceptibility to antibiotics including the exopolymer matrix 
enclosing the biofilms, which can act as an ion-exchange matrix and impede charged 
antimicrobial agents (57, 168, 312, 337).
Since oral bacteria live  in close proximity they  are likely to  exchange  genes more 
readily. A donor containing a plasmid was introduced in both natural and laboratory- 
based biofilms and the experiment showed an initial rapid spread of the plasmid in 
the heterogenous bacterial communities (160,  184).  Therefore the transient passing 
of cells  carrying  conjugative  plasmids  represents  a  potential  source  of spread  of 
resistance  genes  to  the  indigenous  oral  microbiota.  Furthermore,  the  recovery  of 
Tn97 6-like  elements  in  biofilms  taken  from  the  oral  cavity  (143,  249)  and  the 
transfer of Tn916-like elements in microcosm dental plaques between different oral 
streptococci (243) support the idea that oral bacteria are responsible for harbouring 
and disseminating mobile elements.
1.3.1.2  Antibiotic-resistant bacteria
The  oral  cavity  is  also  exposed to  the  environment,  so  that the  ingestion of food, 
water, a close contact with the surroundings and the consumption of medicines can 
all have an effect on the composition of the microbiota.  A recent study has shown 
that in  a model oral biofilm, the consumption of one antibiotic, tetracycline, had an 
effect  on  the  whole  microbiota;  firstly  altering  its  composition  since  the  sensitive 
population decreased and was replaced with more resistant bacteria, and secondly by 
selecting not only for tetracycline-resistant bacteria but also bacteria resistant to other 
unrelated agents (230).
Oral  bacteria have  also  been  shown to  carry  a  wide  range  of antibiotic resistance 
genes (248) and some of these are contained within conjugative DNA elements (245, 
247, 249).  Therefore there is clear evidence that oral bacteria are  likely to play an 
important role in the development of resistance to antibiotics.
651.3.2 Evidence for gene transfer in oral and model biofilms
1.3.2.1 Gene transfer mechanism in oral bacteria
As  described  previously,  bacteria  can  acquire  antibiotic  resistance  genes  by  three 
different  mechanisms:  transformation,  transduction  and  conjugation.  There  is 
evidence that all three take place in the oral microbiota.
1.3.2.1.1 Transformation
Members  of the  bacterial  genera  Haemophilus,  Neisseria  and  Streptococcus  are 
naturally  competent  for  DNA  uptake  from  their  environment  (163).  The  fact  that 
most  of the  bacteria  live  in  biofilms  in  the  oral  cavity  is  likely  to  facilitate  this 
mechanism of exchange. Biofilm-grown Streptococcus mutans were transformed at a 
rate of 10- to  600-fold higher than planktonic S.  mutans,  and the dead cells in the 
biofilm were able to act as donors of a chromosomally encoded antibiotic- resistant 
determinant (158).  Moreover, experimental evidence showed that S.  gordonii could 
take  up  free  extracellular DNA  from  saliva  in  vitro  (181,  182).  Genetic  exchange 
between  oral  bacteria  from  two  different  genera,  Streptococcus  gordonii  and 
Treponema denticola, in broth and artificial biofilms has been shown to take place by 
transformation (314).
1.3.2.1.2 Transfer of mobile elements
Transfer  of  transposons  has  been  demonstrated  in  a  microcosm  dental  plaque 
between  different  streptococcal  species  (243).  TnP7 6-like  elements  are  commonly 
found  in  the  oral  microbiota  (19,  143,  249)  and  have  been  shown  to  transfer 
tetracycline  resistance  in  a  model  oral  biofilm.  Transfer  of elements  located  on 
mobilisable plasmids can also take place in a biofilm (184); rapid plasmid transfer 
occurred immediately after the introduction of a donor in a biofilm of E.  coli (160). 
Although this last study was not performed in a model oral biofilm it underlines the 
potential  role  of transient  cells,  such  as  in  the  oral  cavity,  carrying  conjugative
66plasmids  as  a  source  of  spread  of  resistance  genes.  Transfer  of  conjugative 
transposons between non-oral bacteria and oral commensals has been demonstrated 
in a mixed species oral biofilm. Tn5397, a conjugative transposon originally isolated 
from Clostridium difficile and conferring tetracycline resistance via te/(M), contained 
in a B. subtilis strain could be transferred within 6 h of inoculation of the donor to the 
oral  commensal  S.  acidominimus  (244).  Thus,  conjugative  transposons  can  be 
transferred between bacteria from different environments.
1.3.2.1.3  Transduction
Examples of transfer by transduction are scarce; transduction has been shown to be 
responsible for the transfer of a chromosomal tetracycline resistance gene between 
strains of S.  aureus in biofilm and liquid culture (301).  However there has been no 
evidence  of transduction  in  oral  biofilms,  and  only  few bacteriophages  have  been 
isolated from the oral cavity (119).
1.3.2.2  Implications of the presence of a pool of resistance genes in the oral cavity
1.3.2.2.1  Viridans streptococci and systemic diseases
Viridans group streptococci (VGS) are part of the indigenous microbiota of the upper 
respiratory  tract  of  healthy  humans.  However,  they  have  been  associated  with 
infective endocarditis, which most often results from the invasion of the bloodstream 
from the  oral  cavity as  a result of poor dentition  or extensive  dental  manipulation 
(66,  162).  The  emergence  of strains  intermediately  resistant  or  highly  resistant  to 
penicillin,  aminoglycosides,  tetracycline  and  macrolides  has  been  described 
worldwide  (74,  218,  294)  and  is  of concern  since  it  not  only  limits  the  available 
options  for  the  therapy  of serious  infections,  but  also  increases  the  reservoir  of 
antibiotic resistance genes that could be passed on to more pathogenic bacteria.
671.3.2.2.2  Gene exchange between commensal oral bacteria and pathogenic bacteria
Viridans group streptococci serve as a reservoir for many antibiotic resistance genes 
(19,  31,  120) and they have the potential to transfer their resistance  genes to more 
pathogenic bacteria.  The  increased use of macrolides is thought to  have  led to the 
emergence of erythromycin resistance in S. pneumoniae and S. pyogenes (60, 83, 98, 
173, 266), two important pathogens that share the same habitat as the VGS, that is 
the upper respiratory tract. Increased resistance of VGS to macrolides has also been 
observed  and  the  genes  conferring  this  were  commonly  found  in  VGS,  S. 
pneumoniae  and  S.  pyogenes.  Particularly  the  mef gene,  which  encodes  an  efflux 
protein,  was  transferred  from  VGS  to  Enterococcus faecalis  (165)  and  between 
Streptococcus  spp.  (259).  One  mef gene  from  an oral Streptococcus  sp.  had  100% 
identity at the DNA and amino acid levels with the mef gene found in S. pneumoniae 
(164); this is proof of gene exchange of this gene between these two species, either 
directly or via an intermediate  organism.  Peptostreptococcus  spp.,  members  of the 
pharyngeal, dental and gingival microbiota, have been found to harbour the ermTR 
gene  (233),  subsequently  named  ermA  (247),  which  is  also  the  most  common 
methylase  gene  found  in  S.  pyogenes  strains  (83).  The  methylase  gene  was 
transferred between these two species suggesting that this gene may circulate among 
both aerobic and anaerobic cocci of the oropharyngeal microbiota (233).
There is good evidence that the altered PBPs in pneumococci, leading to a decreased 
affinity for almost all  p-lactam  antibiotics,  have  emerged  from the  replacement of 
their normal PBP genes with those from penicillin-resistant oral streptococci such as 
S.  mitis  and  S.  oralis  by  transformation  (232,  276).  Recently  fluoroquinolone 
resistance determinants were transferred in vitro between VGS and S. pneumoniae by 
transformation (128) as well as from clinical isolates of VGS to S. pneumoniae (105) 
and  the  mosaic  structure  of the  genes  conferring  fluoroquinolone  resistance  in  S. 
pneumoniae were shown to originate from VGS (15). Equally, penicillin resistance in 
the pathogenic  strains of N.  meningitidis and N.  gonorrhoeae are thought to derive 
from  the  oral  commensal  species,  N. flavescens  and N.  cinerea  by transformation 
(276). Therefore, the indigenous oral microbiota appears to play an important role in 
the development of resistance to antibiotics and in the transfer of these genes to more 
pathogenic bacteria.
681.3.2.2.3 Evidence of antibiotic resistance gene transfer from transient organisms
In  one  study,  the  nucleotide  sequence  for  the  tet(Q)  gene  from  a  Prevotella 
intermedia  strain,  an  oral  pathogen,  was  compared  to  the  sequences  obtained  for 
tet(Q)  from  Bacteroides  thetaiotaomicron,  a  human  intestinal  organism,  and  for 
tet(Q)  from  Prevotella  ruminocola,  a  rumen  bacterium  from  cattle.  Very  high 
similarities (>=97%) were obtained among all three tet(Q)  genes (311),  indicating 
that  natural  horizontal  transfer  of  tetracycline  resistance  has  occurred  between 
bacteria from the rumen of animals and bacteria from the human oral and intestinal 
environment, or that these genes may have transferred via an intermediate host.
There  is  overwhelming  evidence  that  oral  bacteria  are  a  reservoir  for  different 
antibiotic  resistance  genes  and  that  there  is  transfer  of genetic  material  between 
different environments including the oral microbiota.
The  euphoria  produced  by  the  discovery  of antibiotics,  and  thus  the  belief that 
bacterial  infections  would  become  a thing  of the  past,  quickly  vanished  with  the 
emergence  of antibiotic  resistance  both  in hospital  and  in  community  settings.  To 
make  matters  worse,  bacterial  pathogens  have  become  increasingly  resistant  to  a 
variety of antibiotics. The driving force behind the emergence of antibiotic resistance 
in bacteria is the ease with which bacteria can acquire resistance genes, even from 
distantly related genera combined with the selection pressure provided by the use of 
antibiotics.  Commensal  bacteria  (including  those  present  in  the  oral  cavity)  are 
thought to play an important part as a reservoir for antibiotic resistance genes.
69Aims of the study 
«
1)  To  determine  the  prevalence  in  the  oral  cavity  of bacteria  resistant  to  the 
following  antibiotics:  tetracycline,  amoxycillin,  erythromycin,  gentamicin 
and  vancomycin.  The  first  three  of  these  are  the  most  frequently  used 
antibiotics in dentistry (86) and in clinical practice in general, while concerns 
have been raised recently about the emergence  of resistance to the  last two 
antibiotics in pathogenic strains for which no other antibiotics are available.
2)  To  determine  the  nature,  and  prevalence,  of tetracycline  and  erythromycin 
resistance genes contained in antibiotic-resistant bacteria.
3)  To determine if the tetracycline and erythromycin resistance genes found are 
transferable and to investigate the genetic elements responsible for transfer.
Therefore this project will provide details of the prevalence of antibiotic resistance in 
the indigenous oral microbiota of humans as well as provide a better understanding 
of the mechanisms of resistance.
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Materials and Methods
2.1 Bacterial strains and plasmids
Bacterial strains and plasmids used in this study are listed in Appendix 1.
2.2 Sampling and processing of samples
2.2.1  Subjects
Three  batches  of 20  healthy  adults  aged  16-45  years  referred  to  the  Orthodontic 
Department at the Eastman Dental Hospital were invited to participate in the study. 
The patients had not received antibiotics within the last three months and represented 
a cross-section of people from different ethnic groups, gender and age.
2.2.2  Sample collection and processing
For  each  patient,  a  saliva  sample  was  obtained  by  expectoration  into  a  sterile 
container.  Plaque  samples were collected using a calcium alginate  swab (Technical 
Service Consultants, Heywood, UK) and subgingival plaque samples were collected 
from four different sites with sterile paper points; both samples were pooled into 4 
ml of Calgon Ringer's solution (Oxoid, Basingtoke, UK) in a sterile bijou containing 
five sterile 2 mm diameter glass beads (BDH Chemicals, Poole, UK).  The samples 
were vortexed for 30  s to  dissolve the  calcium  alginate  and mixed with the  saliva 
sample for each individual. A 10-fold serial dilution of the sample was then prepared 
in  tryptone  soya  broth  (Oxoid)  and  spread  onto  both  antibiotic-containing  and 
antibiotic-free agar plates (to determine the total number of cultivable bacteria in the 
specimen)  in  duplicate  (petri  dishes  from  Sarstedt).  Iso-sensitest  agar  (Oxoid) 
supplemented with  5%  defibrinated horse  blood  (E&O  Laboratories,  Bonnybridge,
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Aldrich),  gentamicin  (Sigma-Aldrich),  tetracycline  (Sigma-Aldrich),  vancomycin 
(Sigma-Aldrich)  at  a breakpoint  concentration  of 1,  1,  4,  8,  8  pg/ml  respectively, 
based  on  the  recommendations  of  the  NCCLS  (192).  Stock  solutions  of  each 
antibiotic were prepared monthly at a 1000-fold greater concentration than that used 
for  selection.  Gentamicin  and  vancomycin  were  reconstituted  in  distilled  water, 
erythromycin  in  95%  ethanol,  tetracycline  in  50%  ethanol/50%  distilled  water. 
Amoxycillin  was  reconstituted  in  0.01  M  potassium  phosphate  buffer,  pH  7.  All 
antibiotic stock solutions were filter- sterilised and stored at - 20°C.
Staphylococcus aureus NCTC 6571 was used as the quality control organism.
One set of plates was incubated in an anaerobic chamber (MACS  1000, Don Whitley 
Scientific,  Shipley, UK) for 7 days at 37°C and a duplicate set was incubated in air 
supplemented with 5% C02/air for 2 days at 37°C.
2.2.3  Enumeration and storage
After  incubation,  the  resistant  isolates  were  enumerated  according  to  their 
morphology and one representative colony of each colony type was subcultured and 
incubated under both aerobic and anaerobic conditions to  ascertain its atmospheric 
requirements. All obligate aerobes were then subcultured and stored in Microbank™ 
(Pro-Lab Diagnostics)  and kept at -70°C.  Colonies with different morphologies on 
the anaerobic plates were also counted separately; these were then subcultured and 
stored at -70°C (Microbank).
2.2.4 Identification of antibiotic-resistant bacteria
Preliminary identification of the isolates was carried out on the basis of atmospheric 
growth  requirements,  Gram-stain  (from  Pro-Lab  Diagnostics  UK),  catalase  (using 
Hydrogen  Peroxide  from  Sigma)  and  oxidase  (N,  N,  N’,  N’-Tetramethyl-P- 
Phenylenediamine  from  Sigma)  reactions.  Additionally,  a  number  of strains  were
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16S ribosomal RNA (rRNA) gene sequencing (145).  The  16S rRNA was amplified 
using  the  primers  27F  (5’  AGAGTTTGATCMTGGCTCAG-3’)  and  1492R  (5’- 
TACGGYTACCTTGTTACGA  CTT-3’)  (Genosys,  Sigma,  UK)  (145).  Subsequent 
partial DNA sequencing of the 16S rRNA gene was carried out using a single primer 
357F (5’-CTCCTACGGGAGGCAGCAG-3’) and an ABI310 Genetic Analyser (PE 
Biosystems, Warrington, UK).
2.2.5 Antibiotic susceptibility testing
The MIC of each isolate for amoxycillin (Sigma-Aldrich, Poole, UK), erythromycin 
(Sigma-Aldrich),  gentamicin  (Sigma-Aldrich),  tetracycline  (Sigma-Aldrich)  and 
vancomycin  (Sigma-Aldrich)  was  determined  by  an  agar  dilution  assay  on  iso- 
sensitest agar plates  (Oxoid)  supplemented with  5%  defibrinated horse blood.  The 
inoculum  was  standardised  using  a  0.5  Macfarland  standard  in  accordance  with 
NCCLS  recommendations  (192)  and  inoculated  onto  the  agar  using  a  multi-point 
inoculator (Mast  Diagnostics,  Bootle,  UK)  and  were  read  after 24  h  incubation at 
37°C  aerobically  or  48  h  incubation  at  37°C  anaerobically  according  to  the 
atmosphere  requirement  of  the  isolate.  The  highest  dilution  of  antibiotic  that 
inhibited  visible  growth  was  taken  to  be  the  MIC.  Staphylococcus  aureus  NCTC 
6571 and Iso-sensitest broth (Oxoid) were included on the plates as controls.
2.2.6 Statistical Analysis
The outcome measure to be analysed statistically was the proportion in each of the 
three  patient  groups  of resistant isolates  in the  oral  microbiota for each  antibiotic. 
The  analysis  was  carried  out  using  the  Kruskal-Wallis  test  using  SPSS  software 
(SPSS  Inc.  (2000).  SPSS  10.0  Syntax  Reference  Guide.  Chicago,  IL).  Any 
differences  in the proportion of resistant bacteria for each antibiotic  between each 
patient  group  were  assessed  using  the  chi-square  analysis.  A  P  value  <0.05  was 
considered significant.
732.3 Extraction of genomic DNA
DNA from Gram-positive and Gram-negative bacteria was extracted according to the 
Gram-positive bacteria protocol from the Puregene Kit (Flowgen, Gentra System). A 
pure culture of each organism was grown overnight at 37°C on a selective blood agar 
plate. The colonies were suspended in  1   ml of sterile distilled water in an eppendorf 
tube  (Sarstedt)  using  a  swab  (BDH).  The  cells  were  pelleted  by  centrifugation  at 
15,800 g in a bench top microcentrifuge (Jouan A14) for  1   min and resuspended in 
300 pi of Cell Suspension Solution provided by the kit. A volume of 1.5  pi of Lytic 
Enzyme Solution (4,000 U/ml) was added; the samples were inverted 25 times and 
incubated  at  37°C  for  30  minutes  (Grant  incubator)  to  digest  cell  walls.  After 
centrifugation  of the  samples  for  1   min  at  14,000  rpm  (g  force  of  15,800)  the 
supernatant  was  removed  and  the  cells  were  suspended  in  300  pi  of Cell  Lysis 
Solution provided by the kit (Puregene) and gently pipetted up and down to lyse the 
cells.  The  samples  were  heated  at  80°C  for  5  minutes  to  complete  cell  lysis.  A 
volume of 1.5  pi of RNAse A  Solution (4 mg/ml) was added to the cell lysate, the 
samples were mixed by inverting the tubes 25 times and then incubated at 37°C for 1  
h to  denature the RNA.  After cooling the  samples to  room temperature,  100  pi  of 
Protein Precipitation Solution (Puregene) was added to the cell lysate and incubated 
on ice for 30-60 minutes. The samples were centrifuged for 3 minutes at 14,000 rpm 
(g force of 15,800) and the supernatant containing the DNA was poured into a clean
1.5  ml  eppendorf tube  containing  100%  Isopropanol  (Sigma).  The  samples  were 
inverted  gently  50  times  and  centrifuged  for  1   minute  at  14,000  rpm  (g  force  of 
15,800).  After removing the  supernatant,  the  DNA pellet was  washed with 300  pi 
70%  Ethanol  (100%  AnalaR  BDH,  diluted  with  sterile  distilled  water)  and 
centrifuged for  1   minute at  14,000 rpm (g force of 15,800). The tubes were drained 
and allowed to air dry for 30 minutes. The DNA pellet was redissolved overnight in a 
suitable volume (100 pi) of DNA Hydration Solution (Puregen) or sterile water.
Some  samples  yielded  too  low  a  DNA-concentration  and  so  the  DNA  extraction 
procedure was modified. After overnight incubation on a selective blood agar plate, a 
loopful of pure colonies was suspended into a universal (Sarstedt) containing 5 mis 
of brain  heart  infusion  broth  or  BHI  (Oxoid)  and  incubated  on  a  shaker  (Sanyo, 
orbital  incubator) overnight at 37°C.  The cells were centrifuged for 6 min at 5,000
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CqII  Suspension Solution (Puregen) transferred in an eppendorf tube and 30 mg/ml 
of lysozyme solution (Sigma) was added. The samples were incubated at 37°C for 1  
h  centrifuged  for  1   min  at  14,000  rpm  (g  force  of  15,800)  and  the  pellets  were 
resuspended in 300 pi of Cell Lysis Solution (Puregene); then the same procedure as 
before was followed.
2.4 Basic/16S rRNA PCR protocol
Genomic DNA was extracted and purified as noted earlier. The subregion of the 16S 
rRNA gene amplified was  1465-bp sequences between primers 27F and  1492R. In a 
total reaction volume of 50 pi, 0.1 volume of buffer (Bioline) was mixed with 3 pi of 
MgCb (50 mM from Bioline),  1   pi of dNTPs mixture (100 mM from Bioline), 2 pi 
of each primer (25 pmole), 2 pi of template (to a final concentration of 0.1 to  1   pg), 
31.8 pi of sterile distilled water and 0.16 pi of Taq polymerase (Bioline). PCR were 
performed for 29 cycles of 60 s at 94°C, 60 s at 54°C, and 90 s at 72°C, with a final 
extension at 72°C for 5 min (Primus PCR machine).
2.5 Agarose gel electrophoresis
The  genomic  DNA,  plasmid  samples,  PCR  products  were  analysed  by  agarose 
(Amresco, Solo, Ohio, USA) gel electrophoresis (256). The gels were made up with 
1   x TAE (Appendix 2) according to the volume needed. The mixture was heated in a 
microwave  (Sharp  Compact)  and  after  cooling,  0.5  pg/ml  of Ethidium  Bromide 
(Sigma) was added and the agarose was poured into the appropriate tank.
Samples were mixed with 0.5 Volume of Blue/Orange Loading dye, 6X (Promega) 
and  loaded  into  the  gel.  HypperLadderll  (Bioline)  was  used  as  a  marker  unless 
specified and 5  pi was loaded in parallel with the samples. The gels were run at an 
appropriate voltage  for an appropriate  length of time depending on the  size of the 
DNA to be visualised.
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distributed through Flowgen, Ashby de la Zouch, UK) and a picture of each gel was 
taken  (Alpha  Imager™  1220  Documentation  and  Analysis  System)  saved  and 
printed.
2.6 Purification of PCR samples
Prior to sequencing, the PCR products were purified from the other components in 
the  reaction  such  as  excess  primers,  nucleotides,  DNA  polymerase,  oil  and  salts 
using the GenElute™ PCR Clean-Up Kit (Sigma).  Each sample (50 pi) was mixed 
with 5 volume of Binding Solution (250 pi), transferred into a miniprep column and 
centrifuged  for  1   min  at  14,000  rpm  (g  force  of  15,800).  The  flow-through  was 
discarded and 500 pi of diluted Wash Solution (12 ml of Wash Solution diluted with 
48 ml of Ethanol  100%) was added, the sample was centrifuged for 1   min at 14,000 
rpm  (g  force  of  15,800).  The  flow-through  was  discarded  and  the  sample  was 
centrifuged again for 2 min. The column was transferred to a fresh eppendorf tube, 
50  pi of Elution Buffer was applied to the centre of the column and each tube was 
incubated  at  room  temperature  for  1   min.  To  elute  the  DNA,  the  column  was 
centrifuged for 1   min. The sample was run on a gel to confirm the presence of DNA 
before sequencing.
2.7 DNA sequencing
The  sequencing  of PCR products  was  carried  out  according to the  PE  Biosystems 
(Warrington, UK) instructions with the following modifications. In a total volume of 
7 pi, 5 pmol of primers was mixed with 2 pi of 1:4 diluted ABI BigDye Terminator 
Ready Reaction Mix, and  1   to 4 pi of DNA sample. The samples were then run on 
the following program;  rapid thermal ramp to  95°C, held for  10  sec, rapid thermal 
ramp to 50°C, held for 5  sec, rapid thermal ramp to 60°C, held for 4min. These four 
steps are repeated for 99  cycles followed by a rapid thermal ramp to 4°C and held 
until the samples were ready to purify.
762.7.1  Purification of sequencing products
To the PCR tubes was added 15 pi of H2O, 2 pi of 3M NaAcetate (Sigma) and 50 pi 
-20°C 100% ethanol (100% AnalaR BDH) and then incubated on ice for 20 min. The 
samples  were  spun  at  14  K  (g  force  of  15,800)  for  25  min,  the  supernatant  was 
discarded and the pellet washed and centrifuged with 250 pi -20°C 70% ethanol for 
another  15  min at  14 K (g force of 15,800).  The supernatant was removed and the 
sample was  dried at 95°C  for a few seconds and resuspended in 20  pi  of template 
suppresser reaction buffer (Applied Biosystems).  The samples were then loaded on 
the ABI PRISM® 373 DNA Sequencer according to the manufacturer’s instructions 
and  the  results  were  retrieved  from  the  database  and  saved  onto  discs  for  further 
analysis.
2.7.2  Analysis of sequencing products
The sequence data obtained where compared to those in public sequence repositories 
(GenBank) using the basic local alignment search tool (BLAST) (6).
2.8  Filter-mating
Donor  and  recipient  were  grown  separately  on  Iso-sensitest  agar  plates  (Oxoid) 
containing relevant antibiotics at 37°C overnight. Each isolate was suspended in 5 ml 
of Brain Heart Infusion broth (Oxoid) to a density of approximately  109 cells per ml 
(3  McFarland  units).  Donor  and  recipient  bacteria  in  the  ratio  of  1:5  (donor  to 
recipient)  were  mixed.  The  bacterial  suspension  was  then  spread  on  0.45  pm 
nitrocellulose filters (Fisher, Scientific, London, UK) and incubated at 37°C for 24 h. 
After incubation, the mixture was resuspended in 2 ml of BHI broth; the filters were 
removed and placed in a sterile universal containing the broth and vortexed for 10 s. 
100  pi  of the  mixture  was  spread  on  antibiotic-supplemented  plates.  These  were 
incubated for up to 48  h at 37°C.  Transconjugants were tested for the presence of 
specific  antibiotic resistance  genes by PCR and hybridisation as well  as  by partial
7716S rRNA gene sequencing to rule out the presence of a donor mutant. The transfer 
frequency of each mating was calculated as the rate per donor CFU.
2.9  Southern blotting
Southern blotting was performed using the kit from Amersham Pharmacia Biotech 
UK Ltd, Buckinghamshire, England.
2.9.1  Restriction enzyme digests
All the samples were digested from genomic DNA with Hindlll (Promega) at 37°C 
for 2 h. For the digestion reaction 14 pi of DNA (at a concentration in between 10 to 
50  pg/ml)  was mixed with 2  pi  of Buffer,  2  pi  of enzyme  (10 U/pl)  and 2  pi  of 
distilled H2O for a total volume of 20 pi. The whole sample was loaded into a 100 ml 
1% agarose gel  (as described in chapter 2.5) and run overnight at 20 mV.  Lambda 
DNA BstE II Digest (New England Biolabs) was used as the marker.
2.9.2  Processing the Gel
After  running,  the  gel  was  placed  in  a  suitable  container  covered  with  fresh 
depurination  solution  (Appendix  2)  and  agitated  until  the  bromophenol  blue  dye 
turned completely yellow. The depurination solution was discarded and the gel was 
rinsed  with  distilled  water.  The  gel  was  then  covered  with  denaturation  solution 
(Appendix  2)  and  agitated  for 25  min  after the  bromophenol  blue  dye  had  turned 
back to  the  original  blue  color.  The  gel  was  rinsed  again with  distilled  water and 
covered with neutralization solution (Appendix 2) and agitated for 30 min.
2.9.3  Capillary Blotting
The capillary blotting consisted of a pyrex dish filled with 20 x SSC (Appendix 2), 
one  sheet  of Whatman  3MM  saturated  with  20  x  SSC  and  covering  a  supporting 
platform.  The  gel was placed on the  3MM paper, taking care to avoid trapping air
78bubbles and surrounded with cling film to prevent the SSC being absorbed directly
by the paper towels.  A sheet of Hybond N+ nylon membrane was  cut to the exact 
•
size of the gel and placed on top of the gel making sure not to trap any air bubbles. 
Three sheets of absorbent filter paper (Merck, Lutterworth, UK) cut to the size of the 
gel and soaked in 10 x SSC (20 x SSC diluted  1   in 2 in distilled water) were placed 
on top  of the  membrane,  again  avoiding  trapping  air bubbles.  A  5-7  cm  stack  of 
absorbent paper towels were placed on top of the filter paper. This was left overnight 
at room temperature.
2.9.4  Processing the blot
The blotting stack was dismantled and the membrane and gel removed together. The 
membrane was peeled off from the  gel  and placed  on a fresh piece of filter paper 
DNA side up. The DNA side was marked with a pencil. The membrane was placed 
in 6 x  SSC  (20  x  SSC diluted  1   in 3  in distilled water) and rinsed for  1   min with 
gentle agitation to remove any agarose. The membrane was then placed on another 
fresh piece of paper and the DNA fixed by UV  cross-linking in a UV  Stratalinker 
1800  (Stratagen Europe,  Amsterdam, Netherlands)  according to the manufacturer’s 
instructions.
2.9.5 ECL Direct Nucleic Acid Labeling and Detection System
2.9.5.1  Labeling of DNA probes
The  DNA  to  be  labelled  was  diluted  to  a  concentration  of  10  ng/pl  using  sterile 
distilled water. The DNA (100 ng in 10 pi) was denatured by boiling in a water bath 
for 5 min followed immediately by 5 min incubation on ice. The contents of the tube 
were  then  briefly  spun  to  collect  them  in  the  bottom  of the  tube.  An  equivalent 
volume (10 pi) of DNA labeling reagent (Amersham Pharmacia Biotech) was added 
to the cooled DNA and mixed gently but thoroughly. This was followed by addition 
of the gluteraldehyde solution (Amersham Pharmacia Biotech) to the same volume as 
the DNA labeling reagent (10  pi)  and mixed thoroughly.  The  contents  of the tube
79were  again  spun.  The  tube  was  incubated  for  10  min  at  37°C  and,  if not  used 
immediately was held on ice for 10-15 min.
2.9.5.2 Hybridisation and stringency washes
The  hybridisation  buffer  was  prepared  as  followed;  solid  NaCl  was  added  to  the 
required volume of hybridisation buffer (50  ml) to  a final  concentration of 0.5  M. 
Blocking  reagent  was  then  added  to  a  final  concentration  of  5%  (w/v)  and 
immediately  mixed  until  the  blocking  reagent  was  present  as  a  fine  suspension. 
Further mixing with stirring for 1   h at room temperature was followed by incubation 
at  42°C  for  0.5-1.0  h  with  occasional  mixing.  If the  buffer  was  not  being  used 
immediately it could be stored at -20°C for 3 months.
2.9.5.3 Pre-hybridisation using tubes
The hybridisation buffer was preheated to 42°C.  The blot was placed in a suitable 
container with 5 x SSC (20 x SSC diluted  1   in 4 in distilled water). The blots were 
loosely rolled into a tube and placed inside the hybridisation tube. The 5 x SSC was 
poured off and the appropriate amount of hybridisation buffer added (0.0625 -  0.125 
ml/cm2), the blot was pre-hybridised for 2 h at 42°C in a Biometra (Luton, UK) OV3 
rotisserie oven and then the labelled probe was added to the buffer, taking care not to 
place  it  directly  on the  membrane.  Hybridisation  was  carried  out  overnight  in the 
rotisserie oven at 42°C.  The appropriate volume of primary wash buffer containing 
urea (Appendix  2) was  warmed to  42°C.  The hybridisation buffer in the tube was 
discarded and 50-100 ml of 5  x SSC added. The tube was replaced in the rotisserie 
oven and incubated for 20 min at 42°C. The primary wash buffer was discarded and 
replaced with an equal volume of fresh primary wash buffer. This was replaced into 
the rotisserie oven and incubated for 10 min at 42°C. This wash was repeated for a 
second time. The blot was then removed from the hybridisation tube and placed in a 
suitable  container.  This was covered with an excess  of secondary wash buffer 2  x 
SSC (20 x SSC diluted 1   in 10 in distilled water) and incubated at room temperature 
with gentle agitation on a rotary shaker for 5 min.
802.9.5.4  Signal generation and detection 
«
An equal volume of ECL reagent 1  and ECL reagent 2 (Amersham) were mixed in a 
20  ml  universal  tube.  The  amount  mixed  was just  enough  to  cover the  blot.  The 
excess  secondary  wash  buffer  was  drained  from  the  blot  and  the  blot  was  placed 
DNA side up onto a clean piece of cling film (Saran Wrap).  The detection reagents 
were poured onto the blot immediately and incubated at room temperature for 1   min 
with gentle agitation. The excess detection reagents were drained from the blot and it 
was wrapped in cling film (Saran Wrap). Air bubbles were smoothed out and the blot 
was  placed  in  a  film  cassette  DNA  side  up.  Autoradiography  film  (Hyperfilm, 
Amersham)  was  placed  over  the  blot.  The  film  cassette  was  closed  and  the  film 
exposed  for  1   to  3  min.  The  film  was  removed  under  safe  light  conditions  and 
developed.
2.10  Cloning
2.10.1 Plasmid extraction
pUC18  was  used  as  the  plasmid  of choice  for  cloning  because  of its  high-copy 
number.  Prior to extraction one colony containing pUC18 was inoculated in 5 ml of 
LB  (Appendix  2)  containing  50  pg/ml  of  ampicillin,  and  incubated  37°C  with 
shaking  overnight  at  225  rev/min  (Stuart  Scientific  Orbital  Shaker  SOI).  Bacteria 
were recovered by centrifugation at 5000 rpm (g force of 4500)  for 5  min and the 
plasmid  was  extracted  using  the  miniprep  kit  (Qiagen)  according  to  the 
manufacturer’s instructions.
2.10.2 Plasmid digestion and dephosphorylation
pUC18 was digested with the most suitable restriction enzyme in a total volume of 
100 pi. The subsequent dephosphorylation was done at 37°C for one hour by adding 
1   unit (U) of alkaline phosphatase (Promega) at time 0 and 30 min. The mixture was 
inactivated with the addition of 2 pi of 0.5M EDTA (Appendix 2), incubated at 60°C
81for 20 min.  The sample was purified using GenElute™ PCR Clean-Up Kit (Sigma) 
and the final mixture was resuspended in 30 pi of elution buffer (10 mM Tris HC1 pH
«
8.5) provided by the kit.
2.10.3 Gel extraction
This  was  performed  using  the  QIAquick  Gel  Extraction  kit  (Qiagen  Ltd,  West 
Sussex, UK) following the manufacturer’s instructions.
2.10.4 Ligation
Both  the  insert  (gel  extraction product)  and  the  vector  (dephosphorylated  pUC18) 
were mixed together in a total volume  of 100  pi  including  9 U  of T4  DNA ligase 
(Promega)  and  10  pi  of T4  DNA  ligase  buffer  lOx  (Promega).  The  sample  was 
incubated overnight at 15°C and then at 60°C for 20 min to inactivate the reaction.
2.10.5 Transformation
50  pi of the ligation mixture was mixed with 200  pi of chemically competent cells 
(DH5a from Invitrogen).  The sample was incubated on ice for  1   hr, heated at 42°C 
for 1   min. Then the cells were grown in  1   ml of SOC medium (Appendix 2) at 37°C 
for 90 min with constant shaking.  The mixture was plated onto  selective LB plates 
(Appendix  2)  containing  50  pg/ml  of ampicilllin  and  5  pg/ml  of tetracycline,  and 
they were incubated for 18 h at 37°C.
2.11  Oligonucleotide Synthesis
The  synthesis  of all  oligonucleotides  was  carried  out  by  Genosys  Biotechnologies 
(Europe) Ltd (Pampisford, UK). Sequences of all primers used throughout this study 
are shown in Appendix 3.
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Prevalence of antibiotic-resistant cultivable oral bacteria in healthy 
adults
3.1 Abstract
Oral bacteria, as well as causing caries and periodontal diseases, are also responsible 
for  a  number  of  life-threatening  diseases  (endocarditis,  brain  abscess  and  lung 
infection)  for which  antibiotics  are  required (66,  162,  268,  292).  Although concern 
has  been  expressed  about  the  rise  in  the  prevalence  of antibiotic-resistant  bacteria, 
there  is  little  information concerning their prevalence  in the oral  cavity.  The aim  of 
this  chapter  was  to  determine  the  prevalence  of antibiotic-resistant  oral  bacteria  in 
healthy  adults.  Saliva and  plaque  samples were obtained  from  60  healthy adults (in 
three batches of 20 samples) who had not taken antibiotics during the previous three 
months.  Each  sample  was  plated  onto  media  containing  the  following  antibiotics: 
amoxycillin, erythromycin, gentamicin, tetracycline, vancomycin, and then incubated 
anaerobically and  in 5% CCVair.  Resistant isolates were enumerated and identified. 
All  of  the  individuals  were  found  to  harbour  bacteria  resistant  to  erythromycin, 
gentamicin,  tetracycline  and  vancomycin.  Only  4  individuals  did  not  have  any 
cultivable bacteria resistant to amoxycillin. Oral bacteria resistant to gentamicin were 
the most commonly isolated followed by erythromycin, vancomycin, tetracycline and 
amoxycillin.
3.2 Results
Out of the 60 samples screened all of the individuals were found to harbour bacteria 
resistant  to  erythromycin,  gentamicin,  tetracycline,  vancomycin  and  4  individuals 
only (6.7%) did not have any cultivable bacteria resistant to amoxycillin.
83From the 3  groups of patients studied, oral bacteria resistant to gentamicin were the 
most  commonly  isolated  (a mean  of 23.2%  of the  total  viable  count)  followed  by 
erythromycin  (a  mean  of  18.4%  of the  total  oral  count),  vancomycin  (a  mean  of 
16.1%  of the  total  viable  count),  tetracycline  (a  mean  of 9.9%  of the  total  viable 
count) and amoxycillin (a mean of 4.1% of the total viable count) (Fig 3.1).
Figure 3-1: Proportion of antibiotic-resistant isolates expressed as a percentage of the 
total viable count
%  15
Batch 1
Batch2
□  Batch3
Am = amoxycillin, Ery = erythromycin, Gen = gentamicin, Tet = tetracycline, Van = 
vancomycin.
To  establish  whether  the  prevalence  of  antibiotic-resistant  oral  bacteria  varied 
between the different groups, the 3 batches were compared using the Kruskal Wallis 
test. The difference in the proportion of resistant bacteria for each antibiotic and each 
batch was considered significant when the P value < 0.05. There was no significant 
difference found for the proportion of any of the antibiotic-resistant isolates between 
the three batches (Table 3.1).
84Table 3-1: Comparison of the three batches of samples obtained from the three 
patient groups using the Kruskal-Wallis test
Antibiotic P value0
Amoxycillin 0.54
Erythromycin 0.74
Gentamicin 0.36
Tetracycline 0.64
Vancomycin 0.37
aP value <0.05 was considered significant
Most  of  the  gentamicin-resistant  bacteria  isolated  belonged  to  the  genus 
Streptococcus  on  the  basis  of their  morphology,  Gram-stain,  catalase  and  oxidase 
reactions; out of a total of 288  gentamicin-resistant isolates 93% were streptococci. 
Streptococcus spp. are known to be intrinsically resistant to low level of gentamicin 
(< 500 pg/ml) (167) and in this study the MIC for these species varied between 4 and 
32  pg/ml  (MIC90  32  pg/ml)  therefore  the  mechanism  of  resistance  of  the  oral 
streptococci  to  gentamicin  was  intrinsic  rather  than  acquired.  Most  of the  Gram- 
negative  isolates  resistant  to  gentamicin  were  anaerobes,  which  are  intrinsically 
resistant to this antibiotic (214). Therefore all of the gentamicin-resistant isolates in 
this study exhibited an intrinsic resistance to this antibiotic rather than acquired and 
thus were not investigated any further.
Most of the vancomycin-resistant isolates were Gram-negative bacteria (Fig 3.2) that 
are  known to  be  intrinsically  resistant to  this  antibiotic  and  all  of the  vancomycin 
resistant Gram-positive  species were identified as Lactobacillus  spp.  by  16S rRNA 
sequencing,  which are  also  known to be  intrinsically  resistant to  vancomycin (91). 
Therefore from the 60 samples screened no bacteria containing acquired resistance to 
vancomycin were isolated.
85Figure 3-2: Proportion (of the total viable count) of Gram-positive and Gram- 
•negative resistant isolates for each batch and for each antibiotic
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Amoxycillin-resistant bacteria were isolated from 56 out of the 60 samples (93.3%). 
The  median  percentage  was  4.1%,  this  ranged  from  0%  to  34.3%.  A total  of 224 
amoxycillin-resistant bacteria were isolated, the MIC of amoxycillin of these isolates 
ranged  from  1   pg/ml  to  64  pg/ml.  The  majority  (81.8%)  of these  amoxycillin- 
resistant  isolates were also  found to  be  resistant to  erythromycin,  17.6% displayed 
resistance  to  tetracycline  and  17%  were  resistant  to  both  tetracycline  and 
erythromycin (Table 3.2).
86Table 3-2: MIC range, MICsoand MIC90 values for amoxycillin-, tetracycline- and 
^erythromycin-resistant bacteria isolated from the three groups of patients
Antimicrobial
agent
Isolates Median
Value
(%)
MIC
range
(pg/ml)
MIC50
(pg/ml)
MIC90
(pg/ml)
Multi-drug
resistance
Amoxycillin total resistant 
bacteria
4.1 1-64 1 4 81.8% ery-rst 
17.6% tet-rst
streptococci
only
0.53 1-32 2 4 54.3% ery-rst 
2 0 % tet-rst
anaerobes
only
0.92 1-32 4 16 25.5% tet-rst
Tetracycline total resistant 
bacteria
9.9 4-128 16 32 5.6% am-rst 
54.5% ery-rst
Erythromycin total resistant 
bacteria
18.4 1-512 16 32
Gram-positive
only
6.3 1-128 8 128 3% am-rst 
34.8% tet-rst
ery-rst = erythromycin-resistant, tet-rst = tetracycline-resistant, am-rst = amoxycillin- 
resistant.
Out  of  the  60  samples  screened,  all  of  the  individuals  were  found  to  harbour 
tetracycline-resistant  bacteria.  The  median  percentage  was  9.9%,  this  ranged  from 
0.2% to 38.9%. A total of 318 tetracycline-resistant bacteria were isolated, the MIC 
of tetracycline to these isolates ranged from 4 pg/ml to 128 pg/ml (Table 3.2).
The data for the erythromycin-resistant bacteria require careful interpretation because 
many Gram-negative bacteria are intrinsically resistant to this antibiotic or they can 
exhibit resistance through the presence of an efflux pump mtr (multiple transferable 
resistance) that is not specific to macrolides (187, 334). To gain a better idea of the 
occurrence  of erythromycin-resistant  bacteria  in  the  oral  cavity,  the  mean  average 
was  re-calculated  with  Gram-positive  isolates  only.  From  the  3  batches,  a  mean 
average of 6.3% of the total viable count was found to be resistant to erythromycin. 
Out of 129 erythromycin-resistant Gram-positive isolates, 3.1% (4 isolates) were also
87resistant to amoxycillin and 34.8% (46 isolates) were resistant to tetracycline (Table
3.2).
3.3  Discussion
6  8 The total  anaerobic count from the  60  samples ranged  from  1.8x10  to 4.1  x  10 
colony forming units (cfu) per ml of pooled saliva and plaque samples (mean = 7.4 x 
107 cfu) and these results are similar to previous studies; two of which looked at the 
total  viable  count  in the  denture  plaque  of healthy  adults  (327),  while two  studies 
looked  at  the  total  viable  count  in  subgingival  plaque  samples  obtained  from 
periodontal disease patients (113, 143).
In this study, the prevalence of different antibiotic-resistant bacteria in the oral cavity 
of a healthy adults organised in 3  batches of 20 samples each was compared. There 
was no significant difference between the batches when considering the proportion of 
gentamicin-,  vancomycin-,  amoxycillin-,  erythromycin-  and  tetracycline-resistant 
oral  bacteria.  However,  all  of the  vancomycin-resistant  isolates  were  intrinsically 
resistant  to  this  antibiotic  and  most  of  the  gentamicin-resistant  isolates  were 
Streptococcus  spp.  with low level  resistance  (MIC90  32  pg/ml).  Streptococcus  spp. 
are  known  to  be  intrinsically  resistant  to  low  level  of gentamicin  (<500  pg/ml). 
Consequently,  no  bacteria  with  acquired  resistance  to  vancomycin  or  gentamicin 
were isolated in this study.
The oral  microbiota is not static;  it has been shown to change  in composition over 
time, in response to whether the individual has teeth or synthetic materials, with age, 
hormone  status,  diet,  health and environment (248).  This  study has  shown that the 
prevalence  of bacteria resistant to three  antibiotics  (amoxycillin,  erythromycin and 
tetracycline) was not significantly different within a healthy population of different 
origin and different background who had not taken any antibiotics for 3 months prior 
to  sampling.  Therefore,  the  proportion  of antibiotic-resistant  bacteria  in  the  oral 
cavity of a healthy individual appears to be stable. However, the prevalence is likely 
to change when an individual takes antibiotics, which have been shown to have an
88effect on the endogenous microbiota increasing both the number of resistant isolates 
.and the MIC of the already resistant ones (59, 79, 120).
In  the  last  few  decades  we  have  witnessed  an  increase  in  the  resistance  of oral 
viridans group  streptococci to  p-lactams  (5,  16,  74,  126).  In  1986 Koh et al.  (140) 
showed  that  in  a  healthy  population  of  20  individuals  amoxycillin-resistant 
streptococci comprised a mean of 0.85% of the cultivable microbiota. In this study a 
mean  of  0.53%  of  streptococci  were  resistant  to  this  antibiotic.  Resistance  of 
streptococci to p-lactams is still very low in the oral cavity of healthy individuals and 
the increase of resistance has subsequently been reported only in clinical isolates or 
in neutropenic  cancer patients  (5,  16,  74) and might be  due to the  consumption of 
antibiotics leading to an increase in the prevalence of antibiotic-resistant bacteria (59, 
79,  120).  A  strong  association  was  observed  between  penicillin  and  erythromycin 
resistance  in  different  Streptococcus  spp.  (74,  234).  In  this  study,  54%  of 
amoxycillin-resistant streptococci were also resistant to erythromycin, but no linkage 
has  been  identified  yet  between  the  genes  conferring  resistance  to  p-lactam 
antibiotics and erythromycin.
Conversely,  the  mean  percentage  of  oral  bacteria  resistant  to  amoxycillin  with 
respect to the total oral count was quite high (4.1%) compared with that reported in 
other studies (85,  150, 271). However, two of these studies looked at the prevalence 
of p-lactamase-producing bacteria in the oral cavity of children (with a mean value of 
2%) (271), and adults (mean value  1.07% of the total anaerobic count) (150) and the 
third study used a higher concentration of amoxycillin (2  pg/ml) and found a mean 
value  of 0.5%  (85).  Therefore,  it  is  difficult  to  make  a  direct  comparison.  In  this 
project no investigation was made of the mechanism of resistance to amoxycillin or 
the  presence  of p-lactamase-producing  bacteria.  It  is  believed  that  one-third  of P- 
lactam antibiotic-resistant bacteria in the oral  cavity produce  p-lactamases (116);  if 
the  same  applies  to  this  study,  it  would  mean  that  the  mean  percentage  of oral 
bacteria  resistant  to  amoxycillin  through  the  production  of p-lactamase  would  be 
around 1.4%, which is similar to that found in previous studies (150, 271).
All  of  the  60  individuals  harboured  tetracycline-resistant  bacteria  in  their  oral 
microbiota.  The proportion of microorganisms resistant to tetracycline was  slightly
89lower than  reported  previously  (143),  although  Lacroix  et al.  used  a  lower break­
point value  for tetracycline  (4  pg/ml).  On the  other hand,  the  values  were  slightly 
higher than those  reported  in the  studies  of Hawley  et al.  (113)  and  Olsvik et al. 
(209,  210,  211).  However,  two  of these  studies  used  a  higher  concentration  of 
tetracycline to screen for resistant oral bacteria 25  pg/ml (113) and  10 pg/ml (221), 
whereas  the  other  one  used  a  lower  concentration  of tetracycline  (1  pg/ml)  (210, 
211).  These  results  are  difficult  to  compare  since  these  authors  did  not  use  the 
standard  break  point  concentration  of  tetracycline.  The  other  main  difference 
between  these  studies  is  that,  in  the  present  study,  the  samples  were  taken  from 
healthy individual whereas previously the samples were obtained from patients with 
periodontitis.  Although  the  patients  with  periodontitis  had  not  taken  antibiotics  6 
months prior to sampling, their condition and past history might have had an effect 
on the mean values of tetracycline-resistant bacteria; it is well known that antibiotic 
consumption  induces  the  emergence  of resistant  microorganisms  (209,  230),  and 
decreases the susceptibility to the antibiotic administered (59) and that the return to a 
fully susceptible population is not guaranteed (81).
Great differences have been documented between different European countries in the 
use of systemic antibiotics (224), which was shown to have an impact on the level of 
resistance  in  the  subgingival  microbiota  of adult  patients  with  periodontitis  (210, 
211,  307)  therefore  this  might  also  have  an  effect  on  the  mean  percentage  of the 
resistant bacteria in the oral cavity found in different studies.
In  most  studies  Streptococcus  spp.  appeared  to  be  the  most  common  of  the 
tetracycline-resistant  organisms  isolated  from  the  oral  cavity;  in the  present  study, 
they represented 54% of the tetracycline-resistant isolates. Many oral streptococci are 
naturally  competent  (112);  this  may  explain  why  they  are  more  frequently 
tetracycline-resistant  than  any  other  species.  Tetracycline  resistance  has  also  been 
commonly found on conjugative transposons in these species and these elements are 
highly promiscuous (255).
As  noted  previously,  Gram-negative  bacteria  (mostly  Gram-negative  bacilli)  and 
anaerobes  are  naturally  resistant  to  macrolides  (91)  while  Neisseria  spp.  and 
Haemophilus spp.  can be resistant to this antibiotic through the active efflux of the
90drug by,  mtr (334)  and acrAB (257)  pumps respectively,  which are not  specific to 
jnacrolides. Most of the Gram-negative bacteria isolated in this study were identified 
as  Neisseria  spp.  on  the  basis  of their  atmospheric  requirement,  their  Gram-stain 
(Gram-negative diplococci) and the oxidase test (oxidase positive) and some of them 
had a higher MIC than those normally associated with the presence of a mtr efflux 
pump  (110,  187)  or  a  chromosomal  mtr  mutations  (67,  194)  indicating  that these 
organisms are likely to have acquired erythromycin resistance genes (246, 334).
The proportion of streptococci resistant to macrolides has increased for the last two 
decades and more particularly in S. pyogenes and S. pneumoniae, two pathogens of 
the  upper  respiratory  tract  (60,  83,  98,  262,  317).  Erythromycin-resistant  Gram- 
positive bacteria were the  second most common resistant bacteria found in the oral 
cavity  (with  a  mean  average  of 6.3%  of the  total  viable  count)  and  34.8%  of the 
erythromycin-resistant  Gram-positive  bacteria  were  also  resistant  to  tetracycline. 
These oral bacteria can act as a reservoir for erythromycin resistance genes and they 
can  transfer  their  erythromycin  and  tetracycline  resistance  genes  to  other  more 
pathogenic bacteria such as S. pyogenes and S. pneumoniae  (9,  218).  In fact, there 
has been an  increase  in  antimicrobial  resistance  in viridans  streptococci  in the  last 
decade  and  particularly  to  p-lactam  antibiotics,  tetracyclines  and  macrolides  (74, 
294).  In the next chapters, the results of studies on the mechanisms of resistance to 
tetracycline and erythromycin in the oral microbiota will be presented.
91Chapter 4
Prevalence of Tetracycline Resistance Genes in Oral Bacteria
4.1 Abstract
Tetracycline is a broad-spectrum antibiotic used in humans, animals and aquaculture; 
therefore many bacteria from different ecosystems are exposed to this antibiotic. In 
order to  determine  the  genetic  basis  for  resistance  to  tetracycline  in  oral  bacteria, 
saliva  and  dental  plaque  samples  were  obtained  from  two  batches  of 20  healthy 
adults who had not taken antibiotics during the previous three months. The samples 
were  screened  for  the  presence  of  bacteria  resistant  to  tetracycline  and  the 
tetracycline  resistance  genes  in these  isolates  were  identified  using  multiplex  PCR 
and  DNA  sequencing.  In  this  group  of  40  individuals  a  mean  of  9.2%  of  the 
cultivable microbiota was  resistant to  8  pg/ml  of tetracycline.  Most of the isolates 
carried tetracycline resistance genes encoding a ribosomal protection protein (RPP). 
The most common tetracycline resistance genes identified were tet{M), tet{W), tet(O) 
and tet(Q).
4.2 Introduction
Tetracycline  is  a  broad-spectrum  antibiotic,  which  is  used  in  the  treatment  of 
bacterial  infections  in  humans  and  animals,  as  well  as  for  protozoal  infections  in 
humans; it is also used as a growth promoter in animals and in aquaculture and as an 
immunosuppressor in humans (45, 248). It is commonly used in dental practice as a 
prophylactic  agent  and  for  the  treatment  of  oral  infections  (86).  Low  level  of 
tetracycline  is  prescribed  to  patients  with  localized juvenile  periodontitis  since  it 
inhibits the collagenase activity of neutrophils and thus tissue breakdown (115) The 
wide  use  of  tetracycline  has  had  the  effect  of  exposing  commensal  as  well  as 
pathogenic  bacteria  from  different  ecosystems  to  the  drug  resulting  in  a  major 
increase  in tetracycline-resistant  bacteria  since  this  antibiotic  was  first used  in the 
1950s  (45).  Tetracycline  acts  by  binding  to  the  bacterial  30S  ribosomal  subunit
92preventing any further protein synthesis (248). Resistance is commonly mediated by 
efflux of the drug or ribosomal protection; however, there are also two examples of a 
gene  encoding  a tetracycline  inactivation  system  (72,  275).  So  far  nine  classes  of 
genes encoding RPP have been described (Table  1.6), the most common of which is 
tet(M) (45, 248) that is commonly contained within conjugative transposons, which 
have  an  extraordinarily  broad  host  range  (45,  237,  274).  The  tet(Q)  gene  is  also 
common and contained within a conjugative transposon (151), and there is also some 
evidence  that  tet{W)  and  tet(32)  are  contained  within  conjugative  chromosomal 
elements although these are not yet well characterised (21, 180, 264).
Eighteen genes encoding tetracycline efflux pumps have also been described (Table 
1.6).  They are found in both Gram-positive and  Gram-negative  species.  The efflux 
genes from Gram-negative organisms are widely distributed and are associated with 
large plasmids, most of which are conjugative (45). Efflux genes (tet(K) and tet(L)) 
from  Gram-positive  organisms  are  usually  found  on  small  transmissible  plasmids 
(18).  A  novel  tet gene  tet(34)  has  recently  been  described  from  a  Vibrio  sp.  (206) 
(see chapter 1.2.1.2.3.4).
In the oral  cavity,  tet(M)  has  been found  in many different bacterial  genera (143), 
tet(O)  and  tet(Q)  were  isolated  in  Gram-positive  and  Gram-negative  oral  species 
respectively (210, 211) and several efflux genes were isolated  from Gram-negative 
oral  species  (248).  However,  the  prevalence  of the  newly-discovered  tetracycline 
resistance  genes  in  the  oral  cavity  has  not  been  investigated.  Furthermore,  the 
presence of the different tetracycline resistance genes in healthy adults has not been 
investigated.  Therefore,  the  aim  of this  work  was  to  investigate  the  prevalence  of 
tetracycline  resistance  genes  in the  oral  microbiota,  which contains  many  different 
genera  and  species  of  bacteria  thereby  providing  ample  opportunity  for  genetic 
exchange  (111,  189).  Oral  bacteria also have the  opportunity to  come  into  contact 
with bacteria from other body sites (189). In this study, members of the tetracycline- 
resistant oral microbiota were screened for the presence of 12 different tetracycline 
resistance genes. It was found, for the first time, that tet(W)9  like tet{M), is common 
in  oral  bacteria  and  that  tet{O),  tet(Q),  tet(A)  and  tet(S)  are  present  in  some  oral 
species.
934.3 Materials and Methods
Multiplex PCR conditions.  Bacterial  DNA template was prepared using Puregene 
(Flowgen,  Gentra  System).  The  PCR  reaction  mixture  (total  50  pi)  included  2  pi 
template DNA in a final concentration of 0.1  to  1   pg,  1   x PCR buffer, 2.5  U DNA 
Taq polymerase  (Bioline),  300  pM  of each  of the  deoxynucleotides  dATP,  dCTP, 
dGTP, and dTTP and dP^O. The primers and MgCh concentrations were optimised 
for each multiplexed primer group  according to  the method described by Ng et al 
(206). Group I contained primers for tet(K) (1.25 pM), tetQsA) (0.5 pM), tet(O) (1.25 
pM)  and  ter(S)  (0.5  pM)  each  (3.0  mM  MgC12).  Group  II  contained  primers  for 
tet(B)  (0.25  pM),  tet(C)  (0.25  pM)  and  tet(D)  (0.2  pM)  each  (4.0  mM  MgCh). 
Individual PCR reactions were performed for tet(A), tet(Q), tet(W), tet(L) and tet(T); 
primers and PCR conditions for tet(W) and tet(T) were as described by Aminov et al 
(7) (Table 4.1).  Concerning tet(A), tet(Q), tet(L), primers and PCR conditions were 
as described by Ng et al  (195) (Table 4.1).
94Table 4.1: Description of the primers used to detect each of the tetracycline 
resistance genes
tet
genes
Amplicon 
size (bp)
Annealing
temperature
PCR
conditions
(Ref)
Group 1
Multiplex PCR
tet{  B) 659 55°C 7
tet(D) 787 55°C 7
tet(C) 418 55°C 7
Group 2 
Multiplex PCR
tet(K) 169 55°C 195
tet{  M) 406 55°C 195
tet(  O) 515 55°C 195
tet{ S) 667 55°C 195
Individual PCR tet(A) 210 55°C 195
Individual PCR tet{  L) 267 55°C 195
Individual PCR let(Q) 904 55°C 195
Individual PCR tet(T) 169 46°C 7
Individual PCR tet(W) 168 64°C 7
A  multiplex  PCR was  used  for  Group  1   and  2  and  an  individual  PCR for  tet(A), 
tet{L), tet(Q\ tet(T) and tet(W).
Some of the PCR results were confirmed, where required, by DNA sequencing (see 
chapter 2.7).
4.4  Results
In the  first Batch  of 20  samples,  a mean  of 11%  of the  cultivable  microbiota was 
resistant to 8 pg/ml of tetracycline, compared with a mean of 7.8% in Batch 2 (Table
4.2). The difference in mean proportions between the two groups was not statistically 
significant  (P >  0.05).  From the 20  samples processed,  a representative number of 
105 tetracycline-resistant bacteria were isolated for further study from Batch  1   and 
104 isolates from Batch 2.  Most of the isolates carried tetracycline resistance genes
95encoding  a  RPP.  The  most  common  tetracycline  resistance  genes  identified  were 
tet(M),  tet(W),  tet(O)  and  tet(Q)  (they  represented  79%,  21%,  10.5%  and  9.5% 
respectively of all the isolates) in Batch 1, whereas in Batch 2, tet(M), tet(O), tet(W) 
were the most common tetracycline resistance genes isolated (they constituted 78%, 
9.6% and 9.3% respectively of all the isolates). No tet(Q) gene was identified from 
Batch 2. Tetracycline resistance genes encoding an efflux protein were found in only 
5.7% of all the tetracycline-resistant isolates from the two batches (Table 4.2).
96Table  4.2:  Distribution  of the  tetracycline  resistance  genes  among  cultivable  oral 
bacteria
Tetracycline-resistance genes Batch 1  and 2 
(n=209)
% of flora resistant to tetracycline 
SD
9.2% (0.34-38.9%)a 
9.5
% of isolates containing tet{M) 
% of tetracycline-resistant 
microbiota containing tet(M) 
SDb
78% (164 isolates) 
77% (0-100%)a
26.1
% of isolates containing tet(W) 
% of tetracycline-resistant 
microbiota containing tet{W) 
SDb
15.3% (32 isolates) 
9.8% (0-93%)a
19.6
% of isolates containing tet(O) 
% of tetracycline-resistant 
microbiota containing tet(0) 
SDb
10% (20 isolates) 
9.8% (0-100%)a
19.6
% of isolates containing tet(Q) 
% of tetracycline-resistant 
microbiota containing tet(Q) 
SDb
5% (11 isolates) 
4% (0-50%)a
10.9
% of isolates containing tet(A) 2% (4 isolates)
% of isolates containing tet(K) 1.4% (3 isolates)
% of isolates containing tet(L) 1.4% (3 isolates)
% of isolates containing tet(S) 1% (2 isolates)
% of isolates containing tet(B) 1% (2 isolates)
a The percentages in brackets represent the range of values found in the 40 samples 
studied.
b The standard deviation (SD) gives an indication on how spread the data are.
97The  difference  in  mean  proportions,  between  the  two  batches,  of the  three  most 
common tetracycline resistance genes identified (tet(M), tet(W) and tet(O), excluding 
tet(Q), which was only found in Batch  1) were compared using the Kruskal Wallis 
test.  The difference  in the  mean proportion  of the tetracycline  resistance genes for 
each batch was considered  significant when the P value was <0.05. No  significant 
differences were found in the prevalence of the three tetracycline resistance genes in 
the  oral  cavity  in  the  two  batches  (Table  4.3)  therefore  Batch  3  was  not  further 
investigated. The data from Batch 1  and 2 were combined and analysed together.
Table 4.3:  Comparison of the mean proportions, between the two patient groups, of 
the three  most  common tetracycline  resistance  genes  identified  using the  Kruskal- 
Wallis test
Tetracycline- 
resistance gene
P value"
tet(M) 0.27
tet(  W) 0.62
tet{ O) 0.46
a The difference in the mean proportion of the tetracycline resistance genes for each 
patient group was considered significant when the P value was < 0.05
tet(M) was the most common tetracycline resistance gene isolated (Table 4.2); it was 
isolated  from  39  samples.  In  this  group  of 40  individuals,  between  0%  and  100% 
(mean  =  77  %,  SD  =  26.1)  of tetracycline-resistant  bacteria harboured  the  tet(M) 
gene.  15%  (n=25)  of  isolates  carrying  tet(M)  had  one  or  two  other  tetracycline 
resistance genes.  However, this did not have any effect on the MIC  of tetracycline 
since the isolates with one tetracycline resistance gene and the isolates with at least 
two had the same MIC50 and MIC90, which were 16 pg/ml and 32 pg/ml respectively.
tet(W) was the second most common tetracycline resistance gene identified. Between 
0.0%  and  93%  (mean  =  9.8  %,  SD  =  19.6)  of  tetracycline-resistant  bacteria 
harboured the  gene  (Table  4.2).  The  isolates  carrying this  gene  were  identified  by
9816S  rRNA  gene  sequencing  as  Veillonella,  Prevotella,  Streptococcus, 
Staphylococcus,  Rothia,  Lactobacillus or Neisseria  spp.  (Table  4.4).  Out of all  the 
isolates containing tet(W),  34%  (11  isolates out of 34)  contained one  or two other 
tetracycline resistance genes tet(M) (in 9 isolates), tet(0) (one isolate) and tet(L) (one 
isolate) (Table 4.4).
Table 4.4: Tetracycline resistance genes detected for the first time in oral species
Genus tet genes detected for 
the first time in a 
particular genus
Number of times 
it was found in 
each genus
Other tet genes found 
in the same isolate 
(and number of 
isolates with at least 
two tet genes)a
Rothia tet{ W) 8 tet{M) (1)
Actinomyces tet{ W) 6 tet(M) (1) 
tet(  L)(l)
Streptococcus tet(  W) 6 tet(M) (2)
Neisseria tet( W) 5 tet(M) (1) 
tet(  0)(1)
Lactobacillus tet{  W) 3 -
Veillonella tet{ W) 2 tet(M) + tet(S) (1) 
te/(M) (1)
Bacillus tet(  W) 1 -
Staphylococcus tet(  W) 1 -
Veillonella tet{  S) 2 /er(M) + tet(A) (1) 
/e/(M) + /e^(W) (1)
Neisseria tet(0) 1 te/(W) (1)
Neisseria tet(Q) 1 tet(M) (1)
Veillonella tet(A) 1 /e^(M) + tet(S) (1)
a  The  last  column  gives  an  overview  of the  isolates  containing  more  than  one 
tetracycline  resistance  gene.  For  instance,  in  the  first  row,  out  of 8  Rothia  spp. 
containing tet{W), one isolate also carried tet(M) 
tet = tetracycline
99The tet(O) and tet(Q) genes were detected for the first time in Neisseria spp.
4.5 Discussion
Resistance to tetracycline through the carriage of tet{M) was found to be widespread 
among  the  40  healthy  individuals  studied  (77%  of  the  tetracycline-resistant 
microbiota contained  te/(M))  who  had not taken any  antibiotics  in the previous  3 
months.  Tet  M  has  been  considered  to  be  the  most  widespread  tetracycline 
determinant  in  different  environments  and  has  been  found  in  a  variety  of Gram- 
positive and Gram-negative bacteria (248). The wide distribution of tet(M) probably 
reflects the fact that it is contained within broad host range conjugative transposons 
which have previously been found to be common in oral bacteria (19, 51, 237, 243).
This  is the first report of the isolation of the tet(W) gene in bacteria colonising the 
human oral  cavity.  It was the  second most common tetracycline resistance  gene  in 
the cultivable bacteria (Table 4.2). tet{W) was found for the first time in Veillonella, 
Prevotella,  Streptococcus,  Staphylococcus,  Rothia, Actinomyces,  Lactobacillus  and 
Neisseria spp.  (Table 4.4).  This gene was originally identified in the bovine rumen 
anaerobe Butyrivibrio Jibrisolvens and subsequently in human faecal anaerobes, pigs 
and recently in a facultative anaerobe Arcanobacterium pyogenes (17, 21, 264). In B. 
Jibrisolvens tet(W) is contained within a large conjugative transposon, TnB1230 (17) 
which  is  capable  of  high  frequency  conjugative  transfer  among  B.  flbrisolvens 
species.  In  A.  pyogenes  tet(W)  was  associated  with  a  mob  gene,  not  found  in 
TnB1230,  and was capable of conjugative transfer at low frequency (21), indicating 
that there are at least two different genetic elements responsible for the spread of this 
resistance gene.
Recently a new organisation of tet(W) gene was revealed in Megasphaera elsdenii, a 
commensal  anaerobic  swine  strain;  the  tetracycline  resistance  determinant  of this 
strain consisted of mosaic genes formed by recombination of tet{O) and tet(W) class 
genes  (279),  this  mosaic  organisation  was  subsequently  found  in  different  strains 
isolated  from the  faeces  of organically  raised  swine  (278).  Characterisation  of the 
genetic elements carrying tet(W) in the oral cavity will be described in Chapter 7.
100The tet{O) gene was the third most common tetracycline resistance gene isolated in 
this study (Table 4.2).  This gene has been found in different species (45) but in the 
oral/respiratory  tract  it  has  been  isolated  only  in  Gram-positive  species 
{Lactobacillus,  Enterococcus,  Staphylococcus  and  Streptococcus)  (248).  In  this 
study, tet{O) was found for the first time in one Neisseria sp. (Table 4.4). The tet{O) 
gene  was  initially  identified  on  R  plasmids  harboured  by  the  Gram-negative 
Campylobacter  coli  (196)  and  was  subsequently  found  on  the  chromosome  of 
Streptococcus spp.  where it is associated with conjugative elements (101).  Because 
of a G+C  content (40%)  higher than that of Campylobacter coli chromosomal  and 
plasmid  DNAs  (31  to  33%  respectively)  (339),  and  because  this  tetracycline 
resistance  gene  exhibits high  sequence  identity with tet{M)  from Streptococcus sp. 
(273) it is thought that tet{O), like tet(M), originated in a Gram-positive bacterium.
tet(Q)  has  been  reported  to  be  common  in  Gram-negative  oral  bacteria  that  are 
associated with periodontal tissue destruction (142, 211). However, the current study 
has shown for the first time that tet(Q) is present in a commensal Neisseria sp. (Table
4.4).  Previous  work  has  shown  that  the  tet(Q)  gene  is  frequently  associated  with 
conjugative  transposons  in the  Bacteroides  group  (151,  199,  269).  These  elements 
were  found  to  have  a  broad  host  range  and  may  be  responsible  for  the  wide 
dissemination of the tet(Q) gene in oral bacteria; this has not been investigated in this 
project but would be an obvious area of research for the future.
Out of the 209 tetracycline-resistant isolates, the tet(S) gene was found only in two 
different  Gram-negative  anaerobes  {Veillonella  sp.)  from  two  different  samples 
(Table 4.4), it is the first time that tet{S) has been isolated in this genus.  tet{S) was 
first  detected  in  Listeria  monocytogenes  BM4210  where  it  is  carried  by  self- 
transferable  plasmids  (43).  It  has  also  been  found  on  the  chromosome  of 
Enterococcus faecalis  where  it  is  associated  with  a  40-kb  fragment  that  can  be 
mobilised from chromosome to chromosome only in the presence of the conjugative 
plasmid  pIP825  (42,  93).  Recently,  tet{S)  was  shown  to  be  contained  within  a 
functional Tn9/b-like element, in the same relative position as tet{M) (144).
101tet(A), tet(S) and tet(W) were isolated from  Veillonella spp. for the first time (Table
4.4).  Previously  the  only  tetracycline  resistance  genes  isolated  from  this  organism 
were  tet(L),  tet(M)  and  tet(Q)  (45).  This  shows  that  Veillonella  spp.  may  be  an 
important reservoir of different tetracycline resistance genes.
The  carriage  of more  than  one  tetracycline  resistance  gene  was  commonly  found. 
However,  as  indicated  earlier,  this  did  not  have  any  effect  on  the  MIC  of the 
organism indicating that a need for an increased level of tetracycline resistance is not 
the selective pressure for this phenomenon. Rather this could be because some of the 
tetracycline  resistance  genes  are  contained  within  conjugative  transposons  (i.e. 
tet(M),  tet(Q),  te/(W)  and  tet(S)).  The possession of one  conjugative transposon  is 
not  a  barrier  to  that  same  cell  being  able  to  receive  other  related  or  unrelated 
conjugative  transposons  (45,  189).  It  has  also  been  shown  that  some  bacteria  are 
naturally competent (Neisseria, Haemophilus, Streptococcus spp.), which could help 
further dissemination of the tetracycline resistance genes (248).
In conclusion, this study has shown that bacteria in the oral cavity contain a variety 
of tetracycline resistance genes, indicating that oral bacteria have access to and/or are 
a reservoir of resistance genes, and that tet(O), tet{W), tet(S) and tet(Q) genes have 
spread across a broad spectrum of bacterial species. Next, it is important to determine 
the genetic  supports for some of these resistance genes in order to understand how 
they disseminate.
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Characterisation of the Genetic Basis for Erythromycin Resistance
in Oral Bacteria
5.1 Abstract
There has been an increased rate of resistance to erythromycin in clinical as well as 
commensal isolates, which correlates with an increased use of this class of antibiotics 
during  the  last  two  decades.  Resistance  to  macrolides  is  commonly  mediated  by 
methylases  (encoded  by  erm  genes),  by  efflux  of  the  drug,  by  production  of 
inactivating enzymes or, to a lesser extent, by mutation in the ribosomal binding site. 
The  aim  of  this  study  was  to  determine  the  molecular  basis  for  erythromycin 
resistance  in  oral  bacteria.  Twenty  saliva  and  plaque  samples  from  healthy  adults 
were screened for the presence of erythromycin-resistant bacteria and 122 (37 Gram- 
positive  and  85  Gram-negative)  resistant  strains  were  isolated.  All  of the  resistant 
isolates were  screened for possession of the most common erythromycin resistance 
genes  by  PCR.  Forty-two  isolates  (mostly  Gram-positive)  contained  at  least  one 
erythromycin resistance gene, whereas eighty Gram-negative isolates did not contain 
any  detectable  resistance  genes.  The  mef gene  was  the  most  commonly  found, 
followed by erm(B).
5.2 Introduction
The  macrolide  erythromycin  or  its  derivatives  are  commonly  used  in  poultry, 
livestock  and  human  clinical  practice  to  prevent  or  treat  infections  due  to  Gram- 
positive  bacteria.  In  humans,  macrolides  are  used  for  the  treatment  of respiratory 
tract infections or as an alternative in patients who are allergic to penicillin.
Macrolides  bind  to  the  50S  ribosomal  subunit  stimulating  dissociation  of  the 
peptidyl-tRNA  from  the  ribosome  during  elongation,  resulting  in  peptide  chain
103termination and reversible stoppage of protein synthesis.  This binding  site overlaps 
with the binding site of the newer macrolides, ketolides and the structurally unrelated 
lincosamides and streptograminB antibiotics (148).
There are three main mechanisms conferring macrolide resistance.  Acquisition of a 
ribosomal  methylase  (erm)  is  the  most  common  (Table  1.5).  Methylation causes  a 
conformational  change  in  the  prokaryotic  ribosome  and  confers  resistance  to 
macrolides,  lincosamides  and  streptogramins,  giving  the  MLS  phenotype  (247). 
Efflux  proteins  give  rise  to  resistance  by  pumping  the  antibiotic  out  of the  cell 
keeping the  intracellular concentration of the antibiotic  low and the ribosomes free 
from the action of the antibiotic. There are two types of efflux pump: msrAJB is most 
commonly found in Staphylococcus spp. and the mef gene is most commonly found 
in Streptococcus spp. (148) but can also be detected in Neisseria spp. (247). The mef 
gene  confers  resistance  only  to  macrolides,  giving  the  isolate  the  M  phenotype 
whereas the msrA  gene  confers resistance to macrolides and  streptogramins, giving 
the  isolate  the  MS  phenotype  (148).  Resistance  can  also  be  conferred  by  the 
production  of enzymes,  which  inactivate  erythromycin  only,  esterase  (ereA,  ereB) 
and phosphotransferases (mph); these enzymes have been found in highly macrolide- 
resistant Enterobacter spp. (8, 91).
A  fourth  mechanism  of resistance,  a base  substitution  in the  23 S  rRNA  or  in the 
ribosomal  proteins  has  emerged  in  clinical  isolates  since  the  1990s  (see  chapter 
1.2.1.2.3.3).
A healthy oral  microbiota consists mostly of Streptococcus  spp.  including viridans 
group  streptococci  (VGS),  which  have  already  been  studied  for  the  presence  of 
erythromycin resistance genes and VGS is likely to be an important reservoir for the 
dissemination of these genes to more pathogenic species (9,  10, 218, 265). Neisseria 
and  Haemophilus  spp.  can  harbour  an  efflux  pump  (mtr  and  acrAB  respectively); 
these  pumps  reduce  the  outer  membrane  permeability  of the  isolate  to  dyes  and 
detergents  and  increase  the  resistance  to  multiple  antimicrobial  agents  such  as 
macrolides, however they confer only low level resistance to this class of antibiotics 
(187,  334).  Moreover,  some  Gram-negative  bacteria  are  intrinsically  resistant  to
104macrolides due to the low permeability of their outer membrane to these hydrophobic 
compounds (91).
5.3 Materials and Methods
PCR reactions. The resistant isolates were tested for the presence of erythromycin 
resistance  genes  using  either  individual  PCR  assay  as  for  mph(A)  (284)  or  a 
multiplex  PCR.  Group  I  and  II  multiplex  PCR  included  erm(B)  and  erm(C),  and 
erm(A),  erm(F),  msr{A)  respectively using the  same  conditions  as  in Nawaz et al. 
(193).  Group III multiplex PCR consisted of ere(A.), ere(B) and mef(A) as stated in 
Sutcliffe et al. (284).
All  of the  PCR reactions  were  performed  on  DNA  isolated  using the  Puregen  Kit 
(Flowgen, Gentra System). Some of the PCR results were confirmed, when required, 
by DNA sequencing (see chapter 2.7).
Antibiotic  susceptibility.  The  different  macrolide  resistance  phenotypes  were 
identified  using  discs  containing  erythromycin  (30  jag)  or  clindamycin  (10  jag)  as 
described  by  Seppala  et  al.  (265).  Each  isolate  was  resuspended  in  tryptone  soya 
broth  (Sigma)  to  a  density  of  0.5  McFarland  units  and  was  also  tested  for  its 
susceptibility to  azithromycin  (100  jag)  and  spiramycin  (100  jag)  disks  (Oxoid)  on 
Mueller-Flinton agar (Oxoid) with 5% defibinated horse blood (E & O laboratories, 
Bonnybridge,  Scotland).  All  of the  Gram-negative  isolates  were  tested  for  their 
susceptibility to crystal violet (Sigma) and Triton X-100 (Sigma) by the agar plating 
method described by Morse et al. (187).
5.4 Results
In Batch  1, 20 % of the cultivable microbiota from the 20 samples was found to be 
erythromycin-resistant.  From the 20  samples processed,  a representative number of 
122  erythromycin-resistant bacteria were  selected  for further study.  Most (70%)  of 
the  isolates  were  Gram-negative  and  did  not  contain  previously  identified
105erythromycin resistance  genes.  Most  of the  42  isolates  found to  carry  at  least one 
erythromycin  resistance  gene  were  Gram-positives  from  the  Streptococcus  genus. 
Therefore, the mean percentage of erythromycin-resistant isolates with an identified 
erythromycin resistance gene was only 7%.
Most of the Gram-negative bacteria with no identified erythromycin resistance gene 
had a very low MIC (ranging from  1   pg/ml to 8  pg/ml) and 26.5% of all the Gram- 
negative  isolates  were  resistant to  an  elevated  concentration  of both a dye,  crystal 
violet, and a detergent, Triton X-100, thus according to Shafer et al. these isolates are 
likely to be resistant to erythromycin due to the presence of a non-specific mtr efflux 
pump (187, 334).
The  antimicrobial  susceptibility  patterns  for  erythromycin,  clindamycin, 
azithromycin and spiramycin were checked in the 42 isolates containing an identified 
erythromycin  resistance  gene  using  the  disc  method.  These  isolates  exhibited  two 
different  phenotypes:  67%  had  the  M  phenotype;  they  were  fully  resistant  to 
macrolides  (erythromycin,  azithromycin  and  spiramycin)  and  displayed  variable 
zones of inhibition around the clindamycin disc, and 33% had the MLS phenotype; 
they were fully resistant to macrolides and lincosamide (clindamycin) (Table 5.1).
106Table 5.1: Distribution of erythromycin resistance genes in the oral microbiota
*   Class of 
resistance gene 
to macrolides
Nb of 
isolates
Genusa MIC
pg/mlb
Eryc
Erythromycin
resistance
gene(s)
Resistance to 
ery, clin, azm, 
spy disks
Methylase 11 Streptococcus 64 erm(  B) Fully resistant
1 Streptococcus > 128 m ef + erm(  B) Fully resistant
1 Veillonella 32 erm(  B) Fully resistant
1 Prevotella 4 erm(  F) Fully resistant
Efflux 21 Streptococcus 4 mef Variable zones 
of inhibition
1 Streptococcus > 128 m ef  + erm(  B) Fully resistant
3 Neisseria 4-8 mef Variable zones 
of inhibition
2 Lactobacillus 2-8 mef Variable zones 
of inhibition
1 Staphylococcus > 128 msr{  A) Variable zones 
of inhibition
a The MIC breakpoint to erythromycin for Streptococcus, Staphylococcus, Neisseria 
spp. is < 0.5 pg/ml, and for anaerobes is < 2 pg/ml according to the British Society 
for Antimicrobial Chemotherapy (http://www.bsac.org.uk/). 
b The MIC50 and MIC90 of all the isolates with a methylase gene was 64 pg/ml and 
128 pg/ml respectively and the MIC50 and MIC90 of all the isolates with an efflux 
gene was 4 and 16 pg/ml respectively.
Nb = number, ery =  erythromycin,  clin =  clindamycin,  azm = azithromycin,  spy = 
spiramycin.
107Of 28 M-phenotype isolates, 27 were positive with primers specific for the mef gene 
^nd  one  was  positive  with primers  specific  for the  msr(A)  gene.  Of the  14  MLS- 
phenotype isolates,  13  were positive with primers specific  for the erm(B) gene and 
one was positive with primers for the erm{F) gene (Table 5.1). One isolate with the 
MLS phenotype carried both the erm(  B) and mef genes.
The MIC50 and MIC90 of all the isolates with a methylase  gene were 64  pg/ml and 
128  fig/ml  respectively  and the  MIC50 and MIC90 of all the  isolates with an efflux 
gene were 4 pg/ml and 16 pg/ml respectively.
The  susceptibility  of  the  isolates  to  amoxycillin  and  tetracycline  was  also 
determined.  Only  6  isolates  were  also  resistant to  amoxycillin with  a low MIC  (1 
pg/ml), except for one that had a MIC of 32 pg/ml. Five of these isolates carried the 
mef gene and one isolate with the high MIC  for amoxycillin carried the msrA  gene 
although (3-lactam antibiotics are not known to be substrates for these efflux pumps 
(150).  Out  of the  42  isolates  with  an  identified  erythromycin  resistance  gene,  12 
(28%) were also resistant to tetracycline; these last results will be further discussed in 
Chapter 6.
The 42  isolates  were  identified to  the  genus  level  by biochemical tests  and partial 
16S  rRNA  sequencing  (Table  5.1).  Most  of them  belonged  to  the  Streptococcus 
genus (34 out of 42, 81 %) and had either the efflux or methylase genes.
5.5  Discussion
There has been an increased rate of resistance to erythromycin in clinical as well as 
commensal isolates, which correlates with an increased use of this class of antibiotics 
during the last two decades (134,  165, 234, 285, 333).  The current study found that 
7%  of  the  oral  bacteria  from  samples  obtained  from  20  individuals  carried  an 
erythromycin  resistance  gene.  Most  of the  erythromycin-resistant  isolates  with  an 
identified resistance  gene  were  streptococci  and the most common resistance  gene 
was mef followed by erm(B).  These results agree with previous studies which have 
looked at the prevalence of the erythromycin resistance genes in this genus and found
108that viridans streptococci from pharyngeal samples are a reservoir of erm(B) and mef 
•genes (9, 218).  It was not surprising to find that most of the erythromycin-resistant 
isolates  were  streptococci  since  viridans  streptococci  are  important  constituents  of 
the indigenous microbiota of the upper respiratory tract of healthy humans (14).
As noted in previous studies (9, 60, 83,  102,  127,  165, 317), there was a correlation 
between  the  antibiotic  resistance  phenotype  and  genotype  for  each  isolate.  The 
isolates with a methylase gene were fully resistant to the macrolides (erythromycin, 
azithromycin  and  spiramycin)  and  to  the  lincosamide  class  of  antibiotics 
(clindamycin)  whereas  the  isolates  with  a  mef gene  displayed  varying  zones  of 
inhibition around the antibiotic discs (Table 5.1). The MIC50 and MIC90 were higher 
in the isolates with a methylase gene than those with a mef gene as already noted in 
S. pneumoniae (97), therefore, the isolates with an erm gene were more resistant to 
erythromycin than the isolates with a mef gene.  One isolate with both genes had the 
same phenotype as the isolates with the erm{B) gene only; the identification of both 
genes  in  the  same  isolate  and  the  expression  as  MLS  phenotype  has  already been 
described  in Streptococcus pneumoniae  and Streptococcus pyogenes (83,  165,  175, 
218).
Perez-Trallero  et  al  showed  that  94.4%  of  a  total  of  197  subjects  carried 
erythromycin-resistant commensal  streptococci  in their pharynx and that there were 
no statistical  differences  in the number, the  species or the resistance phenotypes of 
erythromycin-resistant  streptococci  found  in  healthy  subjects  or  subjects  with 
pharyngitis (218).  Moreover, half of the erythromycin-resistant streptococci had the 
M  phenotype  and  the  other  half had  the  MLS  phenotype.  In  this  study,  a  high 
percentage  of  individuals  (80%  out  of  a  total  of  60  subjects)  also  carried 
erythromycin-resistant streptococci in their oral cavity.  However, the distribution of 
the phenotypes was different since 67% had the M phenotype and 33% had the MLS 
phenotype.  This difference  in the prevalence of the methylase  genes and the efflux 
genes  in  some  clinical  and  commensal  streptococcal  isolates  has  been observed  in 
different  studies  (83,  97,  175,  191,  285).  It  appears  that  the  resistance  pattern  to 
macrolides  in  Streptococcus  spp.  depends  on  the  geographical  region  and  more 
particularly on the macrolide used in this particular region; a positive correlation was 
found  between  azithromycin  use  and  an  increase  in  macrolide  resistance  (335),
109however no  study has ever shown the  link between the use of a macrolide and the 
prevalence of a particular erythromycin resistance gene.
One of the reasons for the dissemination of the mef gene in VGS is the presence of 
this gene on mobile elements. Recently the m ef  A) gene was shown to be part of a 
7.2-kb non-conjugative transposon Tn7207.1 (260) that was subsequently reported to 
be part of a larger conjugative transposon, Tn7207.3  (259).  The mef gene was also 
found to be inserted into a Tn97b-like element, in a sequence homologous to orf6 of 
Tn916 (Fig 1.8) forming the new element Tn2009 (68).
The current study  showed that a methylase  gene,  erm{B),  was isolated for the first 
time  from  a  Veillonella  sp.  Veillonella  spp.  have  already  been  shown  to  be  an 
important  reservoir  for different  tetracycline  resistance  genes  (see  Chapter 4).  The 
remaining Gram-negative  isolates with no  identified erythromycin resistance  genes 
that  do  not  present  a  mtr  phenotype  are  likely  to  be  intrinsically  resistant  to 
macrolides (91) and this is supported by their low MIC to erythromycin. None of the 
Gram-negative  isolates  with  a  known  erythromycin  resistance  gene  had  the  mtr 
phenotype.
No  ermA  genes  were  detected  during  this  study  although this  gene has previously 
been found in Peptostreptococcus  spp.,  a normal member of the pharyngeal, dental 
and  gingival  microbiota,  and  was  shown  to  transfer,  albeit  at  low  frequency,  to  a 
Streptococcus pyogenes recipient (233); it is possible that no Peptostreptococcus spp. 
were isolated in this study because the collection or transport of specimens were not 
optimised enough for the recovery of these Gram-positive anaerobic cocci (190).  A 
previous  study  looking  at  the  distribution  of  m ef and  erm  genes  in  commensal 
streptococci  resistant to  erythromycin  did  not  isolate  any  erm(A)  in  a total  of 253 
isolates (218), thus erm(A) is not commonly isolated from the oral cavity.
No  PCR products were  detected with primers for ere{A),  ere(B)  and mph,  but this 
was not  surprising  since  these  genes  are  most commonly  found  in highly  resistant 
Enterobacter spp.  (8,  11,  205)  and they have not been isolated from Streptococcus 
spp.
110Ribosomal mutation conferring resistance to macrolides has emerged in the last few 
years  as  the  sole  mechanism  of  resistance  in  clinical  isolates  of  mostly  S. 
pneumoniae (289) and S. pyogenes (23). However, all of the erythromycin-resistant 
streptococci  isolated  in  this  study  contained  either  a  mef or  erm  gene.  Ribosomal 
mutations might have appeared due to the  selective pressure  of increased  levels of 
exposure  to  macrolides  in  recent  years  (289),  but  it  is  not  found  as  the  sole 
mechanism  of resistance  to  macrolides  in  oral  commensal  streptococci,  however 
there  is  still  the  possibility that  it  could be  found  in  conjunction with a resistance 
gene, explaining why it was not detected in this study.
In  this  study,  commensal  streptococci  of  the  oral  cavity  were  shown  to  be  an 
important reservoir for erythromycin resistance genes and may be a reservoir for the 
dissemination of the erm(  B) and the mef genes to more pathogenic bacteria such as S. 
pyogenes and S. pneumoniae. In the next chapter, the transfer of antibiotic resistance 
genes between the oral streptococci and Enterococcus faecalis will be examined.
IllChapter 6
Transfer of Genes Encoding Antibiotic Resistance
6.1 Abstract
Of the 42 isolates that contained an identified erythromycin resistance gene,  12 were 
also  resistant to  tetracycline  and 4  out of these  12  isolates were  shown to transfer 
both  genes  simultaneously  to  an  Enterococcus faecalis  recipient  in  filter-mating 
experiments.  Hybridisation  analysis  showed  that  the  transferred  genes  were 
contained within a conjugative transposon related to Tn7545.
6.2 Introduction
Conjugative transposition is one of the most common mechanisms of horizontal gene 
transfer  between  organisms  of  different  species  or  different  genera  (255).  The 
Tn9J6-Tnl545 family of elements are the best-studied conjugative transposons; they 
have been found  in a wide variety of Gram-positive  and  Gram-negative  organisms 
(51),  and  they  appear  to  have  played  a  significant  role  in  the  dissemination  of 
multiple antibiotic resistance among clinically important species such as streptococci 
(237, 267). Both transposons contain tet(M), identical ends and similar integrase and 
excisase genes (called int/xis respectively) (51).  Tn1545 carries two extra antibiotic 
resistance  genes,  erm{B)  and  aphA-3,  conferring  resistance  to  macrolides  and 
kanamycin respectively. Although this family of conjugative transposons has a wide 
host-range  this  study  is  the  most  complete  investigation  of  Tnl545  elements  in 
viridans streptococci.
1126.3 Materials and Methods
Detection  of  erythromycin  and  tetracycline  resistance  determinants.  The
erythromycin-resistant  isolates  from  Batch  1   that  had  an  identified  erythromycin 
resistance gene (see chapter 5) and that were also resistant to tetracycline were tested 
for  the  presence  of tetracycline  resistance  genes  using  multiplex  PCR  for  tet(K), 
tet(M), tet(O) and te^(S) as described in Ng et al. (195), or an individual PCR assay 
for tet(W) as described in Aminov et al.  (7).
Mating experiments.  Each isolate  with an identified erythromycin resistance  gene 
and  which  was  also  resistant  to  tetracycline  was  tested  for  its  ability  to 
simultaneously  transfer  both  genes  to  Enterococcus  faecal  is  JH2-2  which  was 
resistant to rifampicin (see chapter 2.8). The experiment was repeated four times: the 
transconjugants  were  selected  twice  on  tetracycline  (8  pg/ml)  and  rifampicin  (25 
pg/ml)  plates  and  twice  on  erythromycin  (10  pg/ml)  and  rifampicin  (25  pg/ml) 
plates.  Each  transconjugant  was  also  tested  for  its  resistance  to  the  non-selected 
marker  by  plating  it  onto  tetracycline  or  erythromycin-containing  plates.  The  co­
transferred  resistance  genes  were  identified  by  PCR  and  Southern  blot  for  each 
transconjugant.
Hybridisation.  Total  DNA from the donors and transconjugants was digested with 
HindUl,  run  into  an  agarose  gel  and  transferred  to  Hybond-N+  membrane  by 
Southern  blotting  (see  chapter  2.9).  Hybridisations  were  performed  with  tet(M), 
erm(B), plasmid pAM120 (containing Tn9J6), plasmid pPPM70 (containing aphA-3) 
or int/xis probes (Appendix  1).  The probes were either made from PCR products of 
the respective control  strains  (Appendix  3),  which were then purified using a PCR 
purification  kit  (Sigma)  or  from  the  whole  plasmids  pAM120  and  pPPM70 
(Appendix  1).  The  hybridisation  blots  were  developed  and  exposed  to  Hyperfilm 
ECL (Amersham) for 5 min and overnight.
1136.4 Results
In the course of this study,  12 isolates were identified that, as well as being resistant 
to  erythromycin,  were  also resistant to tetracycline  (Table  6.1).  The most common 
antibiotic resistance genes identified were erm(B) and tet(M) (Table 6.1). One isolate 
contained  msr(A)  and  tet(W)  but  no  transfer  was  detected  from  this  strain  (Table 
6.1).
Four  isolates  out  of  12  could  transfer tetracycline  and  macrolide  resistance  to  the 
Enterococcus faecalis JH2/2  recipient  strain under the  conditions used (Table 6.1). 
The  frequencies  of  transfer  from  the  4  donors  were  variable  according  to  the 
antibiotic used for selection.  Donors E25-3  and E31-2 did not transfer at detectable 
frequencies when tetracycline  was  used as the  selective  antibiotic but were able to
n  7  ,
transfer  at  an  average  frequency  of 3.3  x  10'  and  1.4  x  10’  transconjugants  per 
donor  respectively  when  erythromycin  was  used  as  the  selective  agent.  However 
donors E37-4 and E38-2 had a higher transfer frequency when tetracycline was used 
as  the  selective  antibiotic  (5.15  x  10'4  and  1.5  x  10'5   transconjugants  per  donor
c  o
respectively)  whereas  the  frequencies  of  transfer  were  2.6  x  10'  and  7  x  10' 
transconjugants per donor respectively when erythromycin was used as the selective 
agent (Table 6.1).
All  the  transconjugants  were  resistant  to  both  erythromycin  and  tetracycline  and 
contained  both  tet(M)  and  erm{B).  The  four  different  donors  belonged  to  the 
Streptococcus  genus;  the  MICs  of  the  transconjugants  for  the  two  different 
antibiotics were similar to those of the donors (Table 6.1).
114Table 6.1:  Results of the filter-mating experiments between strains resistant to both
erythromycin and tetracycline as donors and E. faecalis JH2/2 as the recipient
Isolate Genus Transcon­
jugant
Ermr/ Tcr genes 
from the donor and 
their respective 
MIC (pg/ml)
Ermr/Tcr genes from 
the transconjugant 
and their respective 
MIC (pg/ml)
Frequency of 
transfer3  
(CFU/donor cell)
E21-3 Staph nd msr(A)l tet(W) 
(128 and 128)
nd
E23-4 Strep nd erm( B)/ tet(M) 
(32 and 16)
nd
E24-2 Strep nd erm{ B)/ tet( M) 
(128 and 16)
nd
E25-3 Strep E25-3 x 
E. faecalis
erm(B)/ tet(M) 
(64 and 32)
erm( B)/ tetlfA) 
(128 and 32)
5.8 10-y/ 8.6 10-5
E26-5 Strep nd erm( B)/ tet(M) 
(128 and 32)
nd
E31-2 Strep E31  -2 x 
E. faecalis
erm(B)/ tet(M) 
(4 and 32)
erm{ B)/ tet{ M) 
(128 and 64)
1.5 10-'/1.3 10-'
E31-3 Strep nd erm( B)/ tet( M) 
(64 and  16)
nd
E33-3 Strep nd mef/ erm( B)/ tet( M) 
(128 and 16)
nd
E37-4 Strep E37-4 x
E. faecalis
erm(B)/ tet(M) 
(128 and 32)
erm(B)/ tet(M) 
(128 and 64)
1.3  10’'/5.1  10’5  
(8.5  1  O'4/ 1.8 10-4)
E38-2 Strep E38-2 x 
E. faecalis
erm( B)/ tet(}A) 
(128 and 32)
erm{ B)/ tet{ M) 
(128 and 64)
5.4 10 s/ 8.6 10'8 
(2.6 1  O'5/ 3.7 10'6)
E38-4a Veill nd erm(B)/ tet(M) 
(32 and 8)
nd
E38-5 Strep nd erm( B)/ tet( M) 
(64 and 32)
nd
3 Frequency of transfer found when erythromycin was used as the selective agent; in
brackets  are  the  frequencies  of transfer  found  when  tetracycline  was  used  as  the 
selective agent.
Highlighted in yellow are the isolates that co-transferred both resistance genes to E. 
faecalis JH2/2 recipient strain.
Ermr  =  erythromycin  resistance,  Tcr  =  tetracycline  resistance,  nd  =  not  detected, 
Staph = Staphylococcus, Strep = Streptococcus,  Veil  I = Veillonella.
115The  parents  and  transconjugants  were  subjected  to  a  Southern  blot  analysis.  The 
analysis of the blots showed at least two different Tn7545-type genetic elements (Fig 
6.1). In one of which the erm(B) and tet{M) genes are contained on the same 4.8-kb 
Hindlll fragment however aphA-3 and erm(B), int/xis and tet(M) are contained on a 
different HindUl  fragment  (Fig  6.1);  see  lanes  4  (donor  E25-3),  5  (transconjugant 
E25-3  x  E. faecalis),  6  (donor E31-2),  7  (transconjugant  E31-2  x  E. faecalis),  10 
(donor E38-2),  11  (transconjugants E38-2 x E. faecalis). In the second Tnl545-typc 
genetic elements, the erm(B) and tet(M) genes are not contained on the same Hindlll 
fragment, however int/xis and tet(M) as well as aphA-3 and erm(B) are contained on 
the same Hindlll fragment; see lanes 8 (donor E37-4) and 9 (transconjugant E37-4 x 
E. faecalis) (Fig 6.1).
Furthermore,  the  donor  E25-3,  lane  4,  contains  at  least  one  copy  of the  Tnl545 
element (the erm(B), tet(M), int/xis and  aphA-3 genes are contained within a Tn916- 
like  element)  however,  the  hybridization blots  showed the  presence  of three bands 
when using erm(B) and tet{M) as probes and identical band size are also present in 
the pAM120 blot, this might reflect the presence of a Hindlll restriction site within 
these two antibiotic resistance genes.
Donor E31-2, lane 6, contains only one copy of Tnl545, however the transconjugant 
E31-2  x  E. faecalis  in  lane  7  received two  copies  of the  same  element;  the  use of 
erm{B),  tet{M)  and  int/xis as probes  resulted  in the presence  of two bands in each 
blot  and  identical  band  size  are  also  present  in  the  pAM120  blot.  However,  the 
hybridization with aphA-3  probe resulted  in the presence  of one band only but the 
band is very thick and might be due to the presence of two copies of the aphA-3 gene 
with bands of similar size juxtaposed to each other.
Transconjugant  E37-4  x  E.  faecalis  in  lane  9  received  one  copy  of the  Tn 1545 
element.  Each blot also  showed the presence of a high molecular weight band that 
hybridized with each probe and it is likely due to the presence of undigested DNA 
(Fig 6.1).
Donor E38-2,  lane  10,  contains  erm(B)  and  tet(M)  on the  same  Hindlll  fragment, 
however the  band  is  not  showing  on the pAM120  blot and might be  due  to  a low
116DNA  concentration  during  digestion  and/or  a  short  exposure  time  during  the 
development of the hybridization blot. Transconjugant E38-2 x E. faecalis in lane 11 
received two copies of the Tnl545 element; showed by the presence of two bands for 
int/xis.  The occurrence of a thick band for erm(B), tet(M) and aphA-3 might be due 
to the presence of two copies of the genes with bands of similar size juxtaposed to 
each others (Fig 6.1).
Donors E23-4,  lane  12,  E24-2,  lane 13,  and E33-3,  lane  14,  did not transfer any of 
their resistance genes under the conditions used.  Donor E23-4  contains erm(B) and 
tet(M)  genes  on  the  same  4.8-kb  Hindlll  fragment  however  aphA-3  and  erm(B), 
int/xis and tet(M) are contained on a different Hindlll fragment whereas donors E24-
2 and E33-3 contain int/xis and tet{M) on the same Hindlll fragment as well as aphA-
3  and  erm(B)  but erm(B)  and  tet(M)  genes are  not contained  on the  same Hindlll 
fragment (Fig 6.1).
117Figure 6.1: Analysis of the conjugative element involved in the transfer of erm(B) 
and tet(M) by southern blotting
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Southern  blot  hybridisation  analysis  showing  a  linkage  between  tet(M),  erm(B), 
int/xis and aphA-3 genes in the parents and the transconjugants from the filter-mating 
experiments.  The  entire  genomic  DNA  was  digested with Hindlll.  Lambda DNA- 
BstE II digest was used as the molecular size marker and the numbers on the left of 
the blots represent the size in KB of some of the size markers.
Each  panel  shows  the  results  of probing the  same  blot  with  a different probe  (A) 
tet(M), (B) erm(B), (C)  int/xis, region from Tn916,  (D) pPPM70 containing aphA-3 
and (E) pAM120.
The  lanes  contain  genomic  DNA  as  indicated  (1) E. faecalis JH2/2,  (2) B.  subtilis 
BS34A (see Appendix  1), (3) S. pyogenes AC1  containing erm{B) (see Appendix  1), 
(4) Streptococcus E25-3, (5) transconjugant from the mating Streptococcus E25-3 x 
E.  faecalis  JH2/2,  (6)  Streptococcus  E31-2,  (7)  transconjugant  from  the  mating 
Streptococcus E31-2 x E. faecalis JH2/2, (8) Streptococcus E37-4, (9) transconjugant 
from the mating Streptococcus E37-4 x E. faecalis JH2/2, (10) Streptococcus E38-2, 
(11) transconjugant  from the mating E38-2  x E. faecalis JH2/2,  (12) Streptococcus 
E23-4, (13) Streptococcus E24-2, (14) Streptococcus E33-3.
6.5 Discussion
In  the  course  of  this  study,  12  isolates  were  identified  that  were  resistant  to 
erythromycin  and  to  tetracycline  (Table  6.1).  Four  of these  could  transfer  both 
resistance  genes  to  an  Enterococcus faecalis  JH2/2  recipient  strain (Table  6.1).  In 
each  case,  the  co-transferred  genes  were  erm(B)  and  tet(M).  The  conjugative 
transposon Tn1545 has previously been shown to be responsible for the transfer of 
tetracycline  and  erythromycin resistance,  this  element also  contains the kanamycin 
resistance  gene  aphA-3  (276).  The  ends  of Tn1545,  which contain the  int and xis
119genes,  are  almost  identical  to those  of Tn916 (237)  and,  like  Tn97b,  Tnl545  also 
contains the tet(M) gene. Consequently, in order to test for the presence of a Tn1545- 
like element in the strains isolated, the parents and transconjugants were subjected to 
a Southern blot analysis against aphA-3,  tet(M), the int and xis genes of Tn916 and 
pAM120.  The  blots  showed  that  in  all  the  strains  that  contained  a  transferable 
element, the aphA-3,  te/(M), erm(B) and int/xis genes were present and therefore are 
likely  to  be  linked.  No  PCR  products  or  hybridisation  to  the  recipient  DNA  was 
observed (Fig 6.1  lane  1), indicating that a Tn7545-like element was responsible for 
the transfer.
Some  of  the  donors  did  not  transfer  any  of  their  resistance  genes,  although 
hybridisation analysis  indicated that they were likely to be contained on a Tnl545- 
like element.  It is known that the integration site of conjugative transposons has an 
effect on the transfer frequency of the elements (237). Therefore, the non-transferors 
may  be  inserted  into  a  site  from  which  the  excision  frequency  is  low.  Other 
possibilities  for  non-transfer  include:  1)  that  the  conjugative  transposon  has  a 
mutation in a gene essential for mobility or 2) essential host factors may be absent in 
some strains. This last event has been observed in Lactococcus lactis, which can act 
as a recipient of Tn916,  however subsequent transfer of the conjugative transposon to 
another  host  does  not  take  place  implying  that  L.  lactis  is  deficient  for  a  factor 
required for conjugative transposition (29).
The  Tn916-Tnl545  family  of elements  has  been  well  established  in  a  variety  of 
Gram-positive  and  Gram-negative  organisms  (51,  237,  267).  The  Tn7545-like 
element  is  identified  in  this  study  from  viridans  group  streptococci  (two  S. 
parasanguis,  one S.  salivarius and one S.  mitis, according to the partial  16S rRNA 
sequencing)  for  the  first  time.  This  transposon  is  very  common  in  pathogenic 
streptococci  such as S. pyogenes (101) and S. pneumoniae  (174,  185, 267), but the 
association  between  erythromycin  and  tetracycline  resistance  does  not  seem  to 
appear  in  other  groups  of  streptococci  (61)  and  there  are  few  reports  of  this 
association in viridans group  streptococci  (293).  In this last study, they showed the 
presence  of tet(M),  erm(B)  and  int/xis genes by PCR in S.  bovis.  However, further 
investigation  is  required to  confirm the presence  of Tnl545  since  a linkage  of the 
erm and tet genes on the same element was not shown, and it is known that int and
120xis genes can be found not linked to antibiotic resistance genes (144) or some strains 
• resistant to erythromycin (erm(B)) and tetracycline (tet(M)) may carry the composite 
element Tn3872 or one  similar to it (174).  This current study is the most complete 
investigation of the presence of Tn/545 in VGS, as it has proved linkage between the 
tetracycline,  erythromycin and kanamycin resistance genes in these organisms.  The 
presence of a Tn7 545-like element in oral streptococci is not surprising since Tn  916- 
like elements have been shown to be transferred within a model oral biofilm between 
different  oral  streptococci  (243),  demonstrating  that  they  are  responsible  for 
harbouring and disseminating mobile elements.
This  study  has  revealed  the  presence  of  at  least  two  different  Tn/545-like 
conjugative  transposons  (Fig  6.1);  transconjugants  E25-3,  E38-2  and  E31-2 
contained  erm(B)  and  tet(M)  on  the  same  Hindlll  restriction  fragment,  whereas 
transconjugant  E37-4  contained  erm(B)  and  tet(M)  on  different Hindlll  restriction 
fragments.  In the transposon  detected  in S. pneumoniae  by Caillaud et al.  in  1987 
(33), the tetracycline and erythromycin resistance genes were separated by a Hindlll 
site  as  well  as  the  kanamycin  and  erythromycin  resistance  genes,  furthermore  the 
tetracycline resistance gene contains one Hindlll restriction site.
When int/xis is used to probe Hindlll digested DNA the number of bands reflects the 
number  of copies  of the  transposon  since  it  is  responsible  for the translocation of 
Tn916 and is present in only one copy in Tn916-Tnl545 family of transposons (188, 
237).  The hybridisation showed that all of the isolates tested possessed at least one 
copy  of a  Tn/545-like  element  (they  all  have  one  band  only  when  probed  with 
int/xis)  and  in  lanes  7  and  11  the  transconjugants  received  two  copies  of  the 
transposon  since  they  have  two  bands  when  probed  with  int/xis  (Fig  1.9).  The 
presence  of multiple  copies  of the  transposon  after  filter-mating  has  already  been 
observed among conjugative transposons (207). Although the Tn9/d-Tn/545 family 
of elements  is  not  replicative,  the  presence  of a  second  copy might be  due to the 
intracellular  transposition  of Tn916  from  one  of two  daughter  chromosomes  after 
passage of the replication fork followed by insertion into a chromosomal region that 
has  not  yet  replicated  (237).  Another  explanation  might  be  the  co-transfer  or  the 
independent transfer of Tn916 copies during a mating event (51).
121The transfer frequencies  obtained in this  study were  similar to the ones previously 
.found for Tn9/b-like elements, that is from  10'9 and  10'4 transconjugants per donor 
(51).
No  isolates  with  the  m ef gene  only  were  found  to  be  resistant  to  tetracycline, 
although  a  previous  study  found  that  most  of  the  erythromycin-resistant  oral 
streptococci of the MLS  and M phenotype were also resistant to tetracycline (101). 
The mechanisms behind the rapid dissemination of the mef gene are being revealed. 
It could be due to the clonal expansion of one strain, since some studies have shown 
a  link  between  the  serotype  and  the  presence  of this  gene  (234),  or to  horizontal 
transfer.  In one study, the m ef gene was shown to be transferable between different 
species  in the  presence  of DNAses,  indicating that transfer is by conjugation or by 
transduction (164). Indeed, some m ef genes have recently been found to be contained 
within a novel transposon Tn/207.3 (259) or within the Tn2009 element consisting 
of the m ef gene inserted into a TnP/d-like transposon (68).
In this study, it was demonstrated that there is variation in the genetic organisation of 
the Tnl545-\ike elements and that these elements are widespread in the oral cavity. 
Linkage  of multiple  antibiotic  resistance  genes  on  the  same  mobile  element  is  of 
public health importance, because use of any of the antibiotics to which the element 
confers resistance  selects  for retention of the transposon and,  accordingly, multiple 
antibiotic resistance genes. In the oral microbiota, interspecies exchange of resistance 
genes combined with antibiotic selection pressure, could select for more pathogenic 
multidrug-resistant bacteria.
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Identification of the Genetic Support for tet{W)
7.1 Abstract
There is considerable potential for genetic exchange between bacteria from different 
habitats.  Recently,  a  new  tetracycline  resistance  gene,  tet(W),  was  isolated  from 
Butyrivibrio fibrisolvens,  a rumen bacterium.  In the  current study,  tet{W) has been 
isolated from the oral cavity for the first time and was found to be the second most 
common tetracycline resistance gene after tet(M). One Rothia strain carrying tet(W) 
was  further  investigated.  The  gene  was  cloned  into  pUC18  and  the  recombinant 
plasmid  sequenced.  The  plasmid  contained  an  insert  of approximately  13-kb,  the 
sequence  of which  shows  that  tet(W)  is  linked  to  two  different  transposases,  and 
located between two identical copies of the mef gene. Further PCR amplifications for 
this region of DNA on  other oral  isolates  containing tet(W)  demonstrated that this 
structure  accounted  for  many  of  the  genetic  supports  for  tet{W)  in  the  oral 
environment.
7.2 Introduction
The  first  tet(W)  gene  was  identified  from  the  bovine  rumen  anaerobe Butyrivibrio 
fibrisolvens  and  subsequently  in  human  faecal  anaerobes,  pigs  and  in a facultative 
anaerobe  Arcanobacterium  pyogenes  (17,  21,  264).  In  B.  fibrisolvens  tet(W)  is 
contained within a large conjugative transposon,  TilB1230 (17) which is capable of 
high frequency  conjugative transfer among B. fibrisolvens  species.  In A. pyogenes, 
tet(W)  is  associated  with  a  mob  gene,  not  found  in  TilB1230,  and was capable  of 
conjugative transfer at low frequency (21).
Commensal  bacteria  have  often  been  shown  to  serve  as  reservoirs  of antibiotic 
resistance genes eg those of the intestinal tract of humans and animals (17,  180, 264)
123and viridans  group  streptococci  of the upper respiratory tract of humans (31,  340). 
•The  presence  of  different  types  of  elements  carrying  tet{W)  among  commensal 
rumen bacteria is clear evidence of their likely role in the expansion, dissemination, 
and  preservation  of antibiotic  resistance  genes  and  also  in  the  evolution  of those 
genes. By determining the genetic support of tet(W) in the oral cavity, we wanted to 
get a better understanding of the origin of this gene as well as the reason for its wide 
dissemination in this habitat.
7.3  Materials and Methods
The  methods  for  sampling  and  detection of tet(W) have been described previously 
(see chapters 3 and 4).
PCR. In order to determine if the genetic support of the tet(W) genes we observed in 
our oral  samples were  similar to the tet(W) gene from Butyrivibrio fibrisolvens we 
carried  out  PCR  amplifications  using  specific  primers  for the  whole  gene  isolated 
from TnB1230 (primers  Bf and Br Fig 7.1) as well as primers including the whole 
gene  and  the  upstream  region  specific  for  TnB1230  (primers  Af and  Br  Fig  7.1). 
Both  sets  of primers  were  provided  by  Brunei  et  al.  (Appendix  3)  and  the  PCR 
conditions were as follows, one cycle of 5 min at 94°C, 60 s at 50°C, 2 min at 72°C 
was performed followed by 29 cycles of 60 s at 94°C, 60 s at 50°C, and 2 min at 72°C 
with a final extension at 72°C for 10 min.
124Figure 7.1: Position of the tet(W) primers compared with the whole gene isolated in 
. TnB1230 from Butyrivibrio fibrisolvens
Af  Bf
-►   -►
  ►   —
-------------------------  1  kb
This diagram represents part of Tn67250-containing tet(W) (179). The tet(W) gene 
is  represented  by  the  thick  black  line,  two  putative  nitroreductases  upstream  and 
downstream of tet(W) are represented by dashes.  Primers Af, Bf and Br (Appendix 
3)  were  used  in  two  different  PCR  reactions  to  compare  /er(W)-positive  isolates 
found in this study with tet(W) from TilB1230.  The arrows show the likely direction 
of transcription.
Cloning.  One  Rothia  isolate  containing  tet(W)  was  selected  for  cloning  (isolate 
T40.1  in  Table  7.1).  The  genomic  DNA  was  extracted  (see  chapter  2.3)  and  the 
concentration  of DNA  obtained  was  approximately  25  ng/pl,  it  was  then  partially 
digested with Mbol  (Biolab).  For the digestion reaction,  34  pi  of DNA was mixed 
with 4 pi of Buffer (10 x Buffer 3, Biolab), 2 pi of enzyme (5U/pl), in a total volume 
of 40 pi; the digestion was repeated twice at 37°C at two different times, one for 10 
min and another for  15  min.  Both digestions were pooled and run into a gel and the 
region between 4- and  10-kb was cut from the gel and purified using a gel extraction 
kit  (see  chapter  2.10.3).  Ligation  into  pUC18  and  transformation  into  DH5a 
(Invitrogen)  were  performed  as  stated  in  chapters  2.10.4  and  2.10.5  respectively. 
Transformants  containing  tet{W)  were  selected  for  on plates  containing  ampicillin 
(50 pg/ml) and tetracycline (5 pg/ml).
Subcloning.  Part  of  the  insert  (around  6  kb  downstream  tet(W))  could  not  be 
sequenced  and  so  was  digested  and  subcloned.  The  plasmid  containing  the  insert 
which  conferred  resistance  was  extracted  as  stated  in chapter  2.10.1  and the  final 
concentration obtained  was  around  50  ng/pl.  For the digestion reaction 5  pi of the
125plasmid-containing  the  insert was  digested  with two  enzymes:  2  pi  of 7/mdIII  (20 
.U/pl, Biolab) and 2 pi of EcoRl (20 U/pl, Biolab), and the reaction was mixed with 2 
pi  of Buffer (10  x  Buffer 2,  Biolab),  9  pi  of dL^O  in a total volume of 20  pi and 
incubated at 37°C for 60 min. The digestion was run into a gel and according to the 
data  already  obtained  it  was  deduced that  bands  of 2  and  5  kb  were the bands  of 
interest (Fig 7.2) and thus were cut from the gel and purified using a gel extraction 
kit (see chapter 2.10.3).  The vector, pUC18, was also digested with both enzymes, 
the mixture was as follows:  10 pi of vector was mixed with 3 pi of Hindlll (20 U/pl, 
Biolab), 3  pi of EcoRl (20 U/pl, Biolab),  10 pi of buffer (10 x Buffer 2, Biolab), 74 
pi of dFLO in a total volume of 100 pi, the digestion was incubated for 2 hrs at 37°C. 
Subsequent  plasmid  dephosphorylation,  ligation  and transformation reactions  were 
performed as stated in chapters 2.10.2, 2.10.4 and 2.10.5 respectively.
Sequencing.  Part of the  insert of pPPMW  (approximately 7 kb) was sequenced by 
the  Lark  Technology  Inc  (Takeley,  UK)  and  the  remainder  of  the  insert  was 
subcloned into pUC18 and sequenced using the universal primers M13F and M13R 
(Appendix  3)  as  stated  in  chapter  2.7.  Subsequent  primers  were  designed  using 
Primer3  program  (http://frodo.wi.mit.edu/cgi-bin/primer3/primer3  www.cgi).  The 
sequencing  was  performed  on  both  strands  and  was  compared  to  those  in  public 
sequence  repositories  (GenBank)  using  the  basic  local  alignment  search  tool 
(BLAST) (6).
Comparison  of tet(W)  organisation.  The  different  tet(W)  isolates were  compared 
by PCR using different sets of primers (Fig 7.3  and Appendix 3), the primers were 
designed  as  stated above.  The  PCR conditions were as folows 35  cycles of 60  s at 
94°C, 60 s at 64°C and  180 s at 72°C with a final extension at 72°C for 5 min. Some 
of the PCR results were confirmed, where required, by DNA sequencing (see chapter 
2.7).
Mating experiments. The Rothia sp.  from which tet(W) was cloned (isolate T40.1) 
was tested for its ability to transfer the tet(W) gene to Enterococcus faecalis JH2-2 
which is resistant to rifampicin (see chapter 2.8). The transconjugants were selected 
on tetracycline (5 pg/ml) and rifampicin (25 pg/ml) containing agar.
126Stability assay. To study the stability of the insert in E.  coli, the clones were grown 
pvemight in LB broth (Appendix  1) containing ampicillin (50  pg/ml), serial diluted 
and plated onto ampicillin-containing plates and incubated for 18 hrs at 37°C. Plates 
containing around 50  single colonies were replicated onto a set of ampicillin plates 
only (50  pg/ml) and a set of ampicillin and tetracycline plates (5  pg/ml). The same 
experiment  was  performed  with  the  original  strain  T40.1,  the  only  difference  was 
that it was grown overnight in BHI broth (Oxoid) without antibiotics.
7.4  Results
7.4.1  DNA sequence analysis of tet(W) cloned from Rothia sp.
The  flanking  regions  of the  tet(W)  genes  found  in  this  study  were  compared,  by 
PCR, with the flanking regions of tet{W) isolated from TnB1230 from Butyrivibrio 
fibrisolvens.  PCR  with  primers  Bf-Br  and  Af-Br  (Fig  7.1)  yielded  products  in  11 
isolates out of 31  containing tet(W), however when these strains were re-tested it was 
found that the tet(W) gene was lost. The stability of the tet{W) gene in these strains 
could not be measured easily as the organisms all contained another tet gene.  This 
could be due to recombination between the repeated flanking regions. Unfortunately 
no more work could be performed on these strains. Out of the 20 remaining isolates 
containing  tet{W),  one  Rothia  sp.  (isolate  T40-1  in  Table  7.1)  was  further 
investigated.  The  tet(W)  gene was cloned into pUC18 (see materials and methods). 
Four clones were  isolated on tetracycline-containing plates (5  pg/ml) and tested by 
PCR for the presence of tet{ W) and all produced a product of the expected size (data 
not shown). The restriction pattern obtained with Hindlll and EcoRl was identical in 
each,  showing that an  insert of 13  kb  had been cloned  (Fig 7.2  lanes  1   to 4).  One 
plasmid was chosen for further study and designated pPPMW.
127Figure 7.2: Restriction pattern of pPPMW and pPPMW-1
Lanes  1   to  4  contain  DNA  from  the  4  clones  containing  te/(W),  pPPMW,  lane  5 
contains  plasmid  DNA  that  has  spontaneously  lost the  te/(W)  gene,  pPPMW-1,  and 
lane  6  contains  pUC18.  The  samples  were  double  digested with HindlW  and EcoRl. 
The  1  -kb  DNA  ladder (Biolabs) was used as the molecular size marker and the band 
size are written in kilobase on the left hand side of the gel.
The  DNA  sequence  o f pPPM W   was  determined  (Table  7.1,  Fig 7.3).  Ten orfs were 
identified  o f  which  only  orf4,  which  has  sequence  identity  with  the  end  of  the 
asparate/ornithine  carbamoyltransferase,  has  the  same  direction  of transcription  as 
tet{W)  (Fig  7.3).  Orf5  is  homologous to  the transposase  of the  IS30 family and  it is 
associated with a 38  bp  inverted  repeat  (Table  7.1).  Orfs6 and  7 are almost identical 
to the  IS 1081  transposase  of the  IS256 family;  however the gene coding for IS 1081 
in  pPPM W   has  been  split  by  a  mutation  which  introduces  a  stop  codon  (Fig  7.3). 
Two  additional  ORFs  potentially  involved  in  determining  resistance  to  macrolides 
were found  upstream  and downstream of tet(W) and were homologous to the mef(A) 
gene  (Table  7.1).  Downstream   o f orfl  there  are  two  ORFs,  orf2  and  orf3  that  are 
homologous to the ATPase components of the ABC transporter family.  However the 
gene  in  pPPM W   has  been  split  by  the  insertion  of  34  nucleotides  leading  to  a
128mutation  and  the  insertion  of a stop  codon  (Table  7.1  and Fig  7.3).  Moreover, the 
presence  of a  ribosomal  binding  site  within these  34  nucleotides  suggests that the 
second orf, or/3,  is functional.
Table 7.1: Closest relatives to the orfs flanking tet{W) of Rothia sp.
ORF Length 
of pre­
dicted 
protein
G+C
Con­
tent
Closest relative 
in the database
Source
orga­
nism
Likely Function 
of protein
%
Iden-
titiy
E
value
orfi 413 aa 58% m ef Strep macrolide-efflux
protein
42% le-75
orfl 74 aa 51% ATPase Strep ATPase 
components of 
ABC transporters
68% 2e-14
orfi 403 aa 56% ATPase Strep ATPase 
components of 
ABC transporters
60% e-137
orfi 97 aa 62% end of asparate/ 
ornithine 
carbamoyltransf 
erase
Enteroc/
Lactoc
asparate/ornithine 
binding domain
62% 2e-15
orfi 403 aa 74% IS 30
transposase
Strep putative family of 
transposase
30% le-34
tetifiJ) 524 aa 53% tet( W) Butyri tetracycline 
resistance protein
97% 0.0
orfi 224 aa 62% IS 256 
transposase
Mycob putative family of 
transposase
83% 2e-91
orfi 148 aa 61% IS 256 
transposase
Mycob putative family of 
transposase
78% 2e-57
orfi 204 aa 58% putative protein Burkhol putative protein 30% >5
orfi 428 aa 58% m ef Strep macrolide-efflux
protein
42% le-86
aa  =  amino  acids,  Strep  =  Sreptococcus  spp.,  Enteroc/Lactoc  =
Enterococcus/Lactococcus  spp.,  Butyri  =  Butiryvibrio  fibriosolvens,  My  cob  = 
Mycobacterium avium, Burhold = Burkholderia ambifaria.
129Figure 7.3: Genetic support of tet(W) in an oral Rothia sp.
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Schematic diagram of the deduced  genetic organisation of a) the whole  13-kb insert 
contained  in  pPPM W   and  b)  the  deletion  derivative  (pPPMW-1)  after  the 
spontaneous  loss  of  tet(W).  The  likely  direction  of transcription  of the  genes  is 
shown  by  the  arrowed  boxes.  The  vertical  arrows  represent  the  disruption  of the 
ORF:  the  ORF  coding  for  ATPases  is  disrupted  by  the  insertion  of  34  extra 
nucleotides  and  there  is  a  point  mutation  in  IS256  leading  to  the  introduction  of a 
stop  codon.  Flighlighted  in  red  are  the  identical  sequences  found  in  the  deletion 
derivative and the right end of the  13-kb insert (the sequences are  100% identical at 
the  nucleotide  level),  and  this  sequence  is  also  repeated  and  99%  identical  at  the 
nucleotide  level  in  the  left  end  of the  13-kb  insert  (highlighted  in  red  dashes).  A 
series of primers were designed to amplify the region between tet{W) and IS256 (set 
1), IS256 (set 2), the region between IS256 and downstream orf$ (set 3), mef (set 4), 
and the region between ATPases and IS30 (set 5).
130The nucleotide  sequence  of tet{W)  from pPPMW was compared with other tet(W) 
genes,  and  it  was  97%  identical  to  tet{W)  from  TnB1230  (accession  number 
AJ222769)  and  91%  identical  to  tet(W)  from  A.  pyogenes  (accession  number 
AY049983).  The nucleotide sequences upstream of tet(W) from pPPMW were also 
aligned with the upstream sequence of tet(W) genes from B. fibrisolvens  1.230, M. 
multiacidus  P208,  and  Clostridium  sp.  strain  K10  and  showed  some  conserved 
regions including a potential terminator structure, possibly involved in regulation of 
tet(W) by attenuation,  although there have been few nucleotide replacements in the 
Rothia strain (Fig 7.4).
Figure 7.4: Comparison of upstream of tet(W)
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AGAAAAGGAGTAAAAAATATGC-GGCAAGGTATTCTTAAATAAAACTATAATCAAATAGT  -2 0 4  
AGAAAAGGAGTAAAAAATATGC-GGCAAGGTATTCTTAAATAAAACTATAATCAAATAGT  -2 0 4  
AGAAAAGGAGTAAAAAATATGCCGGCAAGGTATTCTTAAATAAAACTATAATCAAATAGT  -2 0 3
-TGAGGAGTCTACCAAATATGC-GGCAAGGTATTCTTAAATAAAATTT--------------GATAAT  -1 8 5
*  *  **  * * * * * * * *   * * * * * * * * * * * * * * * * * * * * * *   *  ***  *
GGGAACAAAGGATTATGATAGCTCCTTTTGTAGGGGCTTAGTTTTTTGTACCCAATTTAA  -1 6 4  
GGGAACAAAGGATTATGATAGCTCCTTTTGTAGGGGCTTAGTTTTTTGTACCCAATTTAA  -1 6 4  
GGGAACAAAGGATTATGATAGTTCCTTTTGTGGGGGCGGGATTTTTTGTACCCAATTTAA  -1 6 3
GGGCGCAAAA-------ATGATTGCCCCT —  TGCAGGGGCTTAGTTTTT-GTACCCAATTTAA  -1 5 2
* * *   * * * *   * * * * *   *  * * *   **  * * * * *   * * * * *   * * * * * * * * * * * * *
GAATACTTTTGCCTTATCAATTTTGACATATCCCCAAAAACAGCAATCACAAACAGGTGT  -1 0 4  
GAATACTTTTGCCTTATCAATTTTGACATATCCCCAAAAACAGCAATCACAAACAGGTGT  -1 0 4  
GAATACTTTTGCCTTATCAATTTTGACATATCCA-AAAAACAGCAGTCACAAATAGGTGT  -1 0 4
GAATACTTTTGCCTTTTTAGT---------AAATATCGTGACGGACAGCGGCT-CATGTAAGC—   -9 9
★   *  ★   ★   ★   ★ ★   ★   *
ATGCTGTATATGTGTATGTCCGCAACTTATAATCCCCAGTGGTAAAil&TA^TTTACTGCT  -4 4  
ATGCTGTATATGTGTATGTCCGCAACTTATAATCCCCAGTGGTAAAAGTATTTTACTGCT  -4 4  
ATGCTGTATATGTGTATGTCCGCAAATTATAATCCCCAGTGGTAAAAGTATTTTACTGCT  -4 4  
-CGTCATACTTCTGTTTGTCCG-AAGTCATGATCCCCAGCGGTAAAAGTATTA-GCCGCT  -4 2  
*  ★ ★   ★   ★ ★ ★   ★★★★★★  ★ ★   ★   ★ ★   ★★★★★★★★  ★★★★★★★★★★★★  ★   ★ ★ ★
ioGGGATTTTTATGCCCTTTGGGGCTGTAAAGGGAGGACAATCACATGAAAATAATCAATA  16 
GGGGATTTTTATGCCCTTTGGGGCTGTAAAGGGAGGACAATCACATGAAAATAATCAATA  16 
GGGGATTTTTGTGCCCTTTCGGGCTGTAAAAGGAGGACAATCACATGAAAATAATCAATA  16 
GGGGATTTTTGCGCCCATTTGGGCCTTGTATGGAGGATAG— ACATGAACATTATCAATA  16 
★   ★ ★ ★ ★   ★ ★ ★ ★   ★   ★   ★★★★★★  ★   ★★★ ★★ ★★   ★ ★   ★ ★ ★ ★ ★ ★ ★
The CLUSTLAW program was used to align the nucleotide sequences upstream of 
the  tet(W)  gene  from  T40-1  with  the  upstream  sequence  of tet(W)  genes  from B. 
fibrisolvens  1.230  (GenBank  accession  number  AJ222769),  M  multiacidus  P208 
(GenBank accession number AY603069), and Clostridium sp. strain K10 (GenBank 
accession  number  AY601650).  The  solid  arrows  indicate  the  inverted  repeats,  a 
poly(T)  region  which  could  act  as  a  rho  independent  transcriptional  terminator, 
ribosome  binding  sites  (GGAGGA),  and  the  ATG  start  codon  are  highlighted  in 
green, blue, and red respectively.
1317.4.2  The genetic supports for tet{W) genes in oral isolates 
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From  the  sequence  obtained,  primers  were  designed  upstream  and  downstream  of 
tet{W) in pPPMW to compare the organisation of the flanking region of  tet{W)  with 
the  other te/(W)-containing isolates.  The binding  sites of the primers are  shown in 
Figure 7.3. A total of 20 isolates were tested, including the original strain T40-1 from 
which the tet{W)  gene was cloned.  According to the PCR results with the different 
sets of primers, the isolates were divided into 3 groups (Table 7.2). Group 1  included 
four  isolates  that,  according  to  the  PCR  results,  had  a  similar  genetic  structure 
surrounding  the  tet(W)  gene  to  the  Rothia  T40.1  strain.  Group  2  included  eight 
isolates  that,  according  to  the  PCR  results,  had  homology  only  with  part  of the 
sequence contained within pPPMW. Finally Group 3 contained eight isolates that did 
not have any homology with pPPMW and so did not give any PCR products with the 
primer sets used although two out of these nine isolates had the mef gene and so gave 
a positive PCR product with the primer set 4 (Table 7.2 Group 3).
132Table 7.2: Study of the genetic support of tet(W) isolated from oral bacteria by PCR
Goaps Tet  W 
isolate
Other
tet
genes
PCR  with 
primers 
Bf/Br  and 
Af/Br
PCR with primers designed from 
the sequence of the new element
Genus
Setl Set2 Set3 Set4 Set5
Group 1 T29.1 none - + + + + + Rothia
T40.1 none - + + + + + Rothia
T54.2 none - + +? + + + Rothia
T59.3 none - + + + + + Strep
Group 2 T22.3 tet(  M) - + - + +? Rothia
T56.4 none - + + - + +? Rothia
T60.2 tet(  M) - + + - + + Staph
T60.9 none - + + - + + Actino
T44.5 none - + + - - + Lactob
T48.7 none - + + - - + Lactob
T43.7 none - + + - - - Actino
T51.1 none - + + - - - Lactob
Group 3 T27.5 tet( M) - - - - - - Staph
T32.6 tet(U) - - - - - - Actino
T34.4 tet( L) - - - - - - Actino
T39.3 none - - - - - - Actino
T46.6 none - - - - - - Actino
T50.1 none - - - - + - Rothia
T51.6 none - - - - + - Rothia
T55.5 none - - - - - - Actino
All  the  /^(W)-containing  isolates  found  in  this  study  were  compared  by  PCR to 
identify  the  genetic  support  of this  antibiotic  resistance  gene  in  oral  bacteria.  We 
identified 3  different groups.  Group  1   contained isolates related to the whole of the 
putative new element identified in this study from T40-1, highlighted in red. Group 2 
contained  isolates  related  to  part  of the  putative  new  element.  Finally  Group  3 
contained isolates with no similarities with TnB1230 or the putative new element.
+? = a PCR product was obtained with these isolates and the sequencing of the ends 
indicated  that  the  expected  PCR  product  had  been  amplified  however  the  PCR 
product  had  a  higher  molecular  weight  than  the  positive  control  (see  explanation 
chapter 7.4.2).
Strep  =  Streptococcus,  Staph  =  Staphylococcus,  Actino  =  Actinomyces,  Lactoh  = 
Lactobacillus.
133Furthermore,  one  isolate  from  Group  1   set  2  (Table  7.2  isolate  T54-2)  and  two 
isolates  from  Group  2  set  5  (Table  7.2  isolates T22-3  and T56-4) yielded a bigger 
PCR product than the corresponding positive PCR control (pPPMW); these samples 
were subsequently sequenced. The PCR product from isolate T54-2 using primer set 
2  was  1,285  bp  long  instead  of  1,078  bp  in  pPPMW  and  was  fully  sequenced.  It 
exhibited high sequence identity with the transposase belonging to the IS2Jd family 
sequenced in pPPMW (97% nucleotide identity); however the sequences diverge at 
1,144  bp.  The  reason  for  the  amplification  of a  larger  product  from  T54-2  is the 
presence  of an  inverted  repeat  (highlighted  in  red  in  Fig  7.5)  which  can  act  as  a 
primer binding site.
134Figure 7.5: Comparison of PCR products obtained from pPPMW and T54-2 isolate 
using primer set 2
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IS 2 5 6 /T 5 4 -2
IS256/pPPM W
IS 2 5 6 /T 5 4 -2
IS256/pPPM W
IS 2 5 6 /T 5 4 -2
IS256/pPPM W
IS 2 5 6 /T 5 4 -2
IS256/pPPM W
IS 2 5 6 /T 5 4 -2
IS256/pPPM W
IS 2 5 6 /T 5 4 -2
IS256/pPPM W
IS 2 5 6 /T 5 4 -2
IS256/pPPM W
IS 2 5 6 /T 5 4 -2
IS256/pPPM W
IS 2 5 6 /T 5 4 -2
IS256/pPPM W
IS 2 5 6 /T 5 4 -2
-CAGTGGGGTCAACAAGATCCGCAGCGTCACACCAGGCGCAACGGGTATCGCTACCGGCC  59 
H H H H H H H H B H H I g c a g c g tc a c a c c a g g c g c a a c g g g ta tc g c ta c c g g c c   60 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
CCTGGACACCAGGGTCGGCACCATCGACGTGGCGATCCCCAAGCTGCGCTCAGGCACCTA  119 
CCTGGACACCAGGGTCGGCACCATCGACGTGGCGATCCCCAAGCTGCGCTCAGGCACCTA  120 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
CTTCCCAGAATGGTTACTGCAACGGCGCAAACGCTCCGAAAGCGCCTTGATCACAGTGGT  179 
CTTCCCAGAATGGTTACTGCAACGGCGCAAACGCTGTGAAACCGCGTTGATCACAGTGGT  180 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *   * * * *   * * *   * * * * * * * * * * * * * *
CGCTGACTGCTACCTAGCAGGAGTGTCTACACGCCGTATGGACAAGCTCGTCAAAACCCT  239 
CGCTGACTGCTACCTGGCAGGAGTATCCACGCGCCGTATGGACAAGCTCGTCAAAACCCT  240 
***************  ********  **  **  *****************************
GGGGATCACAGGACTGTCCAAGTCCCAGGTCTCACGCATGGCAGCCGACCTGGACGAGCA  299 
GGGGATCACAGGACTGTCCAAGTCCCAGGTCTCACGGATGGCAACAGACCTCGACGAACA  300 
************************************  ******  *  *****  *****  * *
CGTGGATCAGTTCCGCAACCGGCCCCTCCACGATGCCGGGCCTTTCACCTTCGTCGCCGC  359 
CGTGGACCAGTTCCGCAACCGGCCCCTCCACGATGCCGGGCCTTTCACCTTCGTCGCCGC  360 
* * * * * *   * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
TGACGCACTGACCATGAAAGTACGCGAAGGAGGACGCGTCGTCTCGTGCGCGGTTCTGGT  419 
TGACGCACTGACCATGAAAGTACGCGAAGGAGGACGCGTCGTCTCGTGCGCGGTTCTGGT  420 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
TGCCACCGGAGTCAACAATGACGGACACCGCGAAGTGCTGGGG-TGCGCGTGTCCACCAG  478 
TGCCACCGGAGTCAACAATGACGGACACCGCGAAGTGCTGGGGGTGCGCGTGTCCACCAG  480 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *   * * * * * * * * * * * * * * * *
CGAGACCGCTCCAGCCTGGAAGGAGTTCTTCGCCGACCTGGTCGCCCGAGGCCTGACCGG  538 
CGAAACCGCTCCAGCCTGGAAGGAGTTCTTCGCCGACCTGGTCGCCCGAGGCCTGACCGG  540 
***  ********************************************************
CGTGCGCCTGGTCACCAGTGATGCCCATCTGGGCCTGGTTGAGGCCATCGCCGCCAACCT  598 
CGTGCGCCTGGTCACCAGTGATGCCCATCTGGGCCTGGTTGAGGCCATCGCCGCCAACCT  600 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
ACCCGGAGCCACCTGGCAACGATGCCGTACCCACTACGCCGCTAATCTCATGTCCGTCAC  658 
ACCCGGAGCCACCTGGCAACGATGCCGTACCCACTACGCCGCTAATCTCATGTCCGTCAC  660 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
CCCCAAAGCACTATGGCCCGCTGTCAAAGCGATGCTGCACTCGGTGTATGACCAGCCCGA  718 
CCCCAAAGCACTATGGCCCGCTGTCAAAGCGATGCTGCACTCGGTGTATGACCAGCCCGA  720 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
CGCGGCATCGGTCAACGCTCAATACGACCGGCTCTTGGACTACGTCCACGACAAGCTCCC  778 
CGCGGCATCGGTCAACGCTCAATACGACCGGCTCTTGGACTACGTCCACGACAAGCTCCC  780 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
CGCCGTGTGTGATCACCTCGATCAAGCCAGGGCAGACGTCCTCGCGTTCGCGTCCTTCCC  838 
CGCCGTGTGTGATCACCTCGATCAAGCCAGGGCAGACGTCCTCGCGTTCGCGTCCTTCCC  840 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
CACCGGGGTGTGGACCCAGATCTGGTCCAACAACCCCAATGAGCGCCTCAACCGCGAAAT  898 
CACCGGGGTGTGGACCCAGATCTGGTCCAACAACCCCAACGAACGCCTCAACCGCGAAAT  900 
***************************************  **  *****************
CCGCCGCCGCACCGACACCGTGGGAATCTTCCCCAACCGACAAGCAATCATCCGCCTAGT  958 
CCGCCGCCGCACCGACACCGTGGGAATCTTCCCCAACCGACAAGCAATCATCCGCCTAGT  960 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
CGGAGCCGTCCTCGCCGAACAAAACGACGAATGGGCCGAAGGCCGACGCTACCTCAGCCT  1018 
CGGAGCCGTCCTCGCCGAACAAAACGACGAATGGGCCGAAGGCCGACGCTACCTCAGCCT  1020
CGACATCCTCACCAAATCACGACTCACACCCCAACCCACCCACAGGAGGAACCCCCACT  1078 
CGACATCCTCACCAAATCACGACTCACACCACAACCCACCGGGCAGGAGGACACCCCACT  1080
135* * * * * * * * * * * * * * * * * * * * * * * * * * * ***  *********  ********  *******
IS256/pPPMW
IE256/T54-2
CCAACTCAGCGCATAACCCACCCCGAAGGACACAAAACGATTACACCACTCCACAGGACT 
CCAACTCAGCGCATAACCCAACCCGAAGGACACAAAACGATTACACCACTCCACAGGACT 
********************  ***************************************
1138
1140
IS256/pPPMW
IS256/T54-2
TGACCCGCCAA---GCAGCCACCTCGCGAAATTCAGCACGAGCACGCCCTCCCGGGTATG
TGACCACCGGATGCGTAGGGTTTTCCGGAGTCTAGGGACTTTAGGGAGATGCCGCGCTTG 
*****  *  *  *  **  **  **  *  *  **  *  *  ***  *  **
1195
1200
IS256/pPPMW
IS256/T54-2
GGGCTCATGCCTCGTGCGAGTGATGAGAATCTTCGGGAATGCATCCCCGATGGATAGAAT 
ACCAGCTTGGACTG-GAAAACGTCGAGCA-CTGCCAGGGCGCGCTCTTCGGCGTTTGCCT 
*  **  *  *  *  *  ***  *  **  *  *  **  *  *  *  *  *
1255
1258
IS256/pPPMW
IS256/T54-2
CGGCGCAATCTCCCTCTCGAGCGTCGA  1282 
TGATGaH H ^ H H I   1285 
*  *  *  *  **
The arrows represent the forward (5’-CAGTGGGGTCAACAAGATCC-3’) and the 
reverse primers (5’-AGTGGGGGTTCCTCCTGTT-3’) (Fig 7.3 set 2).
Highlighted in red are the inverted repeats found in the bigger PCR product 
amplified from T54-2. Highlighted in blue is the nucleotide sequence found in the 
bigger PCR product and that differ from the sequence in pPPMW.
The  particularity  of the  larger  product  is  that  it  is  flanked  by  two  inverse  repeat 
sequences of 21  nucleotides allowing the forward primer to act as a reverse primer 
hence the larger PCR product obtained from isolate T56-4.
The  bigger  PCR  products  from  isolates  T22-3  and  T56-4  using primer  set  5  were 
partially sequenced (2,034 bp were sequenced out of a total PCR product of around 
3,500  bp)  and  they  exhibited  high  sequence  identity  with  the  ATPase  and  the 
ornithine  carbamoyltransferase  sequenced  in  pPPMW  (99%  and  100%  nucleotide 
identities respectively), however the nucleotide region between orfi and orf4 could 
not  be  sequenced  and  may  be  due  to  the  presence  of repeated  sequences  in  this 
region.
7.4.3  Stability of tet{W) in E. coli and Rothia sp.
When grown  in the  absence  of tetracycline,  all  of 50  colonies tested had lost their 
resistance to the drug. Plasmids were prepared from 5 sensitive colonies and digested 
with Hindlll  and EcoRl, revealing that an  11 -kb sequence had been deleted (lane 5 
Fig 7.2) in each of the 5  colonies tested, this new plasmid was named pPPMW-1. It 
can be seen from Figure 7.2 that there is a mixture of intense and faint bands in the
136lanes  containing  plasmid  from  tetracycline-resistant  clones.  The  intense  bands 
correspond  to  those  remaining  after  loss  of tetracycline  resistance  indicating  that 
there is a mixture of full length plasmids (pPPMW) and deletants (pPPMW-1). When 
Rothia strain (T40.1) was grown in the absence of tetracycline no loss of tet{W) was 
observed after 21  passages,  showing that the gene is relatively stable in its original 
host.
The  complete  nucleotide  sequence  of the  insert  of pPPMW  and  pPPMW-1  was 
obtained. pPPMW-1 was found to be a deleted version of pPPMW; it consists of orf9 
and part of the unknown or/8 (Fig 7.3).
No transfers of tet(W), from Rothia sp. (T40.1) to JH2/2, were detected under the 
conditions used (see materials and methods), the experiment was performed twice.
7.5  Discussion
7.5.1 The genetic support of tef(W) in pPPMW
The te/(W)  gene was  shown to  be the  second most common tetracycline resistance 
gene identified from the oral cavity (see chapter 4). The genetic support of the gene 
was compared with the genetic support of the original tetfN) gene from Butyrivibrio 
fibrisolvens  by  PCR  using  specific  primers  for  the  upstream  region  of the  gene 
contained  in  TilBJ230;  only  11  out  of 31  isolates  carrying  tet(W)  yielded positive 
PCR  products  suggesting  a  similar  organisation  as  in  TnB1230.  No  further  work 
could  be  carried  out  on  these  organisms  because  of the  loss  of tet(W)  following 
retrieval of the  strains.  The genetic  support of tet(W) was characterised in detail in 
one  of the  20  remaining  isolates  containing  tet(W)  (Rothia  T40-1  Table  7.1).  The 
tet(W) from this strain was cloned into pUC18 to generate pPPMW DNA sequence 
analysis of this insert showed that tet{ W) was flanked by two copies of the mef gene 
including  part  of an  unknown  open  reading  frame  orf9,  two  putative  transposases 
belonging to two different families of insertion sequences (IS30 and IS2J6) and one 
ATPase downstream the tet(W) gene (Fig 7.3 a)).
1377.5.1.1. Features of the transposases 
«
One  putative  transposase  from  the  IS30  family  was  found  downstream  of tet(W), 
another  incomplete  transposase  of the  IS256  family  was  located  upstream  of the 
tetracycline resistance gene. The presence of an inverted repeat upstream of the IS30 
transposase is likely to regulate the transcription of the element at the RNA level; the 
repeat sequence can form a loop preventing transcription of the transposase (56).
Members of the IS30 family usually contain a single orf flanked by inverted repeats 
(IRs)  in  the  range  of 20-30  bp  that  exhibit  significant  homologies.  Various  IS30 
family  members  have  been  identified  as  part  of composite  transposons  associated 
with antibiotic  resistance  genes eg in VRE strains (114), and in macrolide-resistant 
Bacteroides fragilis  (228).  Members  of the  IS30  family  of transposases  have  also 
been  shown  to  be  present  in  oral  streptococci  and  S.  pyogenes  in  several  copies 
although it is not known whether they are associated with antibiotic resistance genes 
in these strains (169).
The IS256-family of transposases was originally found in Mycobacterium sp. (169), 
however  it  is  not  known  whether  this  IS  is  functional  in  Rothia  sp.  since  its 
organisation is slightly different due to a mutation which introduces a stop codon at 
position 675.  In some IS  sequences (eg ISJ), translational frameshifting is used as a 
control mechanism for transposases expression (169).  This could be the case in the 
IS25b-like  element  from  Rothia  sp.  and  further work would be needed to  confirm 
this event in our strain.
IS  elements  are  frequent  components  of multi-resistant  elements.  The  tet(W)  gene 
isolated  in  this  study  is  flanked  by  two  transposases  belonging  to  two  different 
families of IS, IS30 and IS256, therefore it might be part of a composite transposon 
allowing its dissemination in oral bacteria.
1387.5.1.2 Features of the m ef gene 
«
The  m ef gene  has  recently  been  linked  with  two  different  tetracycline  resistance 
genes. It was found to be co-transferred with tet{O) between strains of S. pyogenes as 
well as between S. pyogenes and E. faecalis JH2/2, however the mobile element was 
not identified (101). In a different study, a mef gene was shown to be inserted into a 
Tn97 6-like  element  containing  tet(M),  however  this  new  composite  element, 
Tn2009, could not be transferred (68).  In the present study tet(W) was flanked with 
two copies of the m ef gene, although no co-transfer was shown.
The m ef gene contained in Tn7270.1 and Tn2009 is associated with a member of the 
ABC transporter family (68, 259), as is the case in the current study. An alignment of 
the  deduced  amino  acid  sequence  of m ef and  the  ABC  transporters  from Tn2009, 
Tnl270.1  and  pPPMW  showed  that  the  percentage  identity  was  40%  and  58% 
respectively. The ABC transporter protein provides the energy required for the efflux 
of different  substrates  including  macrolides  and  Streptogramin  A  (302)  and  thus 
might act as a dual efflux system with the mef gene.
7.5.1.3 Features of tet(W) and upstream of the gene in different isolates
The upstream region of tet(W) in pPPMW was compared with the upstream region of 
tet(W)  from  different  isolates  (Fig  7.4),  and  showed  some  conserved  regions  as 
already  mentioned  in  Melville  et  al.  (179).  Overall,  there  is  78%  sequence 
conservation  upstream  of the  tet(W)  genes  from  the  different  strains.  The  region 
upstream  of the  Rothia  gene  is  more  divergent  that  upstream  of the  other  tet(W) 
genes (Fig 7.4).  The presence of conserved regions highlights the likely importance 
of  this  sequence  for  the  tetracycline  resistance  genes.  Indeed,  the  sequence 
immediately  upstream  from  the  tet(W)  gene  was  shown  to  be  required  for  full 
expression of resistance (179) and the  17-bp inverted repeats, also highly conserved 
upstream of tet(O), tet(M), tet(S), tet(T) and tet{32) were shown to be important for 
regulating gene expression in tet(O) (315) and tet(M) (282). Moreover, this sequence 
conservation of tet(W) in the Rothia strain as well as upstream of the gene with the
139previously studied tet(W) from bacteria from the rumen, porcine and human faeces is 
sign of a recent transfer of the gene between these different environments.
7.5.2 Stability of tet(W) in E. coli and Rothia sp.
When  tetracycline  sensitive  deletant  (pPPMW-1)  was  compared  with the  original 
clone  (pPPMW)  the  regions  remaining  after  deletion  were  the  downstream  and 
upstream  sequence  of tet{W),  including  one  copy  of the  mef gene  and  part of an 
unknown ORF (orfS) (Fig 7.3). However, homologous recombination between these 
two almost identical copies of m ef in pPPMW resulting in the loss of the tet(  W) gene 
in pPPMW-1  is  unlikely  since the E.  coli host  strain,  DH5a, used for cloning is a 
recA mutant. The basis of instability of this element in E. coli is not clear; it could be 
due to the action of the transposases that flank the tet(W) gene. The construction of 
mutants  in these transposases would be useful to test this hypothesis.  When Rothia 
T40.1  was  grown  in  the  absence  of tetracycline,  the  tet{W)  gene  appeared  very 
stable. This loss of stability of an element once it is cloned has already been observed 
with Tn916 (96)  and the  Tn4451/Tn4453  family of mobilisable transposons (2).  In 
the case of Tn4451, the instability is due to the action of the transposase tnpX, if this 
is deleted, the transposon becomes stable whereas the instability in Tn916 is thought 
to be due to the products of the int and xis genes.
7.5.3 The genetic support of tet(W) in oral isolates
In a total of 20 te/(W)-containing oral bacteria isolated and studied, different genetic 
supports  for  the  tet(W)  gene  were  identified:  four  te/(W)-containing  oral  bacteria 
were found to have related flanking DNA to the one sequenced in pPPMW including 
both  transposases,  the  unknown  orf  the  m ef gene  and  the  ATPases,  eight tet(W)- 
containing  oral  bacteria  showed  similarities  with  only  part  of the  flanking  DNA 
sequenced in pPPMW  (they  all contained IS256 and some had the mef gene or the 
ATPases  or  both),  and  eight  te/(W)-containing  oral  bacteria  did  not  have  any 
similarities  with  any  of the  flanking  DNA  and  thus  require  further  work.  Further 
study is also needed to determine if the Rothia tet(W) is mobile and to continue the
140sequencing upstream and downstream of the cloned region to determine whether this 
new element is part of a larger composite transposon.
This work is of importance since it shows that one antibiotic resistance gene, tet(W), 
can be  contained  within different mobile  elements  in the  oral microbiota.  The fact 
that the new putative element was identified in different genera in the oral microbiota 
is  further  confirmation  that  oral  bacteria  can  transfer  antibiotic  resistance  genes 
between isolates from different species and genera.
141Chapter 8 
Final Discussion
Because  the  oral  bacteria  form  a  community  made  up  of  different  species  and 
because they have the opportunity for contact with bacteria from other environments 
through  the  ingestion  of  food,  vomiting  and  kissing,  they  are  likely  to  play  an 
important role as a reservoir of antibiotic-resistant bacteria and antibiotic resistance 
genes.  This  study  showed  that  antibiotic-resistant bacteria and antibiotic resistance 
genes are present in the oral cavity and that oral bacteria may play an important role 
in the evolution and dissemination of antibiotic resistance genes.
The proportion of resistant bacteria in the oral cavity of healthy adults to commonly 
used  antibiotics  (tetracycline,  erythromycin  and  amoxycillin)  was  shown  to  be 
important.  Out of 60 samples screened, all of the individuals were found to harbour 
bacteria  resistant  to  tetracycline  and  erythromycin  and  only  4  individuals  did  not 
have  any  cultivable  bacteria  resistant  to  amoxycillin.  However  no  bacteria  with 
acquired  resistance  to  gentamicin  or  vancomycin,  antibiotics  of the  last  resort  for 
some  multidrug-resistant  bacterial  infections,  were  isolated  during  the  study.  This 
study  illustrates  how  the  use  of  antibiotics  can  exert  a  selection  pressure  in  an 
environment, such as the oral microbiota, and lead to the establishment of a resistant 
population.
Out  of two  batches  of 20  samples  each,  a representative  209  tetracycline-resistant 
bacteria were screened for the presence of tetracycline resistance genes. Most of the 
isolates carried tetracycline resistance genes encoding a ribosomal protection protein. 
The most common tetracycline resistance genes identified were tet(M), tet(W), tet(0) 
and  tet(Q).  The  tet(M)  gene  had  already  been  found  to  be  the  most  common 
tetracycline  resistance  gene  isolate  from  the  oral  microbiota (248)  however tet(W) 
was isolated for the first time from this habitat. It was originally identified in a rumen 
bacterium,  Butyrivibrio fibrisolvens,  and  was  subsequently  found  in human  faecal 
anaerobes, pigs and the animal pathogen, Arcanobacterium pyogenes. Moreover the
142sequence conservation in these different tet(W) genes is sign of a recent transfer of 
the gene between these different environments.
Out of one batch of 20 samples, a representative  122 erythromycin-resistant isolates 
were  screened  for  the  presence  of  erythromycin  resistance  genes.  A  total  of 28 
isolates carried the m ef gene while  14 isolates were resistant to erythromycin through 
the  production  of a  methylase,  erm(B).  The  remaining  isolates  with  no  identified 
erythromycin  resistance  genes  were  Gram-negative  bacteria  and  are  likely  to  be 
intrinsically resistant to the drug or to carry a non-specific mtr efflux pump. Most of 
the isolates with an identified erythromycin resistance gene belonged to the viridans 
group  streptococci.  These results agree with previous studies which have looked at 
the prevalence of the erythromycin resistance genes in pharyngeal samples and found 
that viridans streptococci are a reservoir of erm{  B) and mef genes (9, 218, 340).
A Tn7545-like element was isolated for the first time from viridans streptococci. The 
Tn916  and  Tn\545  family  of  conjugative  transposons  are  responsible  for  the 
widespread  dissemination  of  tetracycline  and  macrolide  resistance  in  pathogenic 
bacteria,  S. pyogenes  and S.  pneumoniae  and therefore viridans  streptococci might 
act as a reservoir for this type of element in the oral cavity. The Tn7545-like element 
isolated  in  this  study  exhibited  a  variation  in  its  structure  between  different  oral 
streptococci underlying the fact that these elements are not static.
One  tetracycline  resistance  gene,  tet(W),  was  isolated  for  the  first  time  from 
cultivable oral bacteria and was  shown to be the second most common tetracycline 
resistance gene after tetifA). By studying the genetic support of tet(W) we showed at 
least  four  different  types  of flanking  regions  in  oral  bacteria.  Some  tet(W)  genes 
were  flanked  by  two  different  IS  elements  and  two  copies  of the  mef gene.  Some 
were  flanked  by  only  part  of  the  new  putative  element  including  the  IS25d 
transposase, and some also had the m ef gene while others had the mef gene plus the 
ATPase  and  ornithine  carbamoyltransferase.  Finally,  a  last  group  of tet(W)  genes 
were not flanked by any of the sequences mentioned above.
These results are  a reminder that antibiotics act upon the entire population exposed 
pathogenic as well as commensal. In the last few decades there has been a period of
143strong  selection  pressure  that  has  encouraged  the  evolution  and  dissemination  of 
antibiotic-resistant organisms.  The diversity of bacterial gene pools, the mobility of 
genes across species and genus boundaries, and the short generation times and large 
population  sizes  of bacteria  make  it  even  more  difficult  to  curtail  this  spread  of 
antibiotic resistance. As seen in this study an ongoing evolution is occurring as these 
bacteria  cope  with  the  ever-changing  landscape  in  the  environment,  and  although 
there  has  been  an  increased  awareness  about  the  consequences  of  overuse  of 
antibiotics  in  humans  as  well  as  animals,  some  drastic  changes  are  still needed to 
curtail  the  dissemination  of  resistance  genes  among  bacteria.  The  study  and 
discovery  of  new  elements  responsible  for  the  spread  of  resistance  is  also  of 
importance in gaining a better understanding about the origin of these elements.
144References
1.  Abraham EP, Chain E.  1940. An enzyme from bacteria able to destroy penicillin. 
Nature 3713:837.
2.  Adams V, Lyras D, Farrow KA, Rood JI. 2002. The clostridial mobilisable 
transposons. Cell Mol Life Sci. 59(12):2033-43.
3.  Addy M, Slayne MA, Wade WG.  1992. The formation and control of dental 
plaque-an overview. J Appl Bacteriol. 73(4):269-78.
4.  Agerso Y, Guardabassi L. 2005. Identification of Tet 39, a novel class of 
tetracycline resistance determinant in Acinetobacter spp. of environmental and 
clinical origin. J. Antimicrob. Chemother. 55:566-569.
5.  Alcaide F, Linares J, Pallares R, Carratala J, Benitez MA, Gudiol F, Martin R..
1995.  In vitro activities of 22 beta-lactam antibiotics against penicillin-resistant 
and penicillin-susceptible viridans group streptococci isolated from blood. 
Antimicrob Agents Chemother. 39(10):2243-7.
6.  Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ.1990. Basic local 
alignment search tool. J. Mol. Biol. 215:403-410.
7.  Aminov RI, Chee-Sanford JC, Garrigues N, Teferedegne B, Krapac IJ, White 
BA, Mackie RI. 2002. Development, validation, and application of PCR primers 
for detection of tetracycline efflux genes of Gram-negative bacteria. Appl 
Environ Microbiol. 68(4): 1786-1793.
8.  Andremont A, Gerbaud G, Courvalin P.  1986. Plasmid-mediated high-level 
resistance to erythromycin in Escherichia coli. Antimicrob Agents Chemother. 
29:515-518.
9.  Aracil B, Minambres M, Oteo J, Torres C, Gomez-Garces JL, Alos JI. 2001. High 
prevalence of erythromycin-resistant and clindamycin-susceptible (M phenotype) 
viridans group streptococci from pharyngeal samples: a reservoir of mef genes in 
commensal bacteria. J. Antimicrob. Chemother. 48: 592-594.
14510. Arpin C, Canron MH, Maugein J, Quentin C. 1999. Incidence of mef{A) and
*   meflE) genes in viridans group streptococci. Antimicrob Agents Chemother.
43(9):2335-6.
11. Arthur M, Andremont A, Courvalin P.  1987. Distribution of erythromycin 
esterase and rRNA methylase genes in members of the family 
Enterobacteriaceae highly resistant to erythromycin. Antimicrob Agents 
Chemother. 31(3):404-9.
12. Ayoubi P, Kilic AO, Vijayakumar MN.  1991. Tn5253, the pneumococcal omega 
(cat tet) BM6001  element, is a composite structure of two conjugative 
transposons, Tn5257 and Tn5252. J Bacteriol. 173(5): 1617-22.
13. Bager F, Madsen M, Christensen J, Aarestrup FM. 1997. Avoparcin used as a 
growth promoter is associated with the occurrence of vancomycin-resistant 
Enterococcus faecium on Danish poultry and pig farms. Prev Vet Med. 31(1- 
2):95-l 12.
14. Bagg J, MacFarlane TW, Poxton IR, Miller CH, Smith AJ.  1999. Essentials of 
microbiology for dental students. Oxford University press Inc., NY.
15. Balsalobre L, Ferrandiz MJ, Linares J, Tubau F, de la Campa AG. 2003. Viridans 
group streptococci are donors in horizontal transfer of topoisomerase IV genes to 
Streptococcus pneumoniae. Antimicrob Agents Chemother. 47(7):2072-81.
16. Bantar C, Fernandez Canigia L, Relloso S, Lanza A, Bianchini H, Smayevsky J.
1996.  Species belonging to the "Streptococcus milleri" group: antimicrobial 
susceptibility and comparative prevalence in significant clinical specimens. J 
Clin Microbiol. 34(8):2020-2.
17. Barbosa TM, Scott KP, Flint HJ.  1999. Evidence for recent intergenic transfer of 
a new tetracycline resistance gene, tet(W), isolated from Butyrivibrio 
fibrisolvens, and the occurrence of tet(O) in ruminal bacteria. Environ Microbiol. 
1:53-64.
14618. Bellido JLM, Guirao GY, Zuflaurre NG, Manzanares AA. 2002. Efflux-mediated
r  antibiotic resistance in Gram-positive bacteria. Rev Medical Microbiol. 13(1): 1  -
13.
19. Bentorcha F, Clermont D, de Cespedes G, Horaud T.  1992. Natural occurrence of 
structures in oral streptococci and enterococci with DNA homology to Tn916. 
Antimicrob Agents Chemother. 36(l):59-63.
20. Bertolla F, Simonet P.  1999. Horizontal gene transfers in the environment: 
natural transformation as a putative process for gene transfers between transgenic 
plants and microorganisms. Res Microbiol.  150(6):375-84.
21. Billington SJ, Songer JG, Jost BH. 2002. Widespread distribution of a Tet W 
determinant among tetracycline resistant isolates of the animal pathogen 
Arcanobacterium pyogenes. Antimicrob Agents Chemoter. 46(5): 1281-1287.
22. Billot-Klein D, Gutmann L, Sable S, Guittet E, van Heijenoort J. 1994. 
Modification of peptidoglycan precursors is a common feature of the low- level 
vancomycin-resistant VANB-type Enterococcus D366 and of the naturally 
glycopeptide-resistant species Lactobacillus casei, Pediococcus pentosaceus, 
Leuconostoc mesenteroides, and Enterococcus gallinarum. J. Bacteriol. 176 
(8):2398-2405.
23. Bingen E, Leclercq R, Fitoussi F, Brahimi N, Malbruny B, Deforche D, Cohen R.
2002.  Emergence of group A Streptococcus strains with different mechanisms of 
macrolide resistance. Antimicrob Agents Chemother. 46:1199-1203.
24. Blondeau JM, Yaschuk Y.  1995. In vitro activities of ciprofloxacin, cefotaxime, 
ceftriaxone, chloramphenicol, and rifampin against fully susceptible and 
moderately penicillin-resistant Neisseria meningitidis. Antimicrob Agents 
Chemother. 39(11):2577-9.
25. Bonomo RA. 2000. Multiple antibiotic-resistant bacteria in long-term-care 
facilities: An emerging problem in the practice of infectious diseases. Clin Infect 
Dis. 31(6):1414-22.
14726. Bonten MJ, Willems R, Weinstein RA. 2001. Vancomycin-resistant enterococci: 
why are they here, and where do they come from? Lancet Infect Dis.l(5):314-25.
27. Bonten MJ, Slaughter S, Ambergen AW, Hayden MK, van Voorhis J, Nathan C, 
Weinstein RA.  1998. The role of "colonization pressure" in the spread of 
vancomycin-resistant enterococci: an important infection control variable. Arch 
Intern Med.  158(10):  1127-32.
28. Bradford PA. 2001. Extended-spectrum p-lactamases in the 21st century: 
characterization, epidemiology, and detection of this important resistance threat. 
Clin Microbiol Rev.  14(4):933-951.
29. Bringel F, Van Alstine GL, Scott JR.  1991. A host factor absent from 
Lactococcus lactis subspecies lactis MG1363 is required for conjugative 
transposition. Mol Microbiol. 5(12):2983-93.
30. Brunei R, Scott KP. 2001. Distribution and degree of identity of the newly 
discovered tetracycline resistance gene tet(W). Unpublished data.
31.  . Viridans group streptococci: a reservoir of resistant bacteria in oral cavities. 
Clin Microbiol Infect. 8(2):65-9.
32. Burrus V, Pavlovic G, Decaris B, Guedon G. 2002. Conjugative transposons: the 
tip of the iceberg. Mol Microbiol. 46(3):601-10.
33. Caillaud F, Carlier C, Courvalin P.  1987. Physical analysis of the conjugative 
shuttle transposon Tn1545. Plasmid.  17:58-60.
34. Canchaya C, Foumous G, Chibani-Chennoufi S, Dillmann ML, BrUssow H.
2003.  Phage as agents of lateral gene transfer. Curr Opinion in Microbiol. 6:417- 
424.
35. Canchaya C, Proux C, Foumous G, Bruttin A, Bmssow H. 2003. Prophage 
genomics. Microbiol Mol Biol Rev. 67(2):238-76.
36. Canu A, Malbmny B, Coquemont M, Davies TA, Appelbaum PC, Leclercq R. 
2002. Diversity of ribosomal mutations conferring resistance to macrolides,
148clindamycin, streptogramin, and telithromycin in Streptococcus pneumoniae. 
Antimicrob Agents Chemother. 46(1): 125-31.
37. Casjens S. 2003. Prophages and bacterial genomics: what have we learned so far? 
Mol Microbiol. 49(2):277-300.
38. Catchpole MA.  1992. Sexually transmitted diseases in England and Wales: 1981- 
1990. Communicable Disease Review 2(1): 1-7.
39. Celli J, Trieu-Cuot P.  1998. Circularization of TnP7d is required for expression of 
the transposon-encoded transfer functions: characterization of long tetracycline- 
inducible transcripts reading through the attachment site. Mol Microbiol.
28(1): 103-17.
40. Chadwick PR, Chadwick CD, Oppenheim BA.  1996. Report of a meeting on the 
epidemiology and control of glycopeptide-resistant enterococci. J Hosp Infect. 
33(2):83-92.
41. Chain E, Florey HW, Gardner AD, Heatley NG, Jennings MA, Orr-Ewing J, 
Sanders AG. Penicillin as a chemotherapeutic agent. Lancet 2: 226-228. In 
Microbiology: A Centenary Perspective, edited by Wolfgang K. Joklik, ASM 
Press.  1999, p.l 12.
42. Charpentier E, Gerbaud G, Courvalin P.  1994. Presence of the Listeria 
tetracycline resistance gene /e/(S) in Enterococcus faecalis. Antimicrob. Agents 
Chemoter. 38(10):2330-2335.
43. Charpentier E, Gerbaud G, Courvalin P.  1993. Characterization of a new class of 
tetracycline resistance gene tet(S) in Listeria monocytogenes BM4210. Gene 
131(l):27-34.
44. Chiou CS, Jones AL.  1993. Nucleotide sequence analysis of a transposon
(Tn5393) carrying streptomycin resistance genes in Erwinia amylovora and other 
gram-negative bacteria. J Bacteriol.  175(3):732-40.
14945. Chopra I, Roberts M. 2001. Tetracycline antibiotics: mode of action, applications, 
molecular biology, and epidemiology of bacterial resistance. Microbiol Mol Biol 
Rev. 65(2):232-60
46. Christie PJ. Type IV secretion: intercellular transfer of macromolecules by 
systems ancestrally related to conjugation machines. 2001. Mol Microbiol. 
40(2):294-305.
47. Chuma T, Ikeda T, Maeda T, Niwa H, Okamoto K. 2001. Antimicrobial 
susceptibilities of Campylobacter strains isolated from broilers in the southern 
part of Japan from 1995 to 1999. J Vet Med Sci. 63(9): 1027-9.
48. Chung WO, Werckenthin C, Schwarz S, Roberts MC.  1999. Host range of the 
ermF rRNA methylase gene in bacteria of human and animal origin. J 
Antimicrob Chemother. 43:5-14.
49. Clancy J, Petitpas J, Dib-Hajj F, Yuan W, Cronan M, Kamath AV, Bergeron J, 
Retsema JA.  1996. Molecular cloning and functional analysis of a novel 
macrolide-resistance determinant, mefA, from Streptococcus pyogenes. Mol 
Microbiol. 22(5):867-79.
50. Claverys JP, Martin B. 2003. Bacterial "competence" genes: signatures of active 
transformation, or only remnants? Trends Microbiol. 11(4):161-5.
51. Clewell DB, Flannagan SE, Jaworski DD.  1995. Unconstrained bacterial 
promiscuity: the Tn916-Tnl545 family of conjugative transposons. Trends 
Microbiol. 3(6):229-36.
52. Climo MW, Sharma VK, Archer GL.  1996. Identification and characterization of 
the origin of conjugative transfer (oriT) and a gene {nes) encoding a single­
stranded endonuclease on the staphylococcal plasmid pGOl. J Bacteriol.
178(16):4975-83.
53. Cohen SN, Shapiro JA.  1980. Transposable genetic elements. Sci Am. 242(2):40-
9.
15054. Collis CM, Hall RM.  1992. Site-specific deletion and rearrangement of integron 
insert genes catalyzed by the integron DNA integrase. J Bacteriol. 174(5): 1574-
85.
55. Colquhoun J, Weetch RS.  1950. Resistance to chloramphenicol developing 
during treatment of typhoid fever. Lancet ii, 621-623.
56. Cooper MG. 2000. The cell: a molecular approach. Chapter 2, the flow of genetic 
information. Seconde edition. Boston University. ISBN 0-87893-106-6.
57. Costerton JW, Stewart PS, Greenberg EP.  1999. Bacterial biofilms: a common 
cause of persistent infections. Science. 284(5418): 1318-22.
58. Crellin PK, JI Rood.  1998. Tn4451 from Clostridiumperfringens is a mobilizable 
transposon that encodes the functional Mob protein, TnpZ. Molecular Microb. 
27(3):631.
59. Cremieux AC, Muller-Serieys C, Panhard X, Delatour F, Tchimichkian M, 
Mentre F, Andremont A. 2003. Emergence of resistance in normal human 
aerobic commensal flora during telithromycin and amoxicillin-clavulanic acid 
treatments. Antimicrob Agents Chemother. 47(6):2030-5.
60. Cresti S, Lattanzi M, Zanchi A, Montagnani F, Pollini S, Cellesi C, Rossolini 
GM. 2002. Resistance determinants and clonal diversity in group A streptococci 
collected during a period of increasing macrolide resistance. Antimicrob. Agents 
Chemother. 46:1816-1822.
61. Culebras E, Rodriguez-Avial I, Betriu C, Redondo M, Picazo JJ. 2002. Macrolide 
and tetracycline resistance and molecular relationships of clinical strains of 
Streptococcus agalactiae. Antimicrob Agents Chemother. 46(5): 1574-6.
62. Damrosch DS.  1946. Chemoprophylaxis and sulfonamide resistant streptococci. 
JAMA 130:124-128.
63. Davies J, Wright GD.  1997. Bacterial resistance to aminoglycoside antibiotics. 
Trends Microbiol. 5(6):234-40.
15164. Davies J.  1994. Inactivation of antibiotics and the dissemination of resistance 
genes. Science. 264(5157):375-82.
65. Davison J.  1999. Genetic exchange between bacteria in the environment.
Plasmid. 42(2):73-91.
66. Debelian GJ, Olsen I, Tronstad L.  1994. Systemic diseases caused by oral 
microorganisms. End Dent Trauml.  10:57-65.
67. Delahay RM, Robertson BD, Balthazar JT, Shafer WM, Ison CA.  1997. 
Involvement of the gonococcal MtrE protein in the resistance of Neisseria 
gonorrhoeae to toxic hydrophobic agents. Microbiol.  143:2127-2133
68. Del Grosso M, Scotto d'Abusco A, Iannelli F, Pozzi G, Pantosti A. 2004. Tn2009, 
a Tn97 6-like element containing mefiE) in Streptococcus pneumoniae. 
Antimicrob Agents Chemother. 48(6):2037-42.
69. DeLisle S, Perl TM. 2003. Vancomycin-resistant enterococci: a road map on how 
to prevent the emergence and transmission of antimicrobial resistance. Chest. 
123(5 Suppl):504S-18S.
70. Demaneche S, Kay E, Gourbiere F, Simonet P. 2001. Natural transformation of 
Pseudomonas fluorescens and Agrobacterium tumefaciens in soil. Appl Environ 
Microbiol. 67(6):2617-21.
71. De Vries J, Heine M, Harms K, Wackemagel W. 2003. Spread of recombinant 
DNA by roots and pollen of transgenic potato plants, identified by highly 
specific biomonitoring using natural transformation of an Acinetobacter sp. Appl 
Environ Microbiol. 69(8):4455-62.
72. Diaz-Torres ML, McNab R, Spratt DA, Villedieu A, Hunt N, Wilson M, Mullany 
P. 2003. Novel tetracycline resistance determinant from the oral Metagenome. 
Antimicrob. Agents Chemother. 47:1430-1432.
73. Doem GV, Heilmann KP, Huynh HK, Rhomberg PR, Coffman SL, 
Brueggemann AB. 2001. Antimicrobial resistance among clinical isolates of 
Streptococcus pneumoniae in the United States during 1999-2000, including a
152comparison of resistance rates since 1994-1995. Antimicrob Agents Chemother.
.  45(6): 1721 -9.
74. Doem GV, Ferraro MJ, Brueggemann AB, Ruoff KL. 1996. Emergence of high 
rates of antimicrobial resistance among viridans group streptococci in the United 
States. Antimicrob. Agents Chemother. 40: 891-894.
75. Domagk G.  1935. A contribution to the chemotherapy of bacterial infections. 
Dtsch. med. Wochenschr. 61: 250-253. In Milestones in Microbiology: 1556 to 
1940, translated and edited by Thomas D. Brock, ASM Press. 1998, pl95.
76. Dubnau D.  1999.  DNA uptake in bacteria. Annu. Rev. Microbiol. 53:217— 44.
77. Dubnau D.  1997. Binding and transport of transforming DNA by Bacillus 
subtilis: the role of type-IV pilin-like proteins— a review. Gene. 192(l):191-8.
78. Dubnau D.  1991. Genetic competence in Bacillus subtilis. Microbiol Rev. 
55(3):395-424.
79. Edlund C, Alvan G, Barkholt L, Vacheron F, Nord CE. 2000.  Pharmacokinetics 
and comparative effects of telithromycin (HMR 3647) and clarithromycin on the 
oropharyngeal and intestinal microflora. J Antim Chem. 46:741-749.
80. Endtz HP, Ruijs GJ, van Klingeren B, Jansen WH, van der Reyden T, Mouton 
RP.  1991. Quinolone resistance in Campylobacter isolated from man and poultry 
following the introduction of fluoroquinolones in veterinary medicine. J 
Antimicrob Chemother. 27(2): 199-208.
81. Enne VI, Livermore DM, Stephens P, Hall LM. 2001. Persistence of 
sulphonamide resistance in Escherichia coli in the UK despite national 
prescribing restriction. Lancet. 357(9265):1325-8.
82. Farrell DJ, Morrissey I, De Rubeis D, Robbins M, Felmingham D. 2003. A UK 
multicentre study of the antimicrobial susceptibility of bacterial pathogens 
causing urinary tract infection. J Infect. 46(2):94-100.
83. Farrell DJ, Morrissey I, Bakker S, Felmingham D. 2001. Detection of macrolide 
resistance mechanisms in Streptococcus pneumoniae and Streptococcus
153pyogenes using a multiplex rapid cycle PCR with microwell-format probe 
hybridization. J Antimicrob Chemother. 48(4):541-4.
84. Fenoll A, Jado I, Vicioso D, Perez A, Casal J. 1998. Evolution of Streptococcus 
pneumoniae serotypes and antibiotic resistance in Spain: update (1990 to 1996).
J Clin Microbiol. 36(12):3447-54.
85. Feres M, Haffajee AD, Allard K, Som S, Goodson JM, Socransky SS. 2002. 
Antibiotic resistance of subgingival species during and after antibiotic therapy. J 
Clin Periodontol. 29(8):724-35.
86. Fine DH, Hammond BF, Loesche WJ.  1998. Clinical use of antibiotics in dental 
practice. Int J Antimicrob Agents. 9(4):235-8.
87. Firth NK, Ippen-Ihler, Skurray R.  1996. Structure and function of the F factor and 
mechanism of conjugation. In F. Neidhardt et al. (eds), Escherichia coli and 
Salmonella: Cellular and Molecular Biology, second edition, p. 2377-2401. ASM 
Press, Washington, D.C.
88. Flannagan SE, Zitzow LA, Su YA, Clewell DB.  1994. Nucleotide sequence of 
the 18-kb conjugative transposon Tn916 from Enterococcus faecalis. Plasmid. 
32(3):350-4.
89. Fleming A.  1929. On the antibacterial action of cultures of a penicillium, with 
special reference to their use in the isolation of B. influenzae. Reprinted with 
permission from British Journal o f  Experimental Pathology 10:226-236. (Now 
International Journal o f  Experimental Pathology.) Copyright © 1929. Blackwell 
Science Ltd.
90. Florez C, Garcia-Lopez JL, Martin-Mazuelos E.  1997. Susceptibilities of 55 
strains of Neisseria meningitidis isolated in Spain in 1993 and 1994. 
Chemotherapy. 43(3): 168-70.
91. Fluit AD, Visser MR, Schmitz FJ. 2001. Molecular detection of antimicrobial 
resistance. Clin Microbiol Rev.  14(4):836-871.
15492. Fraise AP. 2002. Biocide abuse and antimicrobial resistance--a cause for
.  concern? J Antimicrob Chemother. 49(1 ):11-2.
93. Francois B, Charles M, Courvalin P.  1997. Conjugation transfer of tet{S) between 
strains of Enterococcus faecalis is associated with the exchange of large 
fragments of chromosomal DNA. Microbiology 143:2145-2154.
94. Friedland I, Stinson L, Ikaiddi M, Harm S, Woods GL. 2003. Phenotypic 
antimicrobial resistance patterns in Pseudomonas aeruginosa and Acinetobacter: 
results of a Multicenter Intensive Care Unit Surveillance Study, 1995-2000. 
Diagnostic Microbiol and Infect Dis. 45:245-250.
95. Fridkin SK, Gaynes RP.  1999. Antimicrobial resistance in intensive care units. 
Clin Chest Med. 2:303-316.
96. Gawron-Burke C, Clewell DB.  1984. Regeneration of insertionally inactivated 
streptococcal DNA fragments after excision of transposon Tn916 in Escherichia 
coli: strategy for targeting and cloning of genes from Gram-positive bacteria. J 
Bacteriol.  159:214-221.
97. Gay K, Stephens DS. 2001. Structure and dissemination of a chromosomal 
insertion element encoding macrolide efflux in Streptococcus pneumoniae. J 
Infect Dis.  184(l):56-65.
98. Gay K, Baughman W, Miller Y, Jackson D, Whitney CG, Schuchat A, Farley 
MM, Tenover F, Stephens DS. 2000. The emergence of Streptococcus 
pneumoniae resistant to macrolide antimicrobial agents: a 6-year population- 
based assessment. J Infect Dis.  182(5): 1417-24.
99. Gerrits MM, Beming M, Van Vliet AH, Kuipers EJ, Kusters JG. 2003. Effects of 
16S rRNA gene mutations on tetracycline resistance in Helicobacter pylori. 
Antimicrob Agents Chemother. 47(9):2984-6.
100.  Gholizadeh Y, Courvalin P. 2000. Acquired and intrinsic glycopeptide 
resistance in enterococci. Int J of Antimicrob Agents.  16:S11-S17.
155101.  Giovanetti E, Brenciani A, Lupidi R, Roberts MC, Varaldo PE. 2003.
Presence of the tet(0) gene in erythromycin- and tetracycline-resistant strains of 
Streptococcus pyogenes and linkage with either the mef[A) or the erm(A) gene. 
Antimicrob Agents Chemother. 47(9):2844-9.
102.  Giovanetti E, Montanari MP, Mingoia M, and Varaldo PE. 1999. Phenotypes 
and genotypes of erythromycin-resistant Streptococcus pyogenes strains in Italy 
and heterogeneity of inducibly resistant strains. Antimicrob Agents Chemother. 
43:1935-1940.
103.  Girons IS, Bourhy P, Ottone C, Picardeau M, Yelton D, Hendrix RW, Glaser 
P, Charon N. 2000. The LEI bacteriophage replicates as a plasmid within 
Leptospira biflexa: construction of an L.  biflexa-Escherichia coli shuttle vector. J 
Bacteriol.  182(20):5700-5.
104.  Glynn MK, Bopp C, Dewitt W, Dabney P, Mokhtar M, Angulo FJ. 1998. 
Emergence of multidrug-resistant Salmonella enterica serotype typhimurium 
DTI04 infections in the United States. N Engl J Med. 338(19): 1333-8.
105.  Gonzalez I, Georgiou M, Alcaide F, Balas D, Linares J, de la Campa AG. 
1998. Fluoroquinolone resistance mutations in the parC.parE, and gyrA genes 
of clinical isolates of viridans group streptococci. Antimicrob Agents 
Chemother. 42(11):2792-8.
106.  Goossens H, Sprenger MJ.  1998. Community acquired infections and 
bacterial resistance. BMJ. 317(7159):654-7.
107.  Grandey M, Gorton R, O’Hora A, Hollyoak V. 2004. Communicable diseases 
in the North East of England. North East Public Health Observatory. ISBN I- 
903945-26-7.
108.  Grohmann E, Muth G, Espinosa M. 2003. Conjugative plasmid transfer in 
Gram-positive bacteria. Microbiol and Mol Biol Rev. 67(2):277-301.
109.  Hanberger H, Garcia-Rodriguez JA, Gobemado M, Goossens H, Nilsson LE, 
Struelens MJ.  1999. Antibiotic susceptibility among aerobic Gram-negative
156bacilli in intensive care units in 5 European countries. French and Portuguese
.  ICU Study Groups. JAMA. 281(1):67-71.
110.  Hagman KE, Lucas CE, Balthazar JT, Snyder L, Nilles M, Judd RC, Shafer 
WM.  1997. The MtrD protein of Neisseria gonorrhoeae is a member of the 
resistance/nodulation/division protein family constituting part of an efflux 
systerm. Microbiol.  143:2117-2125.
111.  Hartley DL, Jones KR, Tobian JA, LeBlanc DJ, Macrina FL. 1984. 
Disseminated tetracycline resistance in oral streptococci: implication of a 
conjugative transposon. Infection Immunity 45:13.
112.  Havarstein LS, Hakenbeck R, Gaustad P.  1997. Natural competence in the 
genus Streptococcus: evidence that streptococci can change pherotype by 
interspecies recombinational exchanges. J Bacteriol.  179(21):6589-94.
113.  Hawley RJ, Lee LN, LeBlanc DJ.  1980. Effects of tetracycline on the 
streptococcal flora of periodontal pockets. Antimicrob Agents Chemother. 
17(3):372-8.
114.  Heaton MP, Discotto LF, Pucci MJ, Handwerger S. 1996. Mobilization of 
vancomycin resistance by transposon-mediated fusion of a VanA plasmid with 
an Enterococcus faecium sex pheromone-response plasmid. Gene 171(1):9-17.
115.  Hendrix RW. 2002. Bacteriophages: evolution of the majority. Theor Popul 
Biol. 61(4):471-80.
116.  Herrera D, van Winkelhoff AJ, Dellemijn-Kippuw N, Winkel EG, Sanz M.
2000.  Beta-lactamase producing bacteria in the subgingival microflora of adult 
patients with periodontitis. A comparison between Spain and The Netherlands. J 
Clin Periodontol. 27(7):520-5.
117.  Hiramatsu K, Aritaka N, Hanaki H, Kawasaki S, Hosoda Y, Hori S, Fukuchi 
Y, Kobayashi I.  1997. Dissemination in Japanese hospitals of strains of 
Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 
350:1670-1673.
157118.  Hiramatsu K, Hanaki H, Ino T, Yabuta K, Oguri T, Tenover FC. 1997.
•  Methicillin-resistant Staphylococcus aureus clinical strain with reduced
vancomycin susceptibility. J Antimicrob Chemother. 40(1): 135-6.
119.  Hitch G, Pratten J, Taylor PW. 2004. Isolation of bacteriophages from the 
oral cavity. Lett App Microbiol. 39:215-219.
120.  Hoiby N. 2000. Ecological antibiotic policy. J Antim Chem. 46 (Sl):59-62.
121.  Hooton TM, Levy SB. 2001. Antimicrobial resistance: a plan of action for 
community practice. Am Fam Physician. 63(6): 1087-98.
122.  House of Lords Report. Session 1997-98. Science and Technology - Seventh 
Report.
123.  Hughes VM, Datta N.  1983. Conjugative plasmids in bacteria of the 'pre­
antibiotic' era. Nature 302(5910):725-6.
124.  Hwa Lee J. 2003. Methicillin (oxacillin)-resistant Staphylococcus aureus 
strains isolated from major food animals and their potential transmission to 
humans. App Env Microbial. 69(11):6489-6494.
125.  Ingman T, Sorsa T, Suomalainen K, Halinen S, Lindy O, Lauhio A, Saari H, 
Konttinen YT, Golub LM.  1993. Tetracycline inhibition and the cellular source 
of collagenase in gingival crevicular fluid in different periodontal diseases. A 
review article. J Periodontol.  1993 Feb;64(2):82-8.
126.  Ioannidou S, Tassios PT, Kotsovili-Tseleni A, Foustoukou M, Legakis NJ, 
Vatopoulos A. 2001. Antibiotic resistance rates and macrolide resistance 
phenotypes of viridans group streptococci from the oropharynx of healthy Greek 
children. Int J Antimicrob Agents.  17(3): 195-201.
127.  Jacobs JA, van Baar GJ, London NH, Tjhie JH, Schouls LM, Stobberingh 
EE. 2001. Prevalence of macrolide resistance genes in clinical isolates of the 
Streptococcus anginosus ("S. miller/") group. Antimicrob Agents Chemother. 
45:2375-2377.
158128.  Janoir C, Podglajen I, Kitzis MD, Poyart C, Gutmann L. 1999. In vitro
*   exchange of fluoroquinolone resistance determinants between Streptococcus 
pneumoniae and viridans streptococci and genomic organization of the parE- 
parC region in S. mitis. J Infect Dis.  180(2):555-8.
129.  Jensen LB, Willems RJL, Van Den Bogaard AE. 2003. Genetic 
characterization of glycopeptide-resistant enterococci of human and animal 
origin from mixed pig and poultry farms. APMIS  111: 669-72.
130.  Jensen LB, Ahrens P, Dons L, Jones RN, Hammerum AM, Aarestrup FM. 
1998. Molecular analysis of Tnl546 in Enterococcus faecium isolated from 
animals and humans. J Clin Microbiol. 36(2):437-42.
131.  Jiang SC, Paul JH.  1998. Gene transfer by transduction in the marine 
environment. Appl Environ Microbiol. 64(8):2780-7.
132.  Johnston AM.  1998. Use of antimicrobial drugs in veterinary practice. BMJ. 
1998 317(7159):665-7.
133.  Kaatz GW, Seo SM.  1999. Mechanisms of fluoroquinolone resistance in 
genetically related strains of Staphylococcus aureus. Antimicrob Agents 
Chemother. 41(12):2733-7.
134.  Kataja J, Huovinen P, Skumik M, the Finnish Study Group for Antimicrobial 
Resistance and Seppala H.  1999. Erythromycin resistance genes in group A 
Streptococci in Finland. Antimicrob Agents Chemother. 43:48-52.
135.  Katayama Y, Ito T, Hiramatsu K. 2000. A new class of genetic element, 
staphylococcal cassette chromosome mec, encodes methicillin resistance in 
Staphylococcus aureus.  Antimicrob. Agents Chemother. 44:1549-1555.
136.  Kehrenberg C, Salmon SA, Watts JL, Schwarz S. 2001. Tetracycline 
resistance genes in isolates of Pasteurella multocida, Mannheimia haemolytica, 
Mannheimia glucosida and Mannheimia varigena from bovine and swine 
respiratory disease: intergeneric spread of the tet(H) plasmid pMHTl. J 
Antimicrob Chemother 48(5):631-40.
159137.  Kiple KF.  1993. Cambridge World History of Human Disease. Cambridge 
University Press, Cambridge, New York.
»
138.  Kirst HA.  1991. New macrolides: expanded horizons for an old class of 
antibiotics. J Antimicrob Chemother.  1991 Dec;28(6):787-90.
139.  Kjeldgaard M, Nyborg J.  1992. Refined structure of elongation factor EF-Tu 
from Escherichia coli. J Mol Biol. 223(3):721-42.
140.  Koh J, Wilson M, Vidic J, Newman HN.  1986. Amoxycillin-resistant 
streptococci in dental plaque. Microbios. 45(182):41-53.
141.  Kohler T, Pechere JC, Plesiat P.  1999. Bacterial antibiotic efflux systems of 
medical importance. Cell Mol Life Sci. 56(9-10):771-8.
142.  Lacroix JM, Walker CB.  1996. Detection and prevalence of the tetracycline 
resistance determinant Tet Q in the microbiota associated with adult 
periodontitis. Oral Microbiol Immunol.  11:282-288.
143.  Lacroix JM, Walker CB.  1995. Detection and incidence of the tetracycline 
resistance determinant tet(M) in the microflora associated with adult 
periodontitis. J Periodontol. 66:102-108.
144.  Lancaster H, Roberts AP, Bedi R, Wilson M, Mullany P. 2004. 
Characterization of Tn916S, a Tn916-like element containing the tetracycline 
resistance determinant tet(S). J Bacteriol.  186(13):4395-8.
145. Lane DJ.  1996.  16S/23S rRNA sequencing, p.  115-175. In E. Stackebrandt, and 
M. Goodfellow (ed.), Nucleic acid techniques in bacterial systematics. Wiley and 
Sons Ltd., Chichester, United Kingdom.
146. Lawrence JG, Ochman H.  1997. Amelioration of bacterial genomes: rates of 
change and exchange. J Mol Evol. 44(4):383-97.
147.  Le Bouguenec C, de Cespedes G, Horaud T.  1990. Presence of chromosomal 
elements resembling the composite structure Tn3701 in streptococci. J Bacteriol. 
172(2):727-34.
160148.  Leclercq R. 2002. Mechanisms of resistance to macrolides and lincosamides: 
nature of the resistance elements and their clinical implications. Clin Infect Dis. 
34(4):482-92.
149.  Leclercq R, Derlot E, Duval J, Courvalin P.  1987. Plasmid-mediated 
resistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J 
Med. 319:157-61.
150.  Legg JA, Wilson M.  1990. The prevalence of beta-lactamase producing 
bacteria in subgingival plaque and their sensitivity to Augmentin. Br J Oral 
Maxillofac Surg. 28(3): 180-4.
151.  Leng Z, Riley DE, Berger DE, Kneger JN, Roberts MC. 1997. Distribution 
and mobility of the tetracycline resistance determinant Tet Q. J Antimicrob 
Chemoter. 40:551-559.
152.  Letellier L, Plancon L, Bonhivers M, Boulanger P. 1999. Phage DNA 
transport across membranes. Res Microbiol.  150(8):499-505.
153.  Levy SB. 2001. Antibacterial household products: cause for concern. Emerg 
Infect Dis. 7(3 Suppl):512-5.
154.  Levy SB, McMurry LM, Barbosa TM, Burdett V, Courvalin P, Hillen W, 
Roberts MC, Rood JI, Taylor DE.  1999. Nomenclature for new tetracycline 
resistance determinants. Antimicrob Agents Chemother. 43(6): 1523-4.
155.  Levy SB.  1998.  “The Challenge of Antibiotic Resistance.”  Scientific 
American.
156.  Levy SB.  1992. Active efflux mechanisms for antimicrobial resistance. 
Antimicrob Agents Chemother. 36:695-703.
157.  Lewis K.  1994. Multidrug resistance pumps in bacteria: variations on a 
theme. Trends Biochem Sci.  19:119-23.
158.  Li YH, Lau PC, Lee JH, Ellen RP, Cvitkovitch DG. 2001. Natural genetic 
transformation of Streptococcus mutans growing in biofilms. J Bacteriol. 
183(3):897-908.
161159.  Li LY, Shoemaker NB, Salyers AA.  1993. Characterization of the 
mobilization region of a Bacteroides insertion element (NBU1) that is excised
«
and transferred by Bacteroides conjugative transposons. J Bacteriol. 
175(20):6588-98.
160.  Licht TR, Christensen BB, Krogfelt KA, Molin S.  1999. Plasmid transfer in 
the animal intestine and other dynamic bacterial populations: the role of 
community structure and environment. Microbiology. 145:2615-22.
161.  Livermore DM. 2000. Antibiotic resistance in staphylococci. International 
Journal of Antimicrobial Agents.  16:S3-S10.
162.  Loesche W.  1997. Association of the oral flora with important medical 
diseases. Curr Opin Period. 4:21-28.
163.  Lorenz MG, Wackemagel W.  1994. Bacterial gene transfer by natural genetic 
transformation in the environment. Microbiol Rev. 58(3):563-602.
164.  Luna VA, Heiken M, Judge K, Ulep C, Van Kirk N, Luis H, Bernardo M, 
Leitao J, Roberts MC. 2002. Distribution of mej{A) in Gram-positive bacteria 
from healthy Portuguese children. Antimicrob Agents Chemother. 46:2513-2517.
165.  Luna VA, Coates P, Eady EA, Cove JH, Nguyen TT, Roberts MC. 1999. A 
variety of Gram-positive bacteria carry mobile mef genes. J Antimicrob 
Chemother. 44:19-25.
166.  Luo N, Sahin O, Lin J, Michel LO, Zhang Q. 2003. In vivo selection of 
Campylobacter isolates with high levels of fluoroquinolone resistance associated 
with gyrA mutations and the function of the CmeABC efflux pump. Antimicrob 
Agents Chemother. 47(l):390-4.
167.  MacGowan AP, Wise R. 2001. Establishing MIC breakpoints and the 
interpretation of in vitro susceptibility tests. J Antimicrob Chemother. 48 Suppl 
1:17-28.
168.  Mah TF, O'Toole GA. 2001. Mechanisms of biofilm resistance to 
antimicrobial agents. Trends Microbiol. 9(l):34-9.
162169.  Mahillon J, Chandler M.  1998. Insertion sequences. Microbiol Mol Biol Rev. 
62(3):725-74.
170.  Marimon JM, Gomariz M, Zigorraga C, Cilia G, Perez-Trallero E. 2004. 
Increasing prevalence of quinolone resistance in human nontyphoid Salmonella 
enterica isolates obtained in Spain from 1981 to 2003. Antimicrob Agents 
Chemother. 2004 Oct;48(10):3789-93.
171.  Marshall CG, Lessard IAD, Park IS, Wright GD.  1998. Glycopeptide 
antibiotic resistance genes in glycopeptide-producing organisms. Antimicrob. 
Agents Chemoter. 42(9):2215-2220.
172.  Marshall CG, Broadhead G, Leskiw BK, Wright GD.  1997. D-Ala-D-Ala 
ligases from glycopeptide antibiotic-producing organisms are highly homologous 
to the enterococcal vancomycin-resistance ligases VanA and VanB. Proc Natl 
Acad Sci USA. 94(12):6480-3.
173.  Martin JM, Green M, Barbadora KA, Wald ER. 2002. Erythromycin-resistant 
group A streptococci in schoolchildren in Pittsburgh. N Engl J Med.
346(16): 1200-6.
174.  McDougal LK, Tenover FC, Lee LN, Rasheed JK, Patterson JE, Jorgensen 
JH, LeBlanc DJ.  1998. Detection of TnP7 7-like sequences within a Tn9/d-like 
conjugative transposon (Tn3872) in erythromycin-resistant isolates of 
Streptococcus pneumoniae. Antimicrob Agents Chemother. 42(9):2312-8.
175.  McGee L, Klugman KP, Wasas A, Capper T, Brink A, and The Antibiotics 
Surveillance Forum Of South Africa. 2001. Serotype 19F multiresistant 
pneumococcal clone harboring two erythromycin resistance determinants 
[erm(B) and me/(A)] in South Africa. Antimicrob Agents Chemother. 45:1595- 
1598.
176.  McManus PS, Stockwell VO, Sundin GW, Jones AL. 2002. Antibiotic use in 
plant agriculture. Annu Rev Phytopathol. 40:443-65.
163177.  McMurry LM, Oethinger M, Levy SB. 1998. Overexpression of mar  A, soxS, 
or acrAB produces resistance to triclosan in laboratory and clinical strains of
«
Escherichia coli. FEMS Microbiol Lett.  166(2):305-9.
178.  Medeiros AA.  1997. Evolution and dissemination of (3-lactamases accelerated 
by generations of (3-lactam antibiotics. Clin Inf Dis. 24(Suppl l):S19-45.
179.  Melville CM, Brunei R, Flint HJ, Scott KP. 2004. The Butyrivibrio 
fibrisolvens tet(W) gene is carried on the novel conjugative transposon TilB1230, 
which contains duplicated nitroreductase coding sequences. J Bacteriol.
186(11):3656-9.
180.  Melville CM, Scott KP, Mercer DK, Flint HJ. 2001. Novel tetracycline 
resistance gene, tet(32), in the Clostridium-related human colonic anaerobe K10 
and its transmission in vitro to the human anaerobe Butyrivibrio fibrisolvens. 
Antimicrob Agents Chemoter. 45(ll):3242-3249.
181.  Mercer DK, Scott KP, Melville CM, Glover LA, Flint HJ. 2001. 
Transformation of an oral bacterium via chromosomal integration of free DNA 
in the presence of human saliva. FEMS Microbiol Lett. 200(2): 163-7.
182.  Mercer DK, Scott KP, Bruce-Johnson WA, Glover LA, Flint HJ. 1999. Fate 
of free DNA and transformation of the oral bacterium Streptococcus gordonii 
DL1 by plasmid DNA in human saliva. Appl Environ Microbiol. 65(1):6-10.
183.  Miller RV, Day MJ (ed.). 2004. Microbial evolution, gene establishment, 
survival, and exchange. ASM press, Washington, D.C.
184.  Molin S, Tolker-Nielsen T. 2003. Gene transfer occurs with enhanced 
efficiency in biofilms and induces enhanced stabilisation of the biofilm structure. 
Curr Opin Biotechnol.  14(3):255-61.
185.  Montanari MP, Cochetti I, Mingoia M, Varaldo PE. 2003. Phenotypic and 
molecular characterization of tetracycline- and erythromycin-resistant strains of 
Streptococcus pneumoniae. Antimicrob Agents Chemother. 47(7):2236-41.
164186.  Momer KAH.  1967. Nobel Lectures, Physiology or Medicine 1901-1921, 
Elsevier Publishing Company, Amsterdam, The Nobel Prize in Physiology or 
Medicine 1905. Presentation Speech by Professor the Count K.A.H. Momer, 
Rector of the Royal Caroline Institute.
187.  Morse SA, Lysko PG, McFarland L, Knapp JS, Sandstrom E, Critchlow C, 
Holmes KK.  1982. Gonococcal strains from homosexual men have outer 
membranes with reduced permeability to hydrophobic molecules. Inf and Imm. 
37(2):432-438.
188.  Mullany P, Roberts AP, Wang H. 2002. Mechanism of integration and 
excision in conjugative transposons. Cell Mol Life Sci. 59:2017-2022.
189.  Mullany P. 2000. Gene transfer in the GI tract and the oral cavity. Microbial 
Ecology in Health and Disease. Suppl 2:73-80.
190.  Murdoch DA.  1998. Gram-positive anaerobic cocci. Clin Microbiol Rev.
11(1):81-120.
191.  Nagai K, Shibasaki Y, Hasegawa K, Davies TA, Jacobs MT, Ubukata K, 
Appelbaum PC. 2001. Evaluation of PCR primers to screen for Streptococcus 
pneumoniae isolates and B-lactam resistance, and to detect common macrolide 
resistance determinants. J Antimicrob Chemother. 48:915-918.
192.  National Committee for Clinical Laboratory Standards.  1993. Methods for 
dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 3rd 
ed. Approved standard M7-A3. National Committee for Clinical Labo-ratory 
Standards, Wayne, Pa.
193.  Nawaz MS, Khan SA, Khan AA, Khambaty FM, Cemiglia CE. 2000. 
Comparative molecular analysis of erythromycin-resistance determinants in 
staphylococcal isolates of poultry and human origin. Mol Cell Probes. 14:311- 
319.
194.  Ng L-K, Martin I, Liu G, Bryden L. 2002. Mutation in 23S rRNA associated 
with macrolide resistance in Neisseria gonorrhoeae. Antimicrob Agents 
Chemother. 46(9): 3020-5.
165195.  Ng L-K, Martin I, Alfo M, Mulvey M. 2001. Multiplex PCR for the detection 
of tetracycline resistance genes. Molecular and Cellular Probes 15:209-215.
196.  Ng L-K, Stiles ME, Taylor DE.  1987. DNA probes for identification of 
tetracycline resistance genes in Campylobacter species isolated from swine and 
cattle. Antimicrob Agents Chemother. 31(11): 1669-74.
197.  Nield BS, Holmes AJ, Gillings MR, Recchia GD, Mabbutt BC, Nevalainen 
KM, Stokes HW. 2001. Recovery of new integron classes from environmental 
DNA. FEMS Microbiol Lett.  195(l):59-65.
198.  Nielsen KM, Smalla K, van Elsas JD. 2000. Natural transformation of 
Acinetobacter sp. strain BD413 with cell lysates of Acinetobacter sp., 
Pseudomonas fluorescens, and Burkholderia cepacia in soil microcosms. Appl 
Environ Microbiol. 66(1):206-12.
199.  Nikolich NP, Schoemaker NB, Salyers AA.  1992. A Bacteroides tetracycline 
resistance gene represents a new class of ribosomal protective tetracycline 
resistance. Antimicrob. Agents Chemoter. 36(5): 1005-1012.
200.  NNIS System. 2003. National Nosocomial Infections Surveillance (NNIS) 
System Report, data summary from January 1992 through June 2003, issued 
August 2003. Am J Infect Control. 31:481-98.
201.  NNIS System. 2001. National Nosocomial Infections Surveillance (NNIS) 
System Report, Data Summary from January 1992-June 2002, Issued August
2002.  Am J Infect Control. 30:458-75.
202.  NNIS System. 2000. National Nosocomial Infections Surveillance (NNIS) 
System Report, Data Summary from January 1992-June 2001, Issued August
2001.  Am J Infect Control. 29:404-21.
203.  Noguchi N, Katayama J, Sasatsu M. 2000. A transposon carrying the gene 
mph(B) for macrolide 2'-phosphotransferase II. FEMS Microbiol Lett.
192(2): 175-8.
166204.  Noguchi N, Tamura Y, Katayama J, Narui K.  1998. Expression of the mph(B) 
gene for macrolide 2'-phosphotransferase II from Escherichia coli in 
Staphylococcus aureus. FEMS Microbiol Lett.  159(2):337-42.
205.  Noguchi N, Emura A, Matsuyama H, O'Hara K, Sasatsu M, Kono M.  1995. 
Nucleotide sequence and characterization of erythromycin resistance determinant 
that encodes macrolide 2'-phosphotransferase I in Escherichia coli. Antimicrob 
Agents Chemother. 39(10):2359-63.
206.  Nonaka L, Suzuki S. 2002. New Mg 2+-dependent oxytetracycline resistance 
determinant Tet 34 in Vibrio isolates from marine fish intestinal contents. 
Antimicrob Agents Chemoter. 46(5): 1550-1552.
207.  Norgren M, Scott JR.  1991. The presence of conjugative transposon Tn916 in 
the recipient strain does not impede transfer of a second copy of the element. J 
Bacteriol.  173(1 ):319-24.
208.  Ochman HJ, Wilson AC.  1987. Evolution in bacteria: evidence for a 
universal substitution rate in cellular genomes. J Mol Evol. 26:74-86.
209.  Olsvik B, Hansen BF, Tenover FC, Olsen I.  1995. Tetracycline-resistant 
micro-organisms recovered from patients with refractory periodontal disease. J 
Clin Periodontol. 22(5):391-6.
210.  Olsvik B, Olsen I, Tenover FC.  1995. Detection of tet(M) and tet(0) using 
the polymerase chain reaction in bacteria isolated from patients with periodontal 
disease. Oral Microbiol Immunol.  10:87-92.
211.  Olsvik B, Olsen I, Tenover FC.  1994. The tet(Q) gene in bacteria isolated 
from patients with refractory periodontal disease. Oral. Microbiol. Immunol. 
10:87-92.
212.  Osborn AM, Boltner D. 2002. When phages, plasmids and transposons 
collide: genomic islands and conjugative- and mobilizable-transposons as a 
mosaic continuum. Plasmid. 48:202 -212.
167213.  Palmer EL, Teviotdale BL, Jones AL.  1997. A relative of the broad-host- 
range plasmid RSF1010 detected in Erwinia amylovora. Appl Environ 
Microbiol. 63(11):4604-7.
214.  Pancoast SJ.  1988. Aminoglycoside antibiotics in clinical use. Med. Clin. 
North. Am. 72:581-602.
215.  Partridge SR, Recchia GD, Scaramuzzi C, Collis CM, Stokes HW, Hall RM.
2000.  Definition of the attll site of class 1   integrons. Microbiology. 146:2855- 
2864.
216.  Paster BJ, Boches SK, Galvin JL, Ericson RE, Lau CN, Levanos VA, 
Sahasrabudhe A, Dewhirst FE. 2001. Bacterial diversity in human subgingival 
plaque. J Bacteriol.  183(12):3770-83.
217.  Paulsen IT, Brown MH, Skurray RA.  1996. Proton-dependent multidrug 
efflux systems. Microbiol Rev. 60(4):575-608.
218.  Perez-Trallero E, Vicente D, Montes M, Marimon JM, and Pineiro L. 2001. 
High proportion of pharyngeal carriers of commensal streptococci resistant to 
erythromycin in Spanish adults. J. Antimicrob. Chemother. 48: 225-229.
219.  Perez-Trallero E, Arenzana JMG, Ayestaran I, Munoz Baroja I. 1989. 
Comparative activity in vitro of 16 antimicrobial agents against penicillin- 
susceptible meningococci and meningococci with diminished susceptibility to 
penicillin. Antimicrob Agents Chemother. 33(9)1622-1623.
220.  Pezzella C, Ricci A, DiGiannatale E, Luzzi I, Carattoli A. 2004. Tetracycline 
and streptomycin resistance genes, transposons, and plasmids in Salmonella 
enterica isolates from animals in Italy. Antimicrob Agents Chemother. 
48(3):903-8.
221.  Piddock LJ.  1995. Quinolone resistance and Campylobacter spp. J 
Antimicrob Chemother.  1995 Dec;36(6):891-8.
222.  Pike R, Lucas V, Stapleton P, Gilthorpe MS, Roberts G, Rowbury R, 
Richards H, Mullany P, Wilson M. 2002. Prevalence and antibiotic resistance
168profile of mercury-resistant oral bacteria from children with and without mercury 
amalgam fillings. J Antimicrob Chemother. 49(5):777-83.
«
223.  Poyart C, Pierre C, Quesne G., Pron B, Berche P, Trieu-Cuot P. 1997. 
Emergence of vancomycin resistance in the genus Streptococcus’ . 
characterization of a vanB transferable determinant in Streptococcus bovis. 
Antimicrob. Agents Chemoter. 41(l):24-29.
224.  Pradier C, Dunais B, Carsenti-Etesse H, Dellamonica P. 1997. Pneumococcal 
resistance patterns in Europe. Eur J Clin Microbiol Infect Dis. 16(9):644-7.
225.  Prescott LM, Harley JP, Klein DA.  1996. Microbiology third edition. Chapter 
1, the history and scope of microbiology, 1-16.
226.  Provvedi R, Dubnau D.  1999. ComEA is a DNA receptor for transformation 
of competent Bacillus subtilis. Mol Microbiol. 31(l):271-80.
227.  Public Health Laboratory Services. 2003. World TB day-24 March 2003.
CDR weekly 20 March 2003.
228.  Rasmussen JL, Odelson DA, Macrina FL.  1987. Complete nucleotide 
sequence of insertion element \S4351 from Bacteroides fragilis. J Bacteriol. 
169(8):3573-80.
229.  Reacher MH, Shah A, Livermore DM, Wale MC, Graham C, Johnson AP, 
Heine H, Monnickendam MA, Barker KF, James D, George RC. 2000. 
Bacteraemia and antibiotic resistance of its pathogens reported in England and 
Wales between 1990 and 1998: trend analysis. BMJ. 320(7229):213-6.
230.  Ready D, Roberts AP, Pratten J, Spratt DA, Wilson M, Mullany P. 2002. 
Composition and antibiotic resistance profile of microcosm dental plaques before 
and after exposure to tetracycline. J Antimicrob Chemother. 49(5):769-75.
231.  Recchia GD, Hall RM.  1997. Origins of the mobile gene cassettes found in 
integrons. Trends Microbiol. 5(10):389-94.
232.  Reichmann P, Konig A, Linares J, Alcaide F, Tenover FC, McDougal L, 
Swidsinski S, Hakenbeck R.  1997. A global gene pool for high-level
169cephalosporin resistance in commensal Streptococcus species and Streptococcus 
pneumoniae. J Infect Dis.  176(4): 1001-12.
233.  Reig M, Galan J, Baquero F, Perez-Diaz JC. 2001. Macrolide resistance in 
Peptostreptococcus spp. mediated by ermTR: possible source of macrolide- 
lincosamide-streptogramin B resistance in Streptococcus pyogenes. Antimicrob 
Agents Chemother. 45:630-632.
234.  Reinert RR, Al-Lahham A, Lemperle M, Tenholte C, Briefs C, Haupts S, 
Gerards HH, Lutticken R. 2002. Emergence of macrolide and penicillin 
resistance among invasive pneumococcal isolates in Germany. J Antimicrob 
Chemother. 49(1 ):61-8.
235.  Reynolds PE.  1989. Structure, biochemistry and mechanism of action of 
glycopeptide antibiotics. Eur J Clin Microbiol Infect Dis. 8(11):943-50.
236.  Rice LB. 2002. Association of different mobile elements to generate novel 
integrative elements. Cell Mol Life Sci. 59(12):2023-32.
237.  Rice LB.  1998. Tn916 family conjugative transposons and dissemination of 
antimicrobial resistance determinants. Antimicrob Agents Chemoter. 
42(8):1871-1877.
238.  Ridenhour MB, Fletcher HM, Mortensen JE, Daneo-Moore L. 1996. A novel 
tetracycline-resistant determinant, tetQJ), is encoded on the plasmid pKqlO in 
Enterococcus faecium. Plasmid. 35(2):71-80.
239.  Robert C, Moellering JR.  1998. Vancomycin-Resistant Enterococci. Clinical 
Infectious Diseases 26:1196-9.
240.  Robert VM, Day MJ. 2004. Microbial evolution, gene establishment, survival 
and exchange. ASM Press, Washington, DC, pl44-157.
241.  Roberts AP, Hennequin C, Elmore M, Collignon A, Karjalainen T, Minton N, 
Mullany P. 2003. Development of an integrative vector for the expression of 
antisense RNA in Clostridium difficile. J Microb Methods. 55:617-24.
170242.  Roberts AP, Braun V, von Eichel-Streiber C, Mullany P. 2001. 
Demonstration that the group II intron from the clostridial conjugative 
transposon Tn5397 undergoes splicing in vivo. J Bacteriology. 183:1296-1299.
243.  Roberts AP, Cheah G, Ready D, Pratten J, Wilson M, Mullany P. 2001. 
Transfer of Tn97d-like elements in microsm dental plaques. Antimicrob Agents 
Chemoter. 45(10):2943-2946.
244.  Roberts AP, Pratten J, Wilson M, Mullany P.  1999. Transfer of a conjugative 
transposon, Tn5397 in a model oral biofilm. FEMS Microbiol Lett. 177(l):63-6.
245.  Roberts MC. 2000. Antibiotic toxicity, interactions and resistance 
development. Periodontol 2000 28:280-297.
246.  Roberts MC, Chung WO, Darcie R, Xia M, Marquez C, Borthagaray G, 
Whittington WL, Holmes KK.  1999. Erythromycin-resistant Neisseria 
gonorrhoeae and oral commensal Neisseria spp carry known rRNA methylase 
genes. Antimicrob Agents Chemother. 43(6): 1367-1372.
247.  Roberts MC, Sutcliffe J, Courvalin P, Jensen LB, Rood J, Seppala H. 1999. 
Nomenclature for macrolide and macrolide-lincosamide-streptogramin B 
resistance determinants. Antimicrob Agents Chemother. 43(12):2823-30.
248.  Roberts MC.  1998. Antibiotic resistance in oral/respiratory bacteria. Crit Rev 
Oral Biol Med. 9:522-540.
249.  Roberts MC.  1996. Tetracycline-resistance determinants: mechanisms of 
action, regulation of expression, genetic mobility, and distribution. FEMS 
Microbiol. Rev.  19:1-24.
250.  Rohwer F, Edwards R. 2002. The Phage Proteomic Tree: a genome-based 
taxonomy for phage. J Bacteriol.  184(16):4529-35.
251.  Romanowski G, Lorenz MG, Wackemagel W.  1993. Plasmid DNA in a 
groundwater aquifer microcosm— adsorption, DNAase resistance and natural 
genetic transformation of Bacillus subtilis. Mol Ecol. 2(3): 171-81.
171252.  Ross JI, Eady EA, Cove JH, Cunliffe WJ.  1998.  16S rRNA mutation 
associated with tetracycline resistance in a Gram-positive bacterium. Antimicrob 
Agents Chemother. 42(7): 1702-5.
253.  Rudy CK, Scott JR.  1994. Length of the coupling sequence of Tn916. J 
Bacteriol.  176(11):3386-8.
254.  Salyers AA, Amabile-Cuevas CF.  1997. Why are antibiotic resistance genes 
so resistant to elimination? Antimicrob Agents Chemother. 41(11):2321-5.
255.  Salyers AA, Shoemaker NB, Stevens AM, Li LY.  1995. Conjugative 
transposons: an unusual and diverse set of integrated gene transfer elements. 
Microbiol Rev. 59(4):579-590.
256.  Sambrook J, Fritsch EF, Maniatis T.  1989. Molecular cloning. A laboratory 
manual, second edition. Cold Spring Harbour Laboratory Press. USA.
257.  Sanchez L, Pan W, Vinas M, Nikaido H.  1997. The acrAB homolog of 
Haemophilus influenzae codes for a functional multidrug efflux pump. J 
Bacteriol.  1997 Nov; 179(21):6855-7.
258.  Sanger F, Coulson AR, Hong GF, Hill DF, Petersen GB. 1982. Nucleotide 
sequence of bacteriophage lambda DNA. J Mol Biol.  162(4):729-73.
259.  Santagati M, Iannelli F, Cascone C, Campanile F, Oggioni MR, Stefani S, 
Pozzi G. 2003. The novel conjugative transposon Tn7207.3 carries the 
macrolides efflux gene mej{A) in Streptococcus pyogenes.
260.  Santagati M, Iannelli F, Oggioni MR, Stefani S, Pozzi G. 2000. 
Characterization of a genetic element carrying the macrolide efflux gene mef{A) 
in Streptococcus pneumoniae. Antimicrob Agents Chemother. 44(9):2585-7.
261.  Schaaff F, Reipert A, Bierbaum G. 2002. An elevated mutation frequency 
favors development of vancomycin resistance in Staphylococcus aureus. 
Antimicrob Agents Chemother. 46(11):3540-3548.
172262.  Schalen C, Gebreselassie D, Stahl S. 1995. Characterization of an 
erythromycin resistance (erm) plasmid in Streptococcus pyogenes. APMIS. 
103(l):59-68.
263.  Schnabel EL, Jones AL.  1999. Distribution of tetracycline resistance genes 
and transposons among phylloplane bacteria in Michigan apple orchards. Appl 
Environ Microbiol. 65(11):4898-907.
264.  Scott KP, Melville CM, Barbosa TM, Flint W. 2000. Occurrence of the new 
tetracycline resistance gene tet(W) in bacteria from the human gut. Antimicrob 
Agents Chemoter. 44:775-777.
265.  Seppala H, Haanpera M, Al-Juhaish M, Jarvinen H, Jalava J, Huovinen P.
2003.  Antimicrobial susceptibility patterns and macrolide resistance genes of 
viridans group streptococci from normal flora. J Antimicrob Chemother. 
52(4):636-44.
266.  Seppala H, Klaukka T, Lehtonen R, Nenonen E, the Finnish Dtudy Group for 
Antimicrobial Resistance, and Huovinen P.  1995. Outpatient use of 
erythromycin: link to increased erythromycin resistance in group A streptococci. 
Clin Inf Dis. 21:1378-1385.
267.  Serai C, Castillo FJ, Rubio-Calvo MC, Fenoll A, Garcia C, Gomez-Lus R.
2001.  Distribution of resistance genes tet(M), aph3'-III, catpC194 and the 
integrase gene of Tn1545 in clinical Streptococcus pneumoniae harbouring 
erm{B) and mef{A) genes in Spain. J Antimicrob Chemother. 47:863-866.
268.  Shinzato T, Saito A.  1995. The Streptococcus milleri group as a cause of 
pulmonary infections. Clin Infect Dis. 21 (Suppl 3):S238-243.
269.  Shoemaker NB, Vlamakis H, Hayes K, Salyers AA. 2001. Evidence for 
extensive resistance gene transfer among Bacteroides spp and among 
Bacteroides and other genera in the human colon. Appl Environ Microbiol. 
67(2):561-568.
173270.  Sidhu MS, Heir E, Sorum H, Hoick A. 2001. Genetic linkage between 
resistance to quaternary ammonium compounds and beta-lactam antibiotics in 
food-related Staphylococcus spp. Microb Drug Resist. 7(4):363-71.
271.  Smith M, Marsh P, Wilson M. 1990. p-Lactamase-producing bacteria in the 
dental plaque of children.  1990. J Paed Dent. 6:15-21.
272.  Solomon JM, Grossman AD.  1996. Who’s competent and when: regulation of 
natural genetic competence in bacteria. Trends Genet.  12:  150-155.
273.  Sougakoff W, Papadopoulou B, Nordmann P, Courvalin P. 1987. Nucleotide 
sequence and distribution of gene tet(O) encoding tetracycline resistance in 
Campylobacter coli. FEMS Microbiol Lett. 44:153-159.
274.  Speer BS, Shoemaker NB, Salyers AA.  1992. Bacterial resistance to 
tetracycline: mechanism, transfer, and clinical significance. Clin Microbiol Rev. 
5(4):37-399.
275.  Speer BS, Bedzyk L, Salyers AA.  1991. Evidence that a novel tetracycline 
resistance gene found on two bacteroides transposons encodes an NADP- 
requiring oxidoreductase. J Bacteriol.  173(1): 176-83.
276.  Spratt BG.  1994. Resistance to antibiotics mediated by target alterations. 
Science.  1994 Apr 15;264(5157):388-93.
277.  Srinivasan A, Dick JD, Perl TM. 2002. Vancomycin resistance in 
staphylococci. Clinic Microb Rev.  15(3):430-438.
278.  Stanton TB, McDowall JS, Rasmussen MA. 2004. Diverse tetracycline 
resistance genotypes of Megasphaera elsdenii strains selectively cultured from 
swine feces. Appl Environ Microbiol. 70(6):3754-7.
279.  Stanton TB, Humphrey SB. 2003. Isolation of tetracycline-resistant 
Megasphaera elsdenii strains with novel mosaic gene combinations of tet{O) and 
tet(W) from swine. Appl Environ Microbiol. 69(7):3874-82.
174280.  Stevens AM, Shoemaker NB, Li LY, Salyers AA.  1993. Tetracycline 
regulation of genes on Bacteroides conjugative transposons. J Bacteriol.
175(19):6134-41.
281.  Stobberingh E, van den Bogaard A, London N, Driessen C, Top J, Willems 
R.  1999. Enterococci with glycopeptide resistance in turkeys, turkey farmers, 
turkey slaughterers, and (sub)urban residents in the south of The Netherlands: 
evidence for transmission of vancomycin resistance from animals to humans? 
Antimicrob Agents Chemother. 43(9):2215-21.
282.  Su YA, He P, Clewell DB.  1992. Characterization of the tet(M) determinant 
of Tn9J6: evidence for regulation by transcription attenuation. Antimicrob. 
Agents Chemother. 36:769-778.
283.  Summers AO, Wireman J, Vimy MJ, Lorscheider FL, Marshall B, Levy SB, 
Bennett S, Billard L.  1993. Mercury released from dental "silver" fillings 
provokes an increase in mercury- and antibiotic-resistant bacteria in oral and 
intestinal floras of primates. Antimicrob Agents Chemother.  1993 
Apr;37(4):825-34.
284.  Sutcliffe J, Grebe T, Tait-Kamradt A, Wondrack L.  1996. Detection of 
erythromycin-resistant determinants by PCR. Antimicrob Agents Chemother. 
40:2562-2566.
285.  Sutcliffe J, Tait-Kamradt A, Wondrack L.  1996. Streptococcus pneumoniae 
and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: 
a common resistance pattern mediated by an efflux system. Antimicrob Agents 
Chemother. 40:1817-1824.
286.  Svartz N.  1965. Nobel Lectures, Physiology or Medicine 1922-1941, Elsevier 
Publishing Company, Amsterdam, The Nobel Prize in Physiology or Medicine 
1939. Presentation Speech by Professor N. Svartz, member of the Staff of 
Professors of the Royal Caroline Institute.
287.  Swann Committee, her Majesty’s Stationary Office, London, September 
1969. Report of Joint Committee on the use of antibiotics in animal husbandry 
and veterinary medicine.
175288.  Swartz MN. 2002. Human diseases caused by foodbome pathogens of animal 
origin. Clin Infect Dis. 34 Suppl 3:S111-22.
289.  Tait-Kamradt A, Davies T, Cronan M, Jacobs MR, Appelbaum PC, Sutcliffe 
J. 2000. Mutation in 23S rRNA and ribosomal protein L4 account for resistance 
in pneumococcal strains selected in vitro by macrolide passage. Antimicrob 
Agents Chemother. 44:2118-2125.
290.  Tan SY. 2003. Antoni van Leeuwenhoek (1632-1723): Father of microscopy. 
Singapore Med J. 44:557-558.
291.  Tauch A, Gotker S, Puhler A, Kalinowski J, Thierbach G. 2002. The 27.8-kb 
R-plasmid pTET3 from Corynebacterium glutamicum encodes the 
aminoglycoside adenyltransferase gene cassette aadA9 and the regulated 
tetracycline efflux system Tet 33 flanked by active copies of the widespread 
insertion sequence \S6100. Plasmid. 48(2): 117-29.
292.  Tabaqchali S.  1998. Anaerobic infections in the head and neck region. Scand 
J Infect Dis. 57: 24-34.
293.  Teng LJ, Hsueh PR, Ho SW, Luh KT. 2001. High prevalence of inducible 
erythromycin resistance among Streptococcus bovis isolates in Taiwan. 
Antimicrob Agents Chemother. 45(12):3362-5.
294.  Teng LJ, Hsueh PR, Chen YC, Ho SW, Luh KT.  1998. Antimicrobial 
susceptibility of viridans group streptococci in Taiwan with an emphasis on the 
high rates of resistance to penicillin and macrolides in Streptococcus oralis. J. 
Antimicrob. Chemother. 41:621-627.
295.  Tenover FC, Weigel LM, Appelbaum PC, McDougal LK, Chaitram J, 
McAllister S, Clark N, Killgore G, O'Hara CM, Jevitt L, Patel JB, Bozdogan B. 
2004. Vancomycin-resistant Staphylococcus aureus isolate from a patient in 
Pennsylvania. Antimicrob Agents Chemother. 48(l):275-80.
296.  Tenover FC, McGowan JE Jr.  1996. Reasons for the emergence of antibiotic 
resistance. Am J Med Sci. 311(1 ):9-l6.
176297.  Thomsberry C, Ogilvie P, Kahn J, Mauriz Y.  1997. Surveillance of 
antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae,
.  and Moraxella catarrhalis in the United States in 1996-1997 respiratory season. 
The Laboratory Investigator Group. Diagn Microbiol Infect Dis. 29(4):249-57.
298.  Threlfall EJ, Fisher IS, Berghold C, Gemer-Smidt P, Tschape H, Cormican 
M, Luzzi I, Schnieder F, Wannet W, Machado J, Edwards G. 2003. Trends in 
antimicrobial drug resistance in Salmonella enterica serotypes Typhi and 
Paratyphi A isolated in Europe,  1999-2001. Int J Antimicrob Agents. 22(5):487- 
91.
299.  Threlfall EJ, Frost JA, Rowe B.  1999. Fluoroquinolone resistance in 
salmonellas and Campylobacters from humans. BMJ. 318(7188):943-4.
300.  Toussaint A, Merlin C. 2002. Mobile elements as a combination of functional 
modules. Plasmid 47:26-35.
301.  Udo EE, Grubb WB.  1996. A phage-mediated transfer of chromosomally 
integrated tetracycline resistance plasmid in Staphylococcus aureus. Curr 
Microbiol. 32(5):286-90.
302.  Van Bambeke F, Balzi E, Tulkens PM. 2000. Antibiotic efflux pumps. 
Biochem Pharmacol. 60(4):457-70.
303.  Van de Beek D, Hensen EF, Spanjaard L, de Gans J, Enting RH, Dankert J.
1997.  Meropenem susceptibility of Neisseria meningitidis and Streptococcus 
pneumoniae from meningitis patients in The Netherlands. J Antimicrob 
Chemother. 40:895-897.
304.  Van den Bogaard AE, London N, Driessen C, Stobberingh EE. 2001. 
Antibiotic resistance of faecal Escherichia coli in poultry, poultry farmers and 
poultry slaughterers. J Antimicrob Chemother. 47(6):763-71.
305.  Van den Bogaard AE, Stobberingh EE. 2000. Epidemiology of resistance to 
antibiotics. Links between animals and humans. Int J Antimicrob Agents. 
14(4):327-35.
177306.  Van den Braak N, van Belkum A, van Keulen M, Vliegenthart J, Verbrugh 
HA, Endtz HP.  1998. Molecular characterization of vancomycin-resistant
,  enterococci from hospitalized patients and poultry products in The Netherlands. J 
Clin Microbiol. 36(7): 1927-32.
307.  Van W inkelhoff AJ, Herrera Gonzales D, Winkel EG, Dellemijn-Kippuw N, 
Vandenbroucke-Grauls CM, Sanz M. 2000. Antimicrobial resistance in the 
subgingival microflora in patients with adult periodontitis. A comparison 
between The Netherlands and Spain. J Clin Periodontol. 27(2):79-86.
308.  Vester B, Douthwaite S. 2001. Macrolide resistance conferred by base 
substitutions in 23S rRNA. Antimicrob Agents Chemother. 45(1): 1-12.
309.  Vidaver AK. 2002. Uses of antimicrobials in plant agriculture. Clin Infect 
Dis. 34 Suppl 3:S107-10.
310.  Wade W. 2002. Unculturable bacteria -  the uncharacterized organisms that 
cause oral infections. J R Soc Med. 95:81-83.
311.  Walker CB. 2000. The acquisition of antibiotic resistance in the periodontal 
microflora. Periodontol. 10:79-88.
312.  Walters MC, Roe F, Bugnicourt A, Franklin MJ, Stewart PS. 2003. 
Contributions of antibiotic penetration, oxygen limitation, and low metabolic 
activity to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and 
tobramycin. Antimicrob Agents Chemother. 47(1 ):317-23.
313.  Wang A, Macrina FL.  1995. Streptococcal plasmid pIP501  has a functional 
oriT site. J Bacteriol.  177( 15):4199-206.
314.  Wang BY, Chi B, Kuramitsu HK. 2002. Genetic exchange between 
Treponema denticola and Streptococcus gordonii in biofilms. Oral Microbiol 
Immunol.  17(2): 108-12.
315.  Wang Y, Taylor DE.  1991. A DNA sequence upstream of the tet( O) gene is 
required for full expression of tetracycline resistance. Antimicrob. Agents 
Chemother. 35:2020-2025.
178316.  Wassenaar TM. http://www.bacteriamuseum.org/aboutus.shtml.
317.  Weber P, Filipecki J, Bingen E, Fitoussi F, Goldfarb G, Chauvin JP, Reitz C, 
Portier H. 2001. Genetic and phenotypic characterization of macrolide resistance 
in group A streptococci isolated from adults with pharyngo-tonsillitis in France.
J Antimicrob Chemother. 48(2):291-4.
318.  Wegener HC, Aarestrup FM, Jensen LB, Hammerum AM, Bager F.  1999. 
Use of antimicrobial growth promoters in food animals and Enterococcus 
faecium resistance to therapeutic antimicrobial drugs in Europe. Em Inf Dis. 
5(3):329-335.
319.  Weisblum B.  1995. Erythromycin resistance by ribosome modification. 
Antimicrob Agents Chemother. 39:577-585.
320.  Werner G, Klare I, Witte W.  1997. Arrangement of the vanA gene cluster in 
enterococci of different ecological origin. FEMS Microbiol Lett.  155(1 ):55-61.
321.  Whittaker CJ, Klier CM, Kolenbrander PE.  1996. Mechanisms of adhesion 
by oral bacteria. Annu Rev Microbiol.50:513-52.
322.  Whittle G, Whitehead TR, Hamburger N, Shoemaker NB, Cotta MA, Salyers 
A A. 2003. Identification of a new ribosomal protection type of tetracycline 
resistance gene, tet(36), from swine manure pits. Appl Environ Microbiol. 
69(7):4151-8.
323.  Whittle G, Shoemaker NB, Salyers AA. 2002. The role of Bacteroides 
conjugative transposons in the dissemination of antibiotic resistance genes. Cell 
Mol Life Sci. 59(12):2044-54.
324.  Whittle G, Hund BD, Shoemaker NB, Salyers AA. 2001. Characterization of 
the  13-kilobase ermF region of the Bacteroides conjugative transposon 
CTnDOT. Appl Environ Microbiol. 67(8):3488-95.
325.  WHO Overcoming Antimicrobial Resistance. World Health Report on 
Infectious Diseases 2000 Dr Gro Harlem Brundtland Director-General, WHO.
179326.  Wilson M. 2005. Microbial inhabitants of humans; their ecology and role in 
health and disease. Cambridge University Press.
•327.  Wilson M, Harding SD, Dickinson C, Howlett JA, Hobkirk JA.  1990.
Cultivable microflora of denture plaque from patients with healthy oral mucosa. 
Med Sci Res.  18:159-160.
328.  Wise R, Hart T, Cars O, Streulens M, Helmuth R, Huovinen P, Sprenger M.
1998.  Antimicrobial resistance is a major threat to public health. BMJ.
317(7159):609-10.
329.  Witte W.  1994. Medical consequence of antibiotic use in agriculture. Science 
279:996-997.
330.  Wondrack L, Massa M, Yang BV, Sutcliffe J.  1996. Clinical strain of 
Staphylococcus aureus inactivates and causes efflux of macrolides. Antimicrob 
Agents Chemother. 40(4):992-8.
331.  Woodford N, Warner M, Aucken HM. 2000. Vancomycin resistance among 
epidemic strains of methicillin-resistant Staphylococcus aureus in England and 
Wales. J Antimicrob Chemother. 45(2):258-9.
332.  Woodford N, Johnson AP, Morrison D, Speller DCE.  1995. Current 
perspectives on glycopeptide resistance. Clin Microbial Rev. 8(4):585-615.
333.  Yan JJ, Wu HM, Huang AH, Fu HM, Lee CT, Wu JJ. 2000. Prevalence of 
polyclonal mefA-containing isolates among erythromycin-resistant group A 
streptococci in southern Taiwan. J Clin Microbiol. 38:2475-2479.
334.  Zarantonelli L, Borthagaray G, Lee EH, Shafer WM.  1999. Decreased 
azithromycin susceptibility of Neisseria gonorrhoeae due to mtrR mutations. 
Antimicrob Agents Chemother. 43(10):2468-72.
335.  Zhanel GG. 43rd Annual ICAAC, Chicago, Symposium. Macrolides: is there 
a difference? (A microbiologist/pharmacologist perspective).
336.  Zhao S, Qaiyumi S, Friedman S, Singh R, Foley SL, White DG, McDermott 
PF, Donkar T, Bolin C, Munro S, Baron EJ, Walker RD. 2003. Characterization
180of Salmonella enterica serotype newport isolated from humans and food animals. 
J Clin Microbiol. 41 (12):5366-71.
.337.  Zheng Z, Stewart PS. 2002. Penetration of rifampin through Staphylococcus 
epidermidis biofilms. Antimicrob Agents Chemother. 46(3):900-3.
338.  Ziha-Zarifi I, Llanes C, Kohler T, Pechere JC, Plesiat P.  1999. In vivo 
emergence of multidrug-resistant mutants of Pseudomonas aeruginosa 
overexpressing the active efflux system MexA-MexB-OprM. Antimicrob Agents 
Chemother. 43(2):287-91.
339.  Zilhao R, Papadopoulou B, Courvalin P.  1988. Occurrence of the 
Campylobacter resistance gene tet{O) in Enterococcus and Streptococcus spp. 
Antimicrob Agents Chemother. 32(12): 1793-6.
340.  Zolezzi P, Laplana LM, Calvo CR, Cepero PG, Erazo MC, Gomez-Lus R.
2004.  Molecular basis of resistance to macrolides and other antibiotics in 
commensal viridans group streptococci and Gemella spp. and transfer of 
resistance genes to Streptococcus pneumoniae. Antimicrob Agents Chemother. 
48(9):3462-7.
181Appendix  1: Bacterial strains and plasmids used in this study
Strains and plasmids Relevant characteristics/source Ref
Strains
B. subtilis BS34A B. subtilis CU2189::Tn9/6a 241
S. pyogenes AC 1 erm(B), plasmid pAC 1 284
S. pyogenes 02C1064 mefi  A) 284
S. aureus RN1389 erm{A), Tn554 in the chromosome 284
S. aureus RN4220 erm(C), plasmid pE194 284
S. aureus RN4220 msrA, plasmid pATIO 284
E. coli BM694 (pAT63) ere  A, pBR322 plasmid with cloned insert 284
E. coli BM694 (pAT72) ereB, pUC8 plasmid with cloned insert 284
E. coli L441D mphA 284
E.  coli V831 erm(F), pVA831  (pBF4) in pBR325 vector 48
E.  coli pSL18 tet(A) 195
E.  coli pRTl 1 tet( B) 195
E.  coli pBR322 tet(C) 195
E.  coli pSL106 tet(D) 195
E.  coli pSL1504 tet{ E) 195
E.  coli pVB.A15 tet( L) 195
E.  coli pAT451 tet( S) 195
E.  coli pNFD13-2 tet(Q) 195
Plasmids
pAM120 pGLlOl  carrying EcoRl  F’(F::Tn9/6) of pADl 96
pPPM70 pUC18 containing IntronAkan 242
pGEM-tetW pGEM carrying a 2.4-kb PCR product with the 7
pGEM-tetO
tet(W) gene from B.fibrisolvens 
pGEM carrying the tet(O) gene from B. 7
pAT451
fibrisolvens
pUC18 carrying a 4.5-kb Cla\ fragment of 7
pAT102
pIP811   with the tet(S) gene 
tet( K) 195
182d This strain originally contained one copy of Tn916 but during the study was shown 
to contain two copies of Tn916
183Appendix 2: Recipes
Buffers, broths, Composition (per litre)
agar
‘  LB (Luria- 1.5% Tryptoneb
Bertani) medium 0.5 % Yeast extractb
and plates 1.0% NaCla
(5.0% Technical Agar 3)b
SOC medium 2% Tryptone b 
0.5% Yeast Extractb 
0.05% NaCla 
2.5 mM KC1a 
10 mM MgCi2a
50 x ETA 2M Tris base3 
57.1  ml Acetic acid3  
0.05 M EDTA 3
add distilled H20  to 1   litre and adjust pH to 8.5 0
Hybridization
solutions
Depurination 250 mM HC13
Denaturation 1.5 M NaCl3 
0.5 M N aO H 3
Neutralization 1.5 M NaCl3 
0.5 M TrisH Cl3 
pH adjusted to 7.5c
SSC x 20 0.3 M Na3 citrate 3 
3.0 M NaCl3 
pH 7.0c
Primary wash 0.4% SDS3
buffer 0.5 x SSC
.  .
184Urea
a from Sigma 
b from Oxoid
c the pH meter used was from Orion model 520A
185Appendix 3: List of the primer sequences used throughout this study
Primer name Primer sequences Size of 
PCR 
products 
in bp
Ref
16S rRNA gene
27F
357F
1492R
5 ’ -  AG  AGTTTG  ATCMTGGCTC  AG-3 ’
5 ’ -CTCCTACGGG  AGGC AGC  AG-3 ’
5 ’-TACGG YTACCTTGTTACGACTT-3 ’
1465
1135
145
M13F
M13R
5 ’ -CCC AGTC ACG  ACGTTGTAAAACG-3 ’ 
5 ’ - AGCGG  AT  A  AC A  ATTTC AC AC AGG-3 ’
tet( M) 5’-GTG GAC AAA GGT AC  A ACG AG-3’ 
5’-CGG TAA AGT TCG TCA CAC AC-3’
406 195
tet( O) 5’-AAC TTA GGC ATT CTG GCT CAC-3’ 
5’-TCC CAC TGT TCC ATA TCG TCA-3’
515 195
tet( S) 5’-CAT AG A CAA GCC GTT GAC C-3’ 
5’-ATG TTT TTG GAA CGC CAG AG-3’
667 195
tet{ W) 5 ’ -G  AG AGCCTGCTAT  ATGCC  AGC-3 ’ 
5 ’ -GGGCGT  ATCC AC A  ATGTTA  AC-3 ’
168 7
tet(K) 5’-TCG ATA GGA AC A GCA GTA-3’ 
5’-CAG CAG ATC CTA CTC CTT-3’
169 195
tet( L) 5’-TCG TTA GCG TGC TGT CAT TC-3’ 
5’-GTA TCC CAC CAA TGT AGC CG-3’
267 195
tet(A) 5’-GCT ACA TCC TGC TTG CCT TC-3’ 
5’-CAT AGA TCG CCG TGA AGA GG-3’
210 195
186tet( B) 5’-TTG GTT AGG GGC AAG TTT TG-3’ 
5’-GTA ATG GGC CAA TAA CAC CG-3’
659 195
'tet{ C) 5’-CTT GAG AGC CTT CAA CCC AG-3’ 
5’ -ATG GTC GTC ATC TAC CTG CC-3’
418 195
tet( E) 5’-AAA CCA CAT CCT CCA TAC GC-3’ 
5’-AAA TAG GCC ACA ACC GTC AG-3’
278 195
te/(T) 5 ’ -  A  AGGTTT  ATT  AT  ATAAAAGTG-3 ’ 
5 ’ -  AGGTGTATCTATG  ATATTT  AC-3 ’
169 7
int/xis 5 ’ -CGCC A AAGGATCCTGTATATG-3 ’
5 ’ -GCTGT  AGGTTTT  AT  C AGCTTTT  GC-3 ’
-900 242
ermA 5’-ACGATATTCACGGTTTACCCACTTA-3’ 
5 ’ -  A  ACC AG AA  AAACCCT  AAAG  AC ACG-3 ’
610 193
ermB 5 ’ -T  A  ACG  ACG  A  A  ACTGGCT  A  A  A  AT-3 ’ 
5 ’ - ATCTGTGGT  ATGGCGGGT  A  AG-3 ’
415 193
ermC 5 ’ - AGT  AC AG  AGGTGT  A  ATTTCG-3 ’ 
5 ’ -  A  ATTCCT  GC AT  GTTTT  A  AGG-3 ’
520 193
mrsA/B 5 ’ -GC A  A  ATGGTGT  AGGTA  AG  AC AACT-3 ’ 
5 ’ - ATC ATGTG ATGT  A  A  AC AA  A  AT-3 ’
399 193
ermF 5’- CGGGTCAGCACTTTACTATTG-3’ 
5 ’ -GG  ACCT  ACCTCT  ATG  AC A  AG-3 ’
466 48
ereA 5 ’ AAC ACCCTG  A  ACCC A  AGGG  ACG-3 ’ 
5’ CTTCACATCCGGATTCGCTCGA-3 ’
420 284
ereB 5 ’ - AG  A  A  ATGG  AGGTTC  AT  ACTT  ACC A-3 ’ 
5 ’ -C ATATAATC ATC ACC  AATGGC A-3 ’
546 284
mphA 5 ’ -  A  ACTGTACGC  ACTTGC-3 ’ 837 284
1875 ’ -GGTACTCTTCGTT  ACC-3 ’
m ef 5 ’ - AGTATC  ATT  A  ATC ACT  AGT  GC-3 ’ 
5 ’ -TTCTTCTGGT  ACT  A  A  A  AGTGG-3 ’
390 284
Bf
Br
A f
5’- TT  GGGGCT  GT  A  A  AGGG  AGG  AC- 3’
5’- CATCGGTGCTCCATAAC- 3
5’- GGT  ACTT  GCTTT  C CT  A  A  AACTG- 3’
1900
2200
30
Setl 5 ’ -CTGTGCC  ACTGG  A  AGG  AAGT-3 ’ 
5 ’ -CGGTAGCGAT  ACCCGTTG-3 ’
806 this
study
Set2 5 ’ -C AGTGGGGTC  AAC A  AGATCC-3 ’ 
5 ’ - AGTGGGGGTTCCTCCTGTT-3 ’
1078 this
study
Set3 5 ’ -CGCTAATCTC ATGTCCGTC  A-3 ’
5 ’ -G A  A  ATGGCGTGC AGAAA  A  AC-3 ’
1498 this
study
Set4 5 ’ -TCTGTTCTGCTGTGCC  ATTC-3 ’
5 ’ -GCT  ATTGA  ATCTGCCCGGT  A-3 ’
1250 this
study
Set5 5 ’ -C AACG  AGTATGC  AGGTCG  ATT-3 ’ 
5 ’-GCTCCAGCATCCTCTGGAC-3 ’
2161 this
study
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